bcr_patient_uuid,pharmaceutical_therapy_drug_name,pharmaceutical_therapy_type,treatment_outcome_at_tcga_followup,vital_status_x,tumor_status_x,followup_reason,treatment_outcome_first_course_x,death_days_to_x,gender,age_at_initial_pathologic_diagnosis,icd_10,tumor_tissue_site,death_days_to_x
30a1fe5e-5b12-472c-aa86-c2db8167ab23,CRA,Chemotherapy,,Dead,WITH TUMOR,,,358,FEMALE,44,C71.9,Brain,358
30a1fe5e-5b12-472c-aa86-c2db8167ab23,Celebrex,Chemotherapy,,Dead,WITH TUMOR,,,358,FEMALE,44,C71.9,Brain,358
30a1fe5e-5b12-472c-aa86-c2db8167ab23,Cis Retinoic Acid,Chemotherapy,,Dead,WITH TUMOR,,,358,FEMALE,44,C71.9,Brain,358
30a1fe5e-5b12-472c-aa86-c2db8167ab23,Celebrex,Chemotherapy,,Dead,WITH TUMOR,,,358,FEMALE,44,C71.9,Brain,358
df3c1d61-79c1-43e9-971a-8029497ffeab,Tamoxifen,Chemotherapy,,Dead,WITH TUMOR,,,144,MALE,50,C71.9,Brain,144
3ac8f759-2df0-4ef5-913f-ce05b8dd8937,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,345,MALE,59,C71.9,Brain,345
3ac8f759-2df0-4ef5-913f-ce05b8dd8937,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,345,MALE,59,C71.9,Brain,345
98714d95-b62e-4f34-9cd1-91542da463eb,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,558,FEMALE,56,C71.9,Brain,558
98714d95-b62e-4f34-9cd1-91542da463eb,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,558,FEMALE,56,C71.9,Brain,558
98714d95-b62e-4f34-9cd1-91542da463eb,CIS Retinoic Acid,Chemotherapy,,Dead,WITH TUMOR,,,558,FEMALE,56,C71.9,Brain,558
fb75eb9d-05be-4e6b-a515-f39efb15e66c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,705,FEMALE,40,C71.9,Brain,705
fb75eb9d-05be-4e6b-a515-f39efb15e66c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,705,FEMALE,40,C71.9,Brain,705
45a58ede-e7a4-424d-851e-e6a4062e46e4,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1077,FEMALE,20,C71.9,Brain,1077
45a58ede-e7a4-424d-851e-e6a4062e46e4,Thalidomide,Chemotherapy,,Dead,WITH TUMOR,,,1077,FEMALE,20,C71.9,Brain,1077
45a58ede-e7a4-424d-851e-e6a4062e46e4,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,1077,FEMALE,20,C71.9,Brain,1077
33ae5566-3c72-4cae-b516-1708db090e32,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,630,FEMALE,18,C71.9,Brain,630
33ae5566-3c72-4cae-b516-1708db090e32,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,630,FEMALE,18,C71.9,Brain,630
33ae5566-3c72-4cae-b516-1708db090e32,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,,,630,FEMALE,18,C71.9,Brain,630
33ae5566-3c72-4cae-b516-1708db090e32,Iressa,Chemotherapy,,Dead,WITH TUMOR,,,630,FEMALE,18,C71.9,Brain,630
83264f30-94be-4573-b519-fb0b0fce36c3,Anti necplatens,Chemotherapy,,Dead,WITH TUMOR,,,2512,MALE,25,C71.9,Brain,2512
83264f30-94be-4573-b519-fb0b0fce36c3,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,2512,MALE,25,C71.9,Brain,2512
697afd24-9632-4244-a455-f95b1fa4f0bf,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,627,MALE,50,C71.9,Brain,627
697afd24-9632-4244-a455-f95b1fa4f0bf,AE 788,Chemotherapy,,Dead,WITH TUMOR,,,627,MALE,50,C71.9,Brain,627
adc0c9c3-002a-4fab-b148-e162020ad051,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,50,C71.9,Brain,
adc0c9c3-002a-4fab-b148-e162020ad051,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,2648,MALE,50,C71.9,Brain,2648
d85fa9be-f7fb-407b-af46-31f495b210d6,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,2362,FEMALE,43,C71.9,Brain,2362
d85fa9be-f7fb-407b-af46-31f495b210d6,Celebrex,Chemotherapy,,Dead,WITH TUMOR,,,2362,FEMALE,43,C71.9,Brain,2362
d85fa9be-f7fb-407b-af46-31f495b210d6,6 Thiguanine,Chemotherapy,,Dead,WITH TUMOR,,,2362,FEMALE,43,C71.9,Brain,2362
d85fa9be-f7fb-407b-af46-31f495b210d6,Xeloda,Chemotherapy,,Dead,WITH TUMOR,,,2362,FEMALE,43,C71.9,Brain,2362
d85fa9be-f7fb-407b-af46-31f495b210d6,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,2362,FEMALE,43,C71.9,Brain,2362
c45e9e8b-35ab-4477-acdc-b18be0b3497d,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,612,FEMALE,38,C71.9,Brain,612
c45e9e8b-35ab-4477-acdc-b18be0b3497d,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,612,FEMALE,38,C71.9,Brain,612
0553e60e-3510-417d-af8a-75947ebe8ab6,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1615,MALE,35,C71.9,Brain,1615
6630e547-2596-4fb7-a657-c19497ff13b2,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1300,MALE,47,C71.9,Brain,1300
6630e547-2596-4fb7-a657-c19497ff13b2,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1300,MALE,47,C71.9,Brain,1300
6630e547-2596-4fb7-a657-c19497ff13b2,Sarasar,Chemotherapy,,Dead,WITH TUMOR,,,1300,MALE,47,C71.9,Brain,1300
43d89926-2378-4498-bfba-6d6624d951b4,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,748,MALE,27,C71.9,Brain,748
43d89926-2378-4498-bfba-6d6624d951b4,Gleevec,Chemotherapy,,Dead,WITH TUMOR,,,748,MALE,27,C71.9,Brain,748
43d89926-2378-4498-bfba-6d6624d951b4,Hydroxyurea,Chemotherapy,,Dead,WITH TUMOR,,,748,MALE,27,C71.9,Brain,748
a1eca6d7-09ba-418a-a787-77be67e672dd,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,370,FEMALE,33,C71.9,Brain,370
a1eca6d7-09ba-418a-a787-77be67e672dd,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,370,FEMALE,33,C71.9,Brain,370
a1eca6d7-09ba-418a-a787-77be67e672dd,Celebrex,Chemotherapy,,Dead,WITH TUMOR,,,370,FEMALE,33,C71.9,Brain,370
a1eca6d7-09ba-418a-a787-77be67e672dd,Xeloda,Chemotherapy,,Dead,WITH TUMOR,,,370,FEMALE,33,C71.9,Brain,370
a1eca6d7-09ba-418a-a787-77be67e672dd,6 Thiguanine,Chemotherapy,,Dead,WITH TUMOR,,,370,FEMALE,33,C71.9,Brain,370
7ef0564e-d95d-4df5-969b-b204c207daea,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,2755,MALE,39,C71.9,Brain,2755
7ef0564e-d95d-4df5-969b-b204c207daea,Celebrex,Chemotherapy,,Dead,WITH TUMOR,,,2755,MALE,39,C71.9,Brain,2755
7ef0564e-d95d-4df5-969b-b204c207daea,Xeloda,Chemotherapy,,Dead,WITH TUMOR,,,2755,MALE,39,C71.9,Brain,2755
7ef0564e-d95d-4df5-969b-b204c207daea,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,2755,MALE,39,C71.9,Brain,2755
69205453-c504-4684-8d32-57c82efc679d,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,430,MALE,60,C71.9,Brain,430
fcce7f31-a392-4177-8dca-cfbe6e73fc2e,Tanceva,Chemotherapy,,Dead,WITH TUMOR,,,326,FEMALE,48,C71.9,Brain,326
de0cb811-bae0-407e-b8b3-97d1512bfa80,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,557,FEMALE,54,C71.9,Brain,557
de0cb811-bae0-407e-b8b3-97d1512bfa80,Xeloda,Chemotherapy,,Dead,WITH TUMOR,,,557,FEMALE,54,C71.9,Brain,557
de0cb811-bae0-407e-b8b3-97d1512bfa80,6 Thiguanine,Chemotherapy,,Dead,WITH TUMOR,,,557,FEMALE,54,C71.9,Brain,557
de0cb811-bae0-407e-b8b3-97d1512bfa80,Celebrex,Chemotherapy,,Dead,WITH TUMOR,,,557,FEMALE,54,C71.9,Brain,557
de0cb811-bae0-407e-b8b3-97d1512bfa80,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,557,FEMALE,54,C71.9,Brain,557
5a448bf3-8e87-4791-91f2-908307a32ed1,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,383,MALE,49,C71.9,Brain,383
4df7d5e4-f762-4e80-b9d1-96ec21fb43ca,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,199,FEMALE,44,C71.9,Brain,199
4df7d5e4-f762-4e80-b9d1-96ec21fb43ca,Celebrex,Chemotherapy,,Dead,WITH TUMOR,,,199,FEMALE,44,C71.9,Brain,199
4df7d5e4-f762-4e80-b9d1-96ec21fb43ca,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,199,FEMALE,44,C71.9,Brain,199
4df7d5e4-f762-4e80-b9d1-96ec21fb43ca,6 Thiguanine,Chemotherapy,,Dead,WITH TUMOR,,,199,FEMALE,44,C71.9,Brain,199
4df7d5e4-f762-4e80-b9d1-96ec21fb43ca,Xeloda,Chemotherapy,,Dead,WITH TUMOR,,,199,FEMALE,44,C71.9,Brain,199
da5f6940-e8ee-4fd1-a8da-4cd68e02e59c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,76,FEMALE,62,C71.9,Brain,76
da5f6940-e8ee-4fd1-a8da-4cd68e02e59c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,76,FEMALE,62,C71.9,Brain,76
7ee03602-bfec-413d-a05b-609cf60c6481,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,604,FEMALE,66,C71.9,Brain,604
7ee03602-bfec-413d-a05b-609cf60c6481,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,604,FEMALE,66,C71.9,Brain,604
9734478b-05a2-4b5c-b8aa-9e6b0b0db02d,Temozomide,Chemotherapy,,Dead,WITH TUMOR,,,254,FEMALE,28,C71.9,Brain,254
686ac6b5-fdb2-417e-9e32-cbad7214e677,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,183,FEMALE,66,C71.9,Brain,183
686ac6b5-fdb2-417e-9e32-cbad7214e677,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,183,FEMALE,66,C71.9,Brain,183
d0fe540c-8e4b-4d97-8966-5899dea8555e,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,600,MALE,50,C71.9,Brain,600
d0fe540c-8e4b-4d97-8966-5899dea8555e,Bevacizumab,Chemotherapy,,Dead,WITH TUMOR,,,600,MALE,50,C71.9,Brain,600
d0fe540c-8e4b-4d97-8966-5899dea8555e,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,600,MALE,50,C71.9,Brain,600
38771a9a-f8b1-4867-b540-56c7d9f5820a,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,804,MALE,57,C71.9,Brain,804
38771a9a-f8b1-4867-b540-56c7d9f5820a,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,804,MALE,57,C71.9,Brain,804
38771a9a-f8b1-4867-b540-56c7d9f5820a,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,804,MALE,57,C71.9,Brain,804
38771a9a-f8b1-4867-b540-56c7d9f5820a,Bevacizumab,Chemotherapy,,Dead,WITH TUMOR,,,804,MALE,57,C71.9,Brain,804
73b1136f-c4b6-472a-b21d-2c789bd53d26,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,31,C71.9,Brain,
73b1136f-c4b6-472a-b21d-2c789bd53d26,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,31,C71.9,Brain,
863c285c-5b87-42b9-b8b3-1ae832a6ded3,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,70,C71.9,Brain,
281e1a57-9a8c-4fa0-ac5e-e5e1df7ef8e2,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,310,FEMALE,68,C71.9,Brain,310
281e1a57-9a8c-4fa0-ac5e-e5e1df7ef8e2,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,310,FEMALE,68,C71.9,Brain,310
b196f82b-ef3f-4e05-99f7-da5df65e691e,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,634,MALE,63,C71.9,Brain,634
5da36fd2-0cea-41b8-90dc-b94c3c28cbd9,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,2729,MALE,28,C71.9,Brain,2729
5da36fd2-0cea-41b8-90dc-b94c3c28cbd9,CIS Retinoic Acid,Chemotherapy,,Dead,WITH TUMOR,,,2729,MALE,28,C71.9,Brain,2729
b72fab50-aed2-48e7-b6ad-2a5bc7157cfd,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,691,FEMALE,59,C71.9,Brain,691
2deec528-4550-47b2-9a0d-cac7eeb24f3e,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1561,FEMALE,63,C71.9,Brain,1561
8e3fbea7-d22e-40fc-8031-58fe6fe091bb,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,268,FEMALE,45,C71.9,Brain,268
8e3fbea7-d22e-40fc-8031-58fe6fe091bb,6 Thiguanine,Chemotherapy,,Dead,WITH TUMOR,,,268,FEMALE,45,C71.9,Brain,268
8e3fbea7-d22e-40fc-8031-58fe6fe091bb,Celebrex,Chemotherapy,,Dead,WITH TUMOR,,,268,FEMALE,45,C71.9,Brain,268
8e3fbea7-d22e-40fc-8031-58fe6fe091bb,Xeloda,Chemotherapy,,Dead,WITH TUMOR,,,268,FEMALE,45,C71.9,Brain,268
8e3fbea7-d22e-40fc-8031-58fe6fe091bb,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,268,FEMALE,45,C71.9,Brain,268
dfaae397-52c3-4d29-b665-971969e23432,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,516,MALE,52,C71.9,Brain,516
883dc176-925a-44f7-9ec8-e0cce33c2a54,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,106,MALE,46,C71.9,Brain,106
883dc176-925a-44f7-9ec8-e0cce33c2a54,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,106,MALE,46,C71.9,Brain,106
f3e57166-c428-4a44-9396-679e3a2b16a2,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,822,MALE,42,C71.9,Brain,822
f3e57166-c428-4a44-9396-679e3a2b16a2,Procarbizine,Chemotherapy,,Dead,WITH TUMOR,,,822,MALE,42,C71.9,Brain,822
f3e57166-c428-4a44-9396-679e3a2b16a2,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,822,MALE,42,C71.9,Brain,822
db38e6b7-102f-4670-875f-b327790c70e4,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1977,FEMALE,29,C71.9,Brain,1977
db38e6b7-102f-4670-875f-b327790c70e4,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1977,FEMALE,29,C71.9,Brain,1977
d0b7d446-5488-41a2-a22a-c1e00a009482,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,355,MALE,54,C71.9,Brain,355
d0b7d446-5488-41a2-a22a-c1e00a009482,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,355,MALE,54,C71.9,Brain,355
d0b7d446-5488-41a2-a22a-c1e00a009482,IL 13,Chemotherapy,,Dead,WITH TUMOR,,,355,MALE,54,C71.9,Brain,355
372a4cc6-8fc9-4157-9cdc-fe020b176249,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,537,MALE,56,C71.9,Brain,537
09ddf661-25fd-4baa-a1e8-bf90b2bb1d31,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,705,MALE,56,C71.9,Brain,705
b363b624-a5b0-46e4-b671-8813cc12eaf4,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,43,C71.9,Brain,
658c8e31-2c60-40f0-ab25-d0d0168647db,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,3041,FEMALE,37,C71.9,Brain,3041
658c8e31-2c60-40f0-ab25-d0d0168647db,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,3041,FEMALE,37,C71.9,Brain,3041
658c8e31-2c60-40f0-ab25-d0d0168647db,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,3041,FEMALE,37,C71.9,Brain,3041
658c8e31-2c60-40f0-ab25-d0d0168647db,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,,,3041,FEMALE,37,C71.9,Brain,3041
658c8e31-2c60-40f0-ab25-d0d0168647db,Tarceva,Chemotherapy,,Dead,WITH TUMOR,,,3041,FEMALE,37,C71.9,Brain,3041
c9b25b65-ef41-4ffb-8b1c-a9e3a3c5cd8c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,476,MALE,52,C71.9,Brain,476
c9b25b65-ef41-4ffb-8b1c-a9e3a3c5cd8c,Bevacizumab,Chemotherapy,,Dead,WITH TUMOR,,,476,MALE,52,C71.9,Brain,476
e117fe84-f003-40a4-96b5-8e26d0513151,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1489,MALE,51,C71.9,Brain,1489
e117fe84-f003-40a4-96b5-8e26d0513151,Hydoxyurea,Chemotherapy,,Dead,WITH TUMOR,,,1489,MALE,51,C71.9,Brain,1489
e117fe84-f003-40a4-96b5-8e26d0513151,Gleevec,Chemotherapy,,Dead,WITH TUMOR,,,1489,MALE,51,C71.9,Brain,1489
96fa386d-f930-45da-96ba-e7ca3f9de5b2,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,432,MALE,57,C71.9,Brain,432
96fa386d-f930-45da-96ba-e7ca3f9de5b2,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,432,MALE,57,C71.9,Brain,432
96fa386d-f930-45da-96ba-e7ca3f9de5b2,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,432,MALE,57,C71.9,Brain,432
74a70685-d95e-45a5-b8a9-80106c8b1bd7,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,485,MALE,49,C71.9,Brain,485
74a70685-d95e-45a5-b8a9-80106c8b1bd7,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,485,MALE,49,C71.9,Brain,485
74a70685-d95e-45a5-b8a9-80106c8b1bd7,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,485,MALE,49,C71.9,Brain,485
6879e9da-dacf-48b3-8e95-760796f96a1b,anti neopastons,Chemotherapy,,Dead,WITH TUMOR,,,372,MALE,40,C71.9,Brain,372
f49b3e5a-6d40-4018-86ae-8396455d8878,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,323,MALE,61,C71.9,Brain,323
f49b3e5a-6d40-4018-86ae-8396455d8878,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,323,MALE,61,C71.9,Brain,323
f49b3e5a-6d40-4018-86ae-8396455d8878,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,323,MALE,61,C71.9,Brain,323
f49b3e5a-6d40-4018-86ae-8396455d8878,CIS Retinoic Acid,Chemotherapy,,Dead,WITH TUMOR,,,323,MALE,61,C71.9,Brain,323
799bfae2-b189-43bc-a3bc-d425cd4fe556,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,484,FEMALE,51,C71.9,Brain,484
799bfae2-b189-43bc-a3bc-d425cd4fe556,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,484,FEMALE,51,C71.9,Brain,484
799bfae2-b189-43bc-a3bc-d425cd4fe556,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,484,FEMALE,51,C71.9,Brain,484
799bfae2-b189-43bc-a3bc-d425cd4fe556,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,,,484,FEMALE,51,C71.9,Brain,484
799bfae2-b189-43bc-a3bc-d425cd4fe556,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,484,FEMALE,51,C71.9,Brain,484
54b4c27e-aaa6-4a79-b289-0ba251a5460e,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,782,FEMALE,46,C71.9,Brain,782
54b4c27e-aaa6-4a79-b289-0ba251a5460e,procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,782,FEMALE,46,C71.9,Brain,782
54b4c27e-aaa6-4a79-b289-0ba251a5460e,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,782,FEMALE,46,C71.9,Brain,782
19146c75-8f41-44f3-8423-7db4d0d0efe1,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,764,MALE,48,C71.9,Brain,764
19146c75-8f41-44f3-8423-7db4d0d0efe1,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,764,MALE,48,C71.9,Brain,764
19146c75-8f41-44f3-8423-7db4d0d0efe1,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,764,MALE,48,C71.9,Brain,764
1e63e985-fbb7-4e43-93a5-e718d0b4ad09,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1433,MALE,36,C71.9,Brain,1433
502f47db-7d3d-4081-ab15-1c38e7e78652,Cis-retinoic acid,Chemotherapy,,Dead,WITH TUMOR,,,345,MALE,62,C71.9,Brain,345
c4171de5-8dac-44bd-a6eb-174f9451dbb7,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,511,MALE,61,C71.9,Brain,511
c4171de5-8dac-44bd-a6eb-174f9451dbb7,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,511,MALE,61,C71.9,Brain,511
e948d951-9299-4dec-9772-60b4ac3569cb,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,393,MALE,57,C71.9,Brain,393
e948d951-9299-4dec-9772-60b4ac3569cb,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,393,MALE,57,C71.9,Brain,393
a2ac9937-f351-4d78-9261-264bf6c21e0c,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,43,C71.9,Brain,
a2ac9937-f351-4d78-9261-264bf6c21e0c,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,43,C71.9,Brain,
521ea765-1bd1-423d-a75d-091243df37a9,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
521ea765-1bd1-423d-a75d-091243df37a9,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
79a68b32-29a3-47bf-9b2b-643ec7323d73,Accutane,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,64,C71.9,Brain,
79a68b32-29a3-47bf-9b2b-643ec7323d73,Accutane,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,618,MALE,64,C71.9,Brain,618
79a68b32-29a3-47bf-9b2b-643ec7323d73,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,64,C71.9,Brain,
79a68b32-29a3-47bf-9b2b-643ec7323d73,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,618,MALE,64,C71.9,Brain,618
79a68b32-29a3-47bf-9b2b-643ec7323d73,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,64,C71.9,Brain,
79a68b32-29a3-47bf-9b2b-643ec7323d73,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,618,MALE,64,C71.9,Brain,618
2cb9975f-2d1e-4c74-867f-8b151c22b246,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,82,FEMALE,81,C71.9,Brain,82
c2651206-36c5-4f3c-a0d6-3ffc07b27a93,temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,620,MALE,67,C71.9,Brain,620
8da3103e-3e6c-4176-a583-d5fe5e60601e,Thalidomide,Chemotherapy,,Dead,WITH TUMOR,,,1448,FEMALE,63,C71.9,Brain,1448
8da3103e-3e6c-4176-a583-d5fe5e60601e,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1448,FEMALE,63,C71.9,Brain,1448
8da3103e-3e6c-4176-a583-d5fe5e60601e,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,1448,FEMALE,63,C71.9,Brain,1448
f66d92ff-85ad-4c83-b127-ce34c8488040,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,121,MALE,67,C71.9,Brain,121
31e6e6c8-9197-4927-bfe4-8f6836f963da,Suramin,Chemotherapy,,Dead,WITH TUMOR,,,691,MALE,66,C71.9,Brain,691
31e6e6c8-9197-4927-bfe4-8f6836f963da,Tamoxifen,Hormone Therapy,,Dead,WITH TUMOR,,,691,MALE,66,C71.9,Brain,691
31e6e6c8-9197-4927-bfe4-8f6836f963da,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,691,MALE,66,C71.9,Brain,691
31e6e6c8-9197-4927-bfe4-8f6836f963da,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,691,MALE,66,C71.9,Brain,691
31e6e6c8-9197-4927-bfe4-8f6836f963da,MGI 114,Chemotherapy,,Dead,WITH TUMOR,,,691,MALE,66,C71.9,Brain,691
bde84ea9-55c9-4d6d-be86-58fd9222c1d6,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1024,MALE,30,C71.9,Brain,1024
bde84ea9-55c9-4d6d-be86-58fd9222c1d6,IL-13PE,Immunotherapy,,Dead,WITH TUMOR,,,1024,MALE,30,C71.9,Brain,1024
7cada85b-00b1-41e5-9924-e09eb077ad56,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,394,MALE,54,C71.9,Brain,394
0133e584-111e-450a-b451-77a2799ef529,EMD,Chemotherapy,,Dead,WITH TUMOR,,,435,MALE,64,C71.9,Brain,435
0133e584-111e-450a-b451-77a2799ef529,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,435,MALE,64,C71.9,Brain,435
0133e584-111e-450a-b451-77a2799ef529,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,435,MALE,64,C71.9,Brain,435
0133e584-111e-450a-b451-77a2799ef529,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,435,MALE,64,C71.9,Brain,435
d0de6676-6ba1-4d79-a9b0-ec3f1e8a8775,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,812,FEMALE,63,C71.9,Brain,812
5bbeb8a7-3ac2-4ef1-bd48-6f83bc994a75,CPT11,Chemotherapy,,Dead,WITH TUMOR,,,362,MALE,40,C71.9,Brain,362
5bbeb8a7-3ac2-4ef1-bd48-6f83bc994a75,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,362,MALE,40,C71.9,Brain,362
4b43da9d-60ee-4269-b44d-d92c034b844c,CAI NABIT 9712,Chemotherapy,,Dead,WITH TUMOR,,,313,MALE,62,C71.9,Brain,313
4b43da9d-60ee-4269-b44d-d92c034b844c,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,313,MALE,62,C71.9,Brain,313
4b43da9d-60ee-4269-b44d-d92c034b844c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,313,MALE,62,C71.9,Brain,313
3258cb3b-f63b-463c-b2e4-d638149157c5,Pyrazinamide,Chemotherapy,,Dead,WITH TUMOR,,,71,FEMALE,53,C71.9,Brain,71
3003cbfa-98d5-464d-90a5-b1bef32bcef1,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,611,FEMALE,33,C71.9,Brain,611
3003cbfa-98d5-464d-90a5-b1bef32bcef1,Carmustine (BCNU),Chemotherapy,,Dead,WITH TUMOR,,,611,FEMALE,33,C71.9,Brain,611
562d2831-ea9e-4ee1-bcee-77138e0a7d9d,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,541,FEMALE,51,C71.9,Brain,541
562d2831-ea9e-4ee1-bcee-77138e0a7d9d,Carmustine (BCNU),Chemotherapy,,Dead,WITH TUMOR,,,541,FEMALE,51,C71.9,Brain,541
562d2831-ea9e-4ee1-bcee-77138e0a7d9d,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,541,FEMALE,51,C71.9,Brain,541
562d2831-ea9e-4ee1-bcee-77138e0a7d9d,Tamoxifen,Chemotherapy,,Dead,WITH TUMOR,,,541,FEMALE,51,C71.9,Brain,541
f5bc5d97-e054-4e53-992d-71b896bd97d5,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,375,MALE,68,C71.9,Brain,375
f5bc5d97-e054-4e53-992d-71b896bd97d5,Tamoxifen,Chemotherapy,,Dead,WITH TUMOR,,,375,MALE,68,C71.9,Brain,375
f5bc5d97-e054-4e53-992d-71b896bd97d5,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,375,MALE,68,C71.9,Brain,375
f5bc5d97-e054-4e53-992d-71b896bd97d5,Paclitaxel,Chemotherapy,,Dead,WITH TUMOR,,,375,MALE,68,C71.9,Brain,375
24ae6f30-eec8-49a7-abde-246b3873679e,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,424,MALE,54,C71.9,Brain,424
24ae6f30-eec8-49a7-abde-246b3873679e,Gliadel wafer,Chemotherapy,,Dead,WITH TUMOR,,,424,MALE,54,C71.9,Brain,424
24ae6f30-eec8-49a7-abde-246b3873679e,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,424,MALE,54,C71.9,Brain,424
24ae6f30-eec8-49a7-abde-246b3873679e,CI 980,Chemotherapy,,Dead,WITH TUMOR,,,424,MALE,54,C71.9,Brain,424
fa1f1cfc-9da0-488b-93fe-60aaff99c171,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,318,MALE,61,C71.9,Brain,318
fa1f1cfc-9da0-488b-93fe-60aaff99c171,CI980,Targeted Molecular therapy,,Dead,WITH TUMOR,,,318,MALE,61,C71.9,Brain,318
fa1f1cfc-9da0-488b-93fe-60aaff99c171,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,318,MALE,61,C71.9,Brain,318
fa1f1cfc-9da0-488b-93fe-60aaff99c171,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,318,MALE,61,C71.9,Brain,318
15e058e8-2f33-4fb4-92af-3d9dea1fa906,Tamoxifen,Chemotherapy,,Dead,WITH TUMOR,,,178,MALE,57,C71.9,Brain,178
bc316a17-9d73-4ef3-97e9-c4ac5516b75a,Carmustin,Chemotherapy,,Dead,WITH TUMOR,,,329,MALE,73,C71.9,Brain,329
da89dcc7-7453-44a7-b43d-5b3478c5d9a7,CAI (NABTT 9712),Chemotherapy,,Dead,WITH TUMOR,,,104,FEMALE,47,C71.9,Brain,104
4a85a43b-4dbc-4081-b552-df06eef1ad80,Oxaliplatin,Chemotherapy,,Dead,WITH TUMOR,,,178,MALE,51,C71.9,Brain,178
224235c1-5b6e-48d5-a5d1-777dfede0f1e,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,598,FEMALE,59,C71.9,Brain,598
224235c1-5b6e-48d5-a5d1-777dfede0f1e,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,598,FEMALE,59,C71.9,Brain,598
224235c1-5b6e-48d5-a5d1-777dfede0f1e,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,598,FEMALE,59,C71.9,Brain,598
bcc72cf4-90ce-466e-a683-bb0ebfb3cf82,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,100,MALE,68,C71.9,Brain,100
01a92062-967a-4900-8dc7-a5ecd3b3f8e2,Carmustine (BCNU),Chemotherapy,,Dead,WITH TUMOR,,,399,MALE,65,C71.9,Brain,399
01a92062-967a-4900-8dc7-a5ecd3b3f8e2,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,399,MALE,65,C71.9,Brain,399
ee3fc631-1e88-4f70-ab31-335851b38640,Tipfarnib (R115777),Chemotherapy,,Dead,WITH TUMOR,,,98,MALE,54,C71.9,Brain,98
22297a8b-4761-4f5c-b080-60a39c3a0670,Tipifarnib (R115777),Chemotherapy,,Dead,WITH TUMOR,,,123,MALE,69,C71.9,Brain,123
7391f99d-9528-46a1-9799-c5f0a7bfc63e,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,34,C71.9,Brain,
7391f99d-9528-46a1-9799-c5f0a7bfc63e,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,MALE,34,C71.9,Brain,
7391f99d-9528-46a1-9799-c5f0a7bfc63e,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,34,C71.9,Brain,
7391f99d-9528-46a1-9799-c5f0a7bfc63e,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,MALE,34,C71.9,Brain,
53abce1d-7e33-4ebd-832f-f3789f67377f,Bevcizumab,Targeted Molecular therapy,,Alive,TUMOR FREE,,,,MALE,38,C71.9,Brain,
53abce1d-7e33-4ebd-832f-f3789f67377f,Bevcizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,2681,MALE,38,C71.9,Brain,2681
53abce1d-7e33-4ebd-832f-f3789f67377f,MEDT 575,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,38,C71.9,Brain,
53abce1d-7e33-4ebd-832f-f3789f67377f,MEDT 575,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,2681,MALE,38,C71.9,Brain,2681
53abce1d-7e33-4ebd-832f-f3789f67377f,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,38,C71.9,Brain,
53abce1d-7e33-4ebd-832f-f3789f67377f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,2681,MALE,38,C71.9,Brain,2681
53abce1d-7e33-4ebd-832f-f3789f67377f,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,38,C71.9,Brain,
53abce1d-7e33-4ebd-832f-f3789f67377f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,2681,MALE,38,C71.9,Brain,2681
1f48f010-98fe-4b5a-b96a-14fb25eff23f,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,63,C71.9,Brain,
1f48f010-98fe-4b5a-b96a-14fb25eff23f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,2126,MALE,63,C71.9,Brain,2126
1f48f010-98fe-4b5a-b96a-14fb25eff23f,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,63,C71.9,Brain,
1f48f010-98fe-4b5a-b96a-14fb25eff23f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,2126,MALE,63,C71.9,Brain,2126
1f48f010-98fe-4b5a-b96a-14fb25eff23f,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,63,C71.9,Brain,
1f48f010-98fe-4b5a-b96a-14fb25eff23f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,2126,MALE,63,C71.9,Brain,2126
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Arsenic Trioxide (ATO),Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Arsenic Trioxide (ATO),Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Lomustine,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Lomustine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,XL184,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b,XL184,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,54,C71.9,Brain,
6573378a-ad14-4654-8810-9f3bd3597bc2,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
6573378a-ad14-4654-8810-9f3bd3597bc2,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1356,MALE,71,C71.9,Brain,1356
6573378a-ad14-4654-8810-9f3bd3597bc2,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
6573378a-ad14-4654-8810-9f3bd3597bc2,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1356,MALE,71,C71.9,Brain,1356
6573378a-ad14-4654-8810-9f3bd3597bc2,Sorafenib,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
6573378a-ad14-4654-8810-9f3bd3597bc2,Sorafenib,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1356,MALE,71,C71.9,Brain,1356
6573378a-ad14-4654-8810-9f3bd3597bc2,Etoposide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
6573378a-ad14-4654-8810-9f3bd3597bc2,Etoposide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1356,MALE,71,C71.9,Brain,1356
6573378a-ad14-4654-8810-9f3bd3597bc2,Erlotinib,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
6573378a-ad14-4654-8810-9f3bd3597bc2,Erlotinib,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1356,MALE,71,C71.9,Brain,1356
6573378a-ad14-4654-8810-9f3bd3597bc2,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
6573378a-ad14-4654-8810-9f3bd3597bc2,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1356,MALE,71,C71.9,Brain,1356
6573378a-ad14-4654-8810-9f3bd3597bc2,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
6573378a-ad14-4654-8810-9f3bd3597bc2,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1356,MALE,71,C71.9,Brain,1356
6573378a-ad14-4654-8810-9f3bd3597bc2,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
6573378a-ad14-4654-8810-9f3bd3597bc2,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1356,MALE,71,C71.9,Brain,1356
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,58,C71.9,Brain,
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1185,MALE,58,C71.9,Brain,1185
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Irinotecan,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,58,C71.9,Brain,
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1185,MALE,58,C71.9,Brain,1185
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Lomustine,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,58,C71.9,Brain,
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Lomustine,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1185,MALE,58,C71.9,Brain,1185
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,58,C71.9,Brain,
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1185,MALE,58,C71.9,Brain,1185
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Bevacizumab,Targeted Molecular therapy,,Alive,TUMOR FREE,,,,MALE,58,C71.9,Brain,
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1185,MALE,58,C71.9,Brain,1185
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,58,C71.9,Brain,
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1185,MALE,58,C71.9,Brain,1185
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Cediranib/Placebo,Targeted Molecular therapy,,Alive,TUMOR FREE,,,,MALE,58,C71.9,Brain,
f08280d6-2c80-4dd7-93d3-a0c55f7da5b3,Cediranib/Placebo,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1185,MALE,58,C71.9,Brain,1185
67e2af1c-3478-4652-8759-b9d5c5b6a3e0,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,,,225,MALE,63,C71.9,Brain,225
67e2af1c-3478-4652-8759-b9d5c5b6a3e0,VP 16 (Etoposide),Chemotherapy,,Dead,WITH TUMOR,,,225,MALE,63,C71.9,Brain,225
67e2af1c-3478-4652-8759-b9d5c5b6a3e0,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,225,MALE,63,C71.9,Brain,225
67e2af1c-3478-4652-8759-b9d5c5b6a3e0,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,225,MALE,63,C71.9,Brain,225
67e2af1c-3478-4652-8759-b9d5c5b6a3e0,Lomustine,Chemotherapy,,Dead,WITH TUMOR,,,225,MALE,63,C71.9,Brain,225
9733968f-262f-4e97-9194-240cda8caf65,Taxol,Chemotherapy,,Dead,WITH TUMOR,,,169,FEMALE,65,C71.9,Brain,169
4d04939f-9509-4e9b-9406-16051afecf82,Carmustine (BCNU),Chemotherapy,,Dead,WITH TUMOR,,,233,MALE,40,C71.9,Brain,233
e3711a9b-6d4c-44df-bbab-0a675046a5df,Carmustine (BCNU),Chemotherapy,,Dead,WITH TUMOR,,,256,FEMALE,52,C71.9,Brain,256
e3711a9b-6d4c-44df-bbab-0a675046a5df,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,256,FEMALE,52,C71.9,Brain,256
5c984433-33cf-42fc-b3ba-511efcdcab19,CI-980,Chemotherapy,,Dead,WITH TUMOR,,,360,MALE,47,C71.9,Brain,360
5c984433-33cf-42fc-b3ba-511efcdcab19,Gliadel wafer,Chemotherapy,,Dead,WITH TUMOR,,,360,MALE,47,C71.9,Brain,360
5c984433-33cf-42fc-b3ba-511efcdcab19,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,360,MALE,47,C71.9,Brain,360
9853c6bb-a42c-4698-abe5-f3c897ebc8f6,Carmustine (BCNU),Chemotherapy,,Dead,WITH TUMOR,,,457,MALE,66,C71.9,Brain,457
9853c6bb-a42c-4698-abe5-f3c897ebc8f6,Tamoxifen,Chemotherapy,,Dead,WITH TUMOR,,,457,MALE,66,C71.9,Brain,457
9853c6bb-a42c-4698-abe5-f3c897ebc8f6,CI-980,Chemotherapy,,Dead,WITH TUMOR,,,457,MALE,66,C71.9,Brain,457
a8033f85-ac9b-41f3-b775-a1aee3f21b8f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,735,FEMALE,61,C71.9,Brain,735
a8033f85-ac9b-41f3-b775-a1aee3f21b8f,CI 980,Chemotherapy,,Dead,WITH TUMOR,,,735,FEMALE,61,C71.9,Brain,735
a8033f85-ac9b-41f3-b775-a1aee3f21b8f,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,735,FEMALE,61,C71.9,Brain,735
054f472f-98cb-4559-b2e2-b5f800fc8eef,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,603,MALE,31,C71.9,Brain,603
054f472f-98cb-4559-b2e2-b5f800fc8eef,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,603,MALE,31,C71.9,Brain,603
054f472f-98cb-4559-b2e2-b5f800fc8eef,Carmustine (BCNU),Chemotherapy,,Dead,WITH TUMOR,,,603,MALE,31,C71.9,Brain,603
054f472f-98cb-4559-b2e2-b5f800fc8eef,Reinoid/CIS retinoic acid,Chemotherapy,,Dead,WITH TUMOR,,,603,MALE,31,C71.9,Brain,603
054f472f-98cb-4559-b2e2-b5f800fc8eef,06-BG,Chemotherapy,,Dead,WITH TUMOR,,,603,MALE,31,C71.9,Brain,603
054f472f-98cb-4559-b2e2-b5f800fc8eef,CAI (NABTT 97212),Chemotherapy,,Dead,WITH TUMOR,,,603,MALE,31,C71.9,Brain,603
054f472f-98cb-4559-b2e2-b5f800fc8eef,06-BG (NABTT 0803),Chemotherapy,,Dead,WITH TUMOR,,,603,MALE,31,C71.9,Brain,603
054f472f-98cb-4559-b2e2-b5f800fc8eef,Vatalanib (PTK787),Chemotherapy,,Dead,WITH TUMOR,,,603,MALE,31,C71.9,Brain,603
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,65,C71.9,Brain,
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1481,FEMALE,65,C71.9,Brain,1481
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,65,C71.9,Brain,
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1481,FEMALE,65,C71.9,Brain,1481
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,65,C71.9,Brain,
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1481,FEMALE,65,C71.9,Brain,1481
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,65,C71.9,Brain,
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1481,FEMALE,65,C71.9,Brain,1481
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Cilengitide,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,65,C71.9,Brain,
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Cilengitide,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1481,FEMALE,65,C71.9,Brain,1481
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,65,C71.9,Brain,
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1481,FEMALE,65,C71.9,Brain,1481
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Cilengitide,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,65,C71.9,Brain,
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Cilengitide,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1481,FEMALE,65,C71.9,Brain,1481
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,65,C71.9,Brain,
6d4ab866-ca0b-4455-898e-df8a6ac3e924,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1481,FEMALE,65,C71.9,Brain,1481
7ffeaa19-61c5-4af1-aafd-36ec65cf4768,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,329,MALE,51,C71.9,Brain,329
7ffeaa19-61c5-4af1-aafd-36ec65cf4768,6 Thioguanine,Chemotherapy,,Dead,WITH TUMOR,,,329,MALE,51,C71.9,Brain,329
7ffeaa19-61c5-4af1-aafd-36ec65cf4768,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,329,MALE,51,C71.9,Brain,329
7ffeaa19-61c5-4af1-aafd-36ec65cf4768,Estramustine,Chemotherapy,,Dead,WITH TUMOR,,,329,MALE,51,C71.9,Brain,329
28bf7388-f041-4ff6-ba70-4dcfa05805a3,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,274,FEMALE,57,C71.9,Brain,274
28bf7388-f041-4ff6-ba70-4dcfa05805a3,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,274,FEMALE,57,C71.9,Brain,274
28bf7388-f041-4ff6-ba70-4dcfa05805a3,Lomustine,Chemotherapy,,Dead,WITH TUMOR,,,274,FEMALE,57,C71.9,Brain,274
6db66d6e-b44e-41fa-b904-aa61af0acf1c,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,2201,MALE,43,C71.9,Brain,2201
6db66d6e-b44e-41fa-b904-aa61af0acf1c,Tamoxifen,Chemotherapy,,Dead,WITH TUMOR,,,2201,MALE,43,C71.9,Brain,2201
6db66d6e-b44e-41fa-b904-aa61af0acf1c,Lomustine,Chemotherapy,,Dead,WITH TUMOR,,,2201,MALE,43,C71.9,Brain,2201
6db66d6e-b44e-41fa-b904-aa61af0acf1c,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,2201,MALE,43,C71.9,Brain,2201
6db66d6e-b44e-41fa-b904-aa61af0acf1c,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,2201,MALE,43,C71.9,Brain,2201
6db66d6e-b44e-41fa-b904-aa61af0acf1c,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,2201,MALE,43,C71.9,Brain,2201
6db66d6e-b44e-41fa-b904-aa61af0acf1c,9 immunoamino camptnetecin,Chemotherapy,,Dead,WITH TUMOR,,,2201,MALE,43,C71.9,Brain,2201
6db66d6e-b44e-41fa-b904-aa61af0acf1c,Hyroxyurea,Chemotherapy,,Dead,WITH TUMOR,,,2201,MALE,43,C71.9,Brain,2201
6db66d6e-b44e-41fa-b904-aa61af0acf1c,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,,,2201,MALE,43,C71.9,Brain,2201
98d3ae4b-1f14-4067-ac60-7eaace5007f2,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,291,FEMALE,56,C71.9,Brain,291
98d3ae4b-1f14-4067-ac60-7eaace5007f2,Taxol,Chemotherapy,,Dead,WITH TUMOR,,,291,FEMALE,56,C71.9,Brain,291
98d3ae4b-1f14-4067-ac60-7eaace5007f2,9AC 9 Aminocamplotecian,Chemotherapy,,Dead,WITH TUMOR,,,291,FEMALE,56,C71.9,Brain,291
a9601d20-d51d-4db3-9e82-7171f5f7e034,Cisplatain,Chemotherapy,,Dead,TUMOR FREE,,,1068,MALE,63,C71.9,Brain,1068
a9601d20-d51d-4db3-9e82-7171f5f7e034,BCNU,Chemotherapy,,Dead,TUMOR FREE,,,1068,MALE,63,C71.9,Brain,1068
652a39f0-c539-4303-bedc-f0d7f4669d9f,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
652a39f0-c539-4303-bedc-f0d7f4669d9f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,384,MALE,71,C71.9,Brain,384
652a39f0-c539-4303-bedc-f0d7f4669d9f,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
652a39f0-c539-4303-bedc-f0d7f4669d9f,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,384,MALE,71,C71.9,Brain,384
652a39f0-c539-4303-bedc-f0d7f4669d9f,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
652a39f0-c539-4303-bedc-f0d7f4669d9f,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,384,MALE,71,C71.9,Brain,384
652a39f0-c539-4303-bedc-f0d7f4669d9f,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,71,C71.9,Brain,
652a39f0-c539-4303-bedc-f0d7f4669d9f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,384,MALE,71,C71.9,Brain,384
522808a2-f19d-4fab-b67e-0c31ec54b757,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,717,FEMALE,39,C71.9,Brain,717
522808a2-f19d-4fab-b67e-0c31ec54b757,Erlotinib,Chemotherapy,,Dead,WITH TUMOR,,,717,FEMALE,39,C71.9,Brain,717
522808a2-f19d-4fab-b67e-0c31ec54b757,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,717,FEMALE,39,C71.9,Brain,717
522808a2-f19d-4fab-b67e-0c31ec54b757,AZD,Chemotherapy,,Dead,WITH TUMOR,,,717,FEMALE,39,C71.9,Brain,717
522808a2-f19d-4fab-b67e-0c31ec54b757,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,,,717,FEMALE,39,C71.9,Brain,717
522808a2-f19d-4fab-b67e-0c31ec54b757,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,717,FEMALE,39,C71.9,Brain,717
522808a2-f19d-4fab-b67e-0c31ec54b757,Lomustine,Chemotherapy,,Dead,WITH TUMOR,,,717,FEMALE,39,C71.9,Brain,717
522808a2-f19d-4fab-b67e-0c31ec54b757,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,,,717,FEMALE,39,C71.9,Brain,717
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,432,MALE,53,C71.9,Brain,432
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,A4QN,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,A4QN,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,432,MALE,53,C71.9,Brain,432
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,Erlotinib (Tarceva),Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,Erlotinib (Tarceva),Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,432,MALE,53,C71.9,Brain,432
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,A4QN,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,A4QN,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,432,MALE,53,C71.9,Brain,432
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,AT 101,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,AT 101,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,432,MALE,53,C71.9,Brain,432
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,432,MALE,53,C71.9,Brain,432
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,432,MALE,53,C71.9,Brain,432
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,Irintotecan,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab,Irintotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,432,MALE,53,C71.9,Brain,432
e2e83064-7d1c-4dd5-993f-cc7a5ee228ed,Temozolomode,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,69,C71.9,Brain,
e2e83064-7d1c-4dd5-993f-cc7a5ee228ed,Temozolomode,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,803,MALE,69,C71.9,Brain,803
e2e83064-7d1c-4dd5-993f-cc7a5ee228ed,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,69,C71.9,Brain,
e2e83064-7d1c-4dd5-993f-cc7a5ee228ed,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,803,MALE,69,C71.9,Brain,803
e2e83064-7d1c-4dd5-993f-cc7a5ee228ed,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,69,C71.9,Brain,
e2e83064-7d1c-4dd5-993f-cc7a5ee228ed,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,803,MALE,69,C71.9,Brain,803
e2e83064-7d1c-4dd5-993f-cc7a5ee228ed,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,69,C71.9,Brain,
e2e83064-7d1c-4dd5-993f-cc7a5ee228ed,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,803,MALE,69,C71.9,Brain,803
e2e83064-7d1c-4dd5-993f-cc7a5ee228ed,Cilengitide,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,69,C71.9,Brain,
e2e83064-7d1c-4dd5-993f-cc7a5ee228ed,Cilengitide,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,803,MALE,69,C71.9,Brain,803
5613f5f6-086d-470b-8f77-6dcb7f8625b7,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,66,C71.9,Brain,
5613f5f6-086d-470b-8f77-6dcb7f8625b7,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1426,MALE,66,C71.9,Brain,1426
5613f5f6-086d-470b-8f77-6dcb7f8625b7,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,66,C71.9,Brain,
5613f5f6-086d-470b-8f77-6dcb7f8625b7,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1426,MALE,66,C71.9,Brain,1426
98e0344d-71c6-477c-a990-0bd0277606af,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,61,C71.9,Brain,
98e0344d-71c6-477c-a990-0bd0277606af,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,61,C71.9,Brain,
98e0344d-71c6-477c-a990-0bd0277606af,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,61,C71.9,Brain,
98e0344d-71c6-477c-a990-0bd0277606af,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,61,C71.9,Brain,
c5e08764-822b-4214-9ce6-f3ec2756190e,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,72,C71.9,Brain,
c5e08764-822b-4214-9ce6-f3ec2756190e,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,72,C71.9,Brain,
c5e08764-822b-4214-9ce6-f3ec2756190e,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,72,C71.9,Brain,
c5e08764-822b-4214-9ce6-f3ec2756190e,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,72,C71.9,Brain,
c5e08764-822b-4214-9ce6-f3ec2756190e,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,72,C71.9,Brain,
c5e08764-822b-4214-9ce6-f3ec2756190e,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,72,C71.9,Brain,
c5e08764-822b-4214-9ce6-f3ec2756190e,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,72,C71.9,Brain,
c5e08764-822b-4214-9ce6-f3ec2756190e,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,72,C71.9,Brain,
c5e08764-822b-4214-9ce6-f3ec2756190e,Irintocean,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,72,C71.9,Brain,
c5e08764-822b-4214-9ce6-f3ec2756190e,Irintocean,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,72,C71.9,Brain,
98e2f2ec-bdcd-490a-bf45-600e3b6c7491,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,74,C71.9,Brain,
98e2f2ec-bdcd-490a-bf45-600e3b6c7491,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,74,C71.9,Brain,
98e2f2ec-bdcd-490a-bf45-600e3b6c7491,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,74,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,dcVax,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,dcVax,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,dc Vax (Dendritic Cell Vaccine),Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,dc Vax (Dendritic Cell Vaccine),Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Dendritic Cell Vaccine (dcvax),Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Dendritic Cell Vaccine (dcvax),Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Cedicanib,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Cedicanib,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Cilengitide,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Cilengitide,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Lomustine CCNU,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Lomustine CCNU,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Carboplatin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
f9ce2045-2821-4843-b5e9-cf7cc7e783d4,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1229,MALE,52,C71.9,Brain,1229
1b6c184a-5868-4a51-8a82-aa16a7e65126,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,50,C71.9,Brain,
1b6c184a-5868-4a51-8a82-aa16a7e65126,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,504,MALE,50,C71.9,Brain,504
1b6c184a-5868-4a51-8a82-aa16a7e65126,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,50,C71.9,Brain,
1b6c184a-5868-4a51-8a82-aa16a7e65126,Avastin,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,504,MALE,50,C71.9,Brain,504
1b6c184a-5868-4a51-8a82-aa16a7e65126,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,50,C71.9,Brain,
1b6c184a-5868-4a51-8a82-aa16a7e65126,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,504,MALE,50,C71.9,Brain,504
2188c194-dfe4-4471-9b8b-050db1a1062c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,30,C71.9,Brain,
2188c194-dfe4-4471-9b8b-050db1a1062c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,632,MALE,30,C71.9,Brain,632
2188c194-dfe4-4471-9b8b-050db1a1062c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,30,C71.9,Brain,
2188c194-dfe4-4471-9b8b-050db1a1062c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,632,MALE,30,C71.9,Brain,632
2188c194-dfe4-4471-9b8b-050db1a1062c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,30,C71.9,Brain,
2188c194-dfe4-4471-9b8b-050db1a1062c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,632,MALE,30,C71.9,Brain,632
2188c194-dfe4-4471-9b8b-050db1a1062c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,30,C71.9,Brain,
2188c194-dfe4-4471-9b8b-050db1a1062c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,632,MALE,30,C71.9,Brain,632
2188c194-dfe4-4471-9b8b-050db1a1062c,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,30,C71.9,Brain,
2188c194-dfe4-4471-9b8b-050db1a1062c,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,632,MALE,30,C71.9,Brain,632
2188c194-dfe4-4471-9b8b-050db1a1062c,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,30,C71.9,Brain,
2188c194-dfe4-4471-9b8b-050db1a1062c,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,632,MALE,30,C71.9,Brain,632
2188c194-dfe4-4471-9b8b-050db1a1062c,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,30,C71.9,Brain,
2188c194-dfe4-4471-9b8b-050db1a1062c,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,632,MALE,30,C71.9,Brain,632
2188c194-dfe4-4471-9b8b-050db1a1062c,Carboplatin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,30,C71.9,Brain,
2188c194-dfe4-4471-9b8b-050db1a1062c,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,632,MALE,30,C71.9,Brain,632
cb9f842c-9bf5-48c3-8d3e-b344b1b6c190,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,79,C71.9,Brain,
cb9f842c-9bf5-48c3-8d3e-b344b1b6c190,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,814,FEMALE,79,C71.9,Brain,814
cb9f842c-9bf5-48c3-8d3e-b344b1b6c190,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,79,C71.9,Brain,
cb9f842c-9bf5-48c3-8d3e-b344b1b6c190,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,814,FEMALE,79,C71.9,Brain,814
ac3582a9-46b1-4322-95fa-9e8b149b8044,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
ac3582a9-46b1-4322-95fa-9e8b149b8044,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,728,MALE,54,C71.9,Brain,728
ac3582a9-46b1-4322-95fa-9e8b149b8044,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
ac3582a9-46b1-4322-95fa-9e8b149b8044,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,728,MALE,54,C71.9,Brain,728
ac3582a9-46b1-4322-95fa-9e8b149b8044,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
ac3582a9-46b1-4322-95fa-9e8b149b8044,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,728,MALE,54,C71.9,Brain,728
ac3582a9-46b1-4322-95fa-9e8b149b8044,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
ac3582a9-46b1-4322-95fa-9e8b149b8044,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,728,MALE,54,C71.9,Brain,728
ac3582a9-46b1-4322-95fa-9e8b149b8044,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
ac3582a9-46b1-4322-95fa-9e8b149b8044,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,728,MALE,54,C71.9,Brain,728
ac3582a9-46b1-4322-95fa-9e8b149b8044,Doxil,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
ac3582a9-46b1-4322-95fa-9e8b149b8044,Doxil,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,728,MALE,54,C71.9,Brain,728
97686ab2-3b7e-4b21-9bf3-9a5a01709e04,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,208,MALE,42,C71.9,Brain,208
98dd5ea6-8d40-4963-bbae-2d37001d71c8,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,123,MALE,75,C71.9,Brain,123
b1ce95bf-7441-4aac-8131-19a177d2b8ac,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,815,MALE,61,C71.9,Brain,815
bdc75722-1076-49f3-8dc7-f2b91e5a15eb,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,56,C71.9,Brain,
bdc75722-1076-49f3-8dc7-f2b91e5a15eb,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,360,FEMALE,56,C71.9,Brain,360
bdc75722-1076-49f3-8dc7-f2b91e5a15eb,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,56,C71.9,Brain,
bdc75722-1076-49f3-8dc7-f2b91e5a15eb,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,360,FEMALE,56,C71.9,Brain,360
bdc75722-1076-49f3-8dc7-f2b91e5a15eb,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,56,C71.9,Brain,
bdc75722-1076-49f3-8dc7-f2b91e5a15eb,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,360,FEMALE,56,C71.9,Brain,360
13d12179-3182-4f41-85a2-90fd50e51480,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,61,C71.9,Brain,
13d12179-3182-4f41-85a2-90fd50e51480,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,466,MALE,61,C71.9,Brain,466
13d12179-3182-4f41-85a2-90fd50e51480,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,61,C71.9,Brain,
13d12179-3182-4f41-85a2-90fd50e51480,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,466,MALE,61,C71.9,Brain,466
13d12179-3182-4f41-85a2-90fd50e51480,Bevacizumab,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,61,C71.9,Brain,
13d12179-3182-4f41-85a2-90fd50e51480,Bevacizumab,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,466,MALE,61,C71.9,Brain,466
9f004b8a-f202-419d-a4d8-01f9430eaca5,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,28,C71.9,Brain,
9f004b8a-f202-419d-a4d8-01f9430eaca5,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,28,C71.9,Brain,
9f004b8a-f202-419d-a4d8-01f9430eaca5,Temozolomode,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,28,C71.9,Brain,
9f004b8a-f202-419d-a4d8-01f9430eaca5,Temozolomode,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,28,C71.9,Brain,
9f004b8a-f202-419d-a4d8-01f9430eaca5,Temozolomode,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,28,C71.9,Brain,
9f004b8a-f202-419d-a4d8-01f9430eaca5,Temozolomode,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,28,C71.9,Brain,
ca893d12-3d6c-4e6f-b0e7-7f4eb8bb724b,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,150,MALE,83,C71.9,Brain,150
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,537,FEMALE,53,C71.9,Brain,537
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,XL 184,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,XL 184,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,537,FEMALE,53,C71.9,Brain,537
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Avastin,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,537,FEMALE,53,C71.9,Brain,537
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,537,FEMALE,53,C71.9,Brain,537
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Temozlomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Temozlomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,537,FEMALE,53,C71.9,Brain,537
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Irinotecan,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,537,FEMALE,53,C71.9,Brain,537
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Carboplatin,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,537,FEMALE,53,C71.9,Brain,537
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
d6a48eb1-7c20-4ae3-ae35-b6b641238ef1,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,537,FEMALE,53,C71.9,Brain,537
e3251837-f6f3-4dad-856f-108e20d03dad,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,81,C71.9,Brain,
e3251837-f6f3-4dad-856f-108e20d03dad,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,382,MALE,81,C71.9,Brain,382
ba383ea6-c885-49f0-bddc-e00be0230a6b,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,72,C71.9,Brain,
ba383ea6-c885-49f0-bddc-e00be0230a6b,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,72,C71.9,Brain,
ba383ea6-c885-49f0-bddc-e00be0230a6b,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,72,C71.9,Brain,
ba383ea6-c885-49f0-bddc-e00be0230a6b,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,72,C71.9,Brain,
ba383ea6-c885-49f0-bddc-e00be0230a6b,R04929097,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,72,C71.9,Brain,
ba383ea6-c885-49f0-bddc-e00be0230a6b,R04929097,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,72,C71.9,Brain,
8ff9f921-f9e9-41c1-a5d4-891fd4cfe979,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,50,C71.9,Brain,
c7b4fd72-b45d-4524-8424-983120abfec0,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
c7b4fd72-b45d-4524-8424-983120abfec0,Avastin,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,506,MALE,59,C71.9,Brain,506
c7b4fd72-b45d-4524-8424-983120abfec0,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
c7b4fd72-b45d-4524-8424-983120abfec0,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,506,MALE,59,C71.9,Brain,506
c7b4fd72-b45d-4524-8424-983120abfec0,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
c7b4fd72-b45d-4524-8424-983120abfec0,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,506,MALE,59,C71.9,Brain,506
c7b4fd72-b45d-4524-8424-983120abfec0,XL 184,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
c7b4fd72-b45d-4524-8424-983120abfec0,XL 184,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,506,MALE,59,C71.9,Brain,506
c7b4fd72-b45d-4524-8424-983120abfec0,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
c7b4fd72-b45d-4524-8424-983120abfec0,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,506,MALE,59,C71.9,Brain,506
c7b4fd72-b45d-4524-8424-983120abfec0,Carboplatin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
c7b4fd72-b45d-4524-8424-983120abfec0,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,506,MALE,59,C71.9,Brain,506
c7b4fd72-b45d-4524-8424-983120abfec0,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
c7b4fd72-b45d-4524-8424-983120abfec0,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,506,MALE,59,C71.9,Brain,506
ae5b2e48-d186-4e77-a797-dcc3b3ca4847,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,182,FEMALE,23,C71.9,Brain,182
ae5b2e48-d186-4e77-a797-dcc3b3ca4847,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,182,FEMALE,23,C71.9,Brain,182
55a063b0-98ad-4700-b3ce-61bfe364fec8,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,133,MALE,65,C71.9,Brain,133
b37d944c-c65c-46d6-bb8b-3eb37cb85b68,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,21,C71.9,Brain,
b37d944c-c65c-46d6-bb8b-3eb37cb85b68,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,21,C71.9,Brain,
b37d944c-c65c-46d6-bb8b-3eb37cb85b68,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,21,C71.9,Brain,
b37d944c-c65c-46d6-bb8b-3eb37cb85b68,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,21,C71.9,Brain,
af055b98-be6a-4012-ac64-f1b6539b23d0,BS1-201,Chemotherapy,,Dead,WITH TUMOR,,,357,FEMALE,54,C71.9,Brain,357
af055b98-be6a-4012-ac64-f1b6539b23d0,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,357,FEMALE,54,C71.9,Brain,357
af055b98-be6a-4012-ac64-f1b6539b23d0,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,357,FEMALE,54,C71.9,Brain,357
3f960d3b-a58c-43d0-a8a4-f3555b399c9d,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,254,MALE,51,C71.9,Brain,254
3f960d3b-a58c-43d0-a8a4-f3555b399c9d,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,254,MALE,51,C71.9,Brain,254
e6e2d4c3-d37c-4de3-ac68-b301800770f0,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,138,FEMALE,78,C71.9,Brain,138
e6e2d4c3-d37c-4de3-ac68-b301800770f0,ABTC 0603 Hydroxychloroquine,Chemotherapy,,Dead,WITH TUMOR,,,138,FEMALE,78,C71.9,Brain,138
8d2e88d9-d8d0-4c42-8aa2-205a788dea58,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,67,C71.9,Brain,
8d2e88d9-d8d0-4c42-8aa2-205a788dea58,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,67,C71.9,Brain,
7a650a2c-bc3f-4e0c-820e-4f492977107b,Hydrochoroquine,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,61,C71.9,Brain,
7a650a2c-bc3f-4e0c-820e-4f492977107b,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,61,C71.9,Brain,
713190ed-c6c1-4695-814b-85ca9b95e6a0,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,60,C71.9,Brain,
3a3fc890-1985-4353-861b-dc3abfb364b1,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,23,C71.9,Brain,
74ce7e7f-e214-4b6e-8551-114a153ab7fb,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,45,C71.9,Brain,
d1547b99-3c96-4c62-8261-5111bcf860a9,Carboplatin,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,45,C71.9,Brain,
d1547b99-3c96-4c62-8261-5111bcf860a9,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,45,C71.9,Brain,
d1547b99-3c96-4c62-8261-5111bcf860a9,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,45,C71.9,Brain,
d1547b99-3c96-4c62-8261-5111bcf860a9,ABT-888 Parp Inhibitor,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,45,C71.9,Brain,
4644a15f-3115-4f27-86b2-b092419431e1,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,63,C71.9,Brain,
4644a15f-3115-4f27-86b2-b092419431e1,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,63,C71.9,Brain,
7eb1d526-923d-4b31-b8be-27d83b3dd025,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,159,FEMALE,64,C71.9,Brain,159
7eb1d526-923d-4b31-b8be-27d83b3dd025,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,159,FEMALE,64,C71.9,Brain,159
7eb1d526-923d-4b31-b8be-27d83b3dd025,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,,,159,FEMALE,64,C71.9,Brain,159
7eb1d526-923d-4b31-b8be-27d83b3dd025,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,159,FEMALE,64,C71.9,Brain,159
d9cae674-1100-44a4-8c61-2f15ea1b6214,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,49,C71.9,Brain,
d9cae674-1100-44a4-8c61-2f15ea1b6214,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,49,C71.9,Brain,
3ed101b5-0007-4957-a25d-4cf43bde08b6,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,164,MALE,58,C71.9,Brain,164
3ed101b5-0007-4957-a25d-4cf43bde08b6,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,164,MALE,58,C71.9,Brain,164
0628cb4a-c480-4b2f-bd2e-bb33e6994302,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,64,C71.9,Brain,
0628cb4a-c480-4b2f-bd2e-bb33e6994302,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,64,C71.9,Brain,
b28b3575-8097-4a97-b32a-5f0eeff64863,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,65,C71.9,Brain,
b28b3575-8097-4a97-b32a-5f0eeff64863,Bevacozimab,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,65,C71.9,Brain,
b28b3575-8097-4a97-b32a-5f0eeff64863,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,65,C71.9,Brain,
b28b3575-8097-4a97-b32a-5f0eeff64863,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,65,C71.9,Brain,
c129c34a-8d40-4d98-b9ad-a10d3f7b3ee0,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
c129c34a-8d40-4d98-b9ad-a10d3f7b3ee0,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
9848f14b-8eab-4ac9-89b0-99a5ebf14696,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,58,C71.9,Brain,
3dddfc44-7bb1-4974-8a65-a84fd4bac484,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,76,C71.9,Brain,
3dddfc44-7bb1-4974-8a65-a84fd4bac484,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,76,C71.9,Brain,
3dddfc44-7bb1-4974-8a65-a84fd4bac484,Vandetanib,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,76,C71.9,Brain,
13429a31-a193-4180-a8b2-cceaa21ecbfd,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,60,C71.9,Brain,
603D2B61-B636-4054-AC95-AB66DABB3B48,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,21,C71.4,Brain,
603D2B61-B636-4054-AC95-AB66DABB3B48,Lomustine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,21,C71.4,Brain,
603D2B61-B636-4054-AC95-AB66DABB3B48,Procarbazine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,21,C71.4,Brain,
41685C5A-A548-483A-8A20-305AD8D61771,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,444,MALE,64,C71.1,Brain,444
41685C5A-A548-483A-8A20-305AD8D61771,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,444,MALE,64,C71.1,Brain,444
41685C5A-A548-483A-8A20-305AD8D61771,Lomustine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,444,MALE,64,C71.1,Brain,444
41685C5A-A548-483A-8A20-305AD8D61771,Procarbazine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,444,MALE,64,C71.1,Brain,444
0CA72EBD-FF33-45B8-A97C-3F1435603D71,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,30,C71.8,Brain,
0CA72EBD-FF33-45B8-A97C-3F1435603D71,Plexxikon PLX3397,,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,30,C71.8,Brain,
0CA72EBD-FF33-45B8-A97C-3F1435603D71,Temozolomide,,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,30,C71.8,Brain,
0CA72EBD-FF33-45B8-A97C-3F1435603D71,Lomustine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,30,C71.8,Brain,
0CA72EBD-FF33-45B8-A97C-3F1435603D71,Procarbazine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,30,C71.8,Brain,
1af5c959-0f36-4a14-8383-ebc0543db3bb,Thalidomide,Targeted Molecular therapy,,Dead,WITH TUMOR,,,690,MALE,62,C71.9,Brain,690
1af5c959-0f36-4a14-8383-ebc0543db3bb,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,690,MALE,62,C71.9,Brain,690
e6dee2d7-ca05-44e2-bf25-1068a416bd14,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,1151,FEMALE,31,C71.9,Brain,1151
e6dee2d7-ca05-44e2-bf25-1068a416bd14,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1151,FEMALE,31,C71.9,Brain,1151
e6dee2d7-ca05-44e2-bf25-1068a416bd14,,Hormone Therapy,,Dead,WITH TUMOR,,,1151,FEMALE,31,C71.9,Brain,1151
e6dee2d7-ca05-44e2-bf25-1068a416bd14,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,1151,FEMALE,31,C71.9,Brain,1151
66d2e309-eaa1-4225-a34d-4565b4ef8019,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,127,FEMALE,57,C71.9,Brain,127
bef21d11-f743-4d9d-8cba-fb5cd24b6927,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,3524,MALE,66,C71.9,Brain,3524
5536201c-e739-46e6-8200-0bdcc28ae9ef,Hydroxyurea,Chemotherapy,,Dead,WITH TUMOR,,,256,MALE,69,C71.9,Brain,256
dbb601ed-e39c-48a6-aa00-645f740fc6e2,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,782,MALE,50,C71.9,Brain,782
dbb601ed-e39c-48a6-aa00-645f740fc6e2,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,,,782,MALE,50,C71.9,Brain,782
dbb601ed-e39c-48a6-aa00-645f740fc6e2,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,782,MALE,50,C71.9,Brain,782
dbb601ed-e39c-48a6-aa00-645f740fc6e2,Hydroxurea,Chemotherapy,,Dead,WITH TUMOR,,,782,MALE,50,C71.9,Brain,782
e1aabb11-f499-445e-a6fd-59a32b3c3531,Tamoxifen,Targeted Molecular therapy,,Dead,WITH TUMOR,,,370,MALE,63,C71.9,Brain,370
e1aabb11-f499-445e-a6fd-59a32b3c3531,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,370,MALE,63,C71.9,Brain,370
e1aabb11-f499-445e-a6fd-59a32b3c3531,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,370,MALE,63,C71.9,Brain,370
e1aabb11-f499-445e-a6fd-59a32b3c3531,Thalidomide,Targeted Molecular therapy,,Dead,WITH TUMOR,,,370,MALE,63,C71.9,Brain,370
0645038d-8abe-4a79-8695-bf8824d33f67,Thalidomide,Targeted Molecular therapy,,Dead,WITH TUMOR,,,298,MALE,46,C71.9,Brain,298
0645038d-8abe-4a79-8695-bf8824d33f67,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,298,MALE,46,C71.9,Brain,298
0645038d-8abe-4a79-8695-bf8824d33f67,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,298,MALE,46,C71.9,Brain,298
0645038d-8abe-4a79-8695-bf8824d33f67,Fenretinide,Chemotherapy,,Dead,WITH TUMOR,,,298,MALE,46,C71.9,Brain,298
dc624b20-2854-4235-ae7e-672156ee30e3,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,889,MALE,32,C71.9,Brain,889
dc624b20-2854-4235-ae7e-672156ee30e3,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,889,MALE,32,C71.9,Brain,889
91063e7e-60db-47a5-aeca-af7c37b1074e,Thalidomide,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1987,MALE,40,C71.9,Brain,1987
91063e7e-60db-47a5-aeca-af7c37b1074e,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,1987,MALE,40,C71.9,Brain,1987
91063e7e-60db-47a5-aeca-af7c37b1074e,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,1987,MALE,40,C71.9,Brain,1987
91063e7e-60db-47a5-aeca-af7c37b1074e,Thalidomide,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1987,MALE,40,C71.9,Brain,1987
872cb8e8-cd79-4c0b-9b54-5553b07a6ca6,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,256,MALE,58,C71.9,Brain,256
872cb8e8-cd79-4c0b-9b54-5553b07a6ca6,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,256,MALE,58,C71.9,Brain,256
a23511df-ed31-4f3f-9fe5-87a3621c0de9,Temador,Chemotherapy,,Dead,WITH TUMOR,,,546,FEMALE,52,C71.9,Brain,546
a23511df-ed31-4f3f-9fe5-87a3621c0de9,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,546,FEMALE,52,C71.9,Brain,546
a23511df-ed31-4f3f-9fe5-87a3621c0de9,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,546,FEMALE,52,C71.9,Brain,546
a23511df-ed31-4f3f-9fe5-87a3621c0de9,Poly LCLC,Chemotherapy,,Dead,WITH TUMOR,,,546,FEMALE,52,C71.9,Brain,546
a23511df-ed31-4f3f-9fe5-87a3621c0de9,cis retinoic acid,Chemotherapy,,Dead,WITH TUMOR,,,546,FEMALE,52,C71.9,Brain,546
bb8230b5-f984-4d28-9f10-b3c89bab1c28,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,,,747,FEMALE,30,C71.9,Brain,747
bb8230b5-f984-4d28-9f10-b3c89bab1c28,Thalomid,Targeted Molecular therapy,,Dead,WITH TUMOR,,,747,FEMALE,30,C71.9,Brain,747
bb8230b5-f984-4d28-9f10-b3c89bab1c28,Enzastaurin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,747,FEMALE,30,C71.9,Brain,747
bb8230b5-f984-4d28-9f10-b3c89bab1c28,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,747,FEMALE,30,C71.9,Brain,747
bb8230b5-f984-4d28-9f10-b3c89bab1c28,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,747,FEMALE,30,C71.9,Brain,747
bb8230b5-f984-4d28-9f10-b3c89bab1c28,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,747,FEMALE,30,C71.9,Brain,747
bb8230b5-f984-4d28-9f10-b3c89bab1c28,Tamoxifen,Targeted Molecular therapy,,Dead,WITH TUMOR,,,747,FEMALE,30,C71.9,Brain,747
f7532982-524f-4ed5-9e0d-50d3a7d72c3c,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,946,FEMALE,59,C71.9,Brain,946
f7532982-524f-4ed5-9e0d-50d3a7d72c3c,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,946,FEMALE,59,C71.9,Brain,946
548c3d4c-7993-40dc-bd02-5bb304188d28,Hyrdroxyurea,Chemotherapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Rapamycin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Thalidomide,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Gleevac,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Interferon Alpha,Immunotherapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,IL-13 Pseudomonas exotoxin,Immunotherapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Cytoxan,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Sorafenib,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Irinotecan,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Tarveca,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
548c3d4c-7993-40dc-bd02-5bb304188d28,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1143,MALE,49,C71.9,Brain,1143
ec504558-e96a-44e9-835a-7b12680681ed,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,678,MALE,50,C71.9,Brain,678
ec504558-e96a-44e9-835a-7b12680681ed,IL-13 with Pseudomonas Exotoxin,Immunotherapy,,Dead,WITH TUMOR,,,678,MALE,50,C71.9,Brain,678
ec504558-e96a-44e9-835a-7b12680681ed,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,678,MALE,50,C71.9,Brain,678
ec504558-e96a-44e9-835a-7b12680681ed,HSPPC-96 Vaccine,Immunotherapy,,Dead,WITH TUMOR,,,678,MALE,50,C71.9,Brain,678
ec504558-e96a-44e9-835a-7b12680681ed,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,678,MALE,50,C71.9,Brain,678
ec504558-e96a-44e9-835a-7b12680681ed,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,678,MALE,50,C71.9,Brain,678
ec504558-e96a-44e9-835a-7b12680681ed,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,678,MALE,50,C71.9,Brain,678
6d6dae20-431d-4fbe-ba47-e7ed8d73b4d8,IL-13 with Pseudomonas exotoxin,Immunotherapy,,Dead,WITH TUMOR,,,468,MALE,76,C71.9,Brain,468
6fc40b53-5db2-4319-a039-b023e1bb1d64,,Targeted Molecular therapy,,Dead,WITH TUMOR,,,454,FEMALE,74,C71.9,Brain,454
6fc40b53-5db2-4319-a039-b023e1bb1d64,VP16,Chemotherapy,,Dead,WITH TUMOR,,,454,FEMALE,74,C71.9,Brain,454
6fc40b53-5db2-4319-a039-b023e1bb1d64,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,454,FEMALE,74,C71.9,Brain,454
6fc40b53-5db2-4319-a039-b023e1bb1d64,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,454,FEMALE,74,C71.9,Brain,454
6fc40b53-5db2-4319-a039-b023e1bb1d64,Marimastat,Targeted Molecular therapy,,Dead,WITH TUMOR,,,454,FEMALE,74,C71.9,Brain,454
314d9188-c8fd-43fc-905d-b6889de542c8,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,548,MALE,74,C71.9,Brain,548
314d9188-c8fd-43fc-905d-b6889de542c8,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,548,MALE,74,C71.9,Brain,548
314d9188-c8fd-43fc-905d-b6889de542c8,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,548,MALE,74,C71.9,Brain,548
314d9188-c8fd-43fc-905d-b6889de542c8,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,548,MALE,74,C71.9,Brain,548
314d9188-c8fd-43fc-905d-b6889de542c8,HSPPC-96 Vaccine,Immunotherapy,,Dead,WITH TUMOR,,,548,MALE,74,C71.9,Brain,548
ea980264-d64d-410a-86dd-c129d7d8d1ee,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,467,MALE,59,C71.9,Brain,467
ea980264-d64d-410a-86dd-c129d7d8d1ee,EMD,Targeted Molecular therapy,,Dead,WITH TUMOR,,,467,MALE,59,C71.9,Brain,467
108a8d8e-1ddb-4c0d-a05b-71573b33b9aa,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,425,MALE,69,C71.9,Brain,425
108a8d8e-1ddb-4c0d-a05b-71573b33b9aa,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,425,MALE,69,C71.9,Brain,425
108a8d8e-1ddb-4c0d-a05b-71573b33b9aa,Tarceva,Immunotherapy,,Dead,WITH TUMOR,,,425,MALE,69,C71.9,Brain,425
108a8d8e-1ddb-4c0d-a05b-71573b33b9aa,Tarceva,Immunotherapy,,Dead,WITH TUMOR,,,425,MALE,69,C71.9,Brain,425
06e32525-6043-45a1-9fef-fa24ab219a1f,Thalidomide,Targeted Molecular therapy,,Dead,WITH TUMOR,,,130,MALE,75,C71.9,Brain,130
06e32525-6043-45a1-9fef-fa24ab219a1f,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,130,MALE,75,C71.9,Brain,130
13480f06-32ee-48b5-a729-a963a7979b90,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,235,MALE,69,C71.9,Brain,235
9773acd0-e8bf-4991-8913-53f0d2adfc72,Accutane,Chemotherapy,,Dead,WITH TUMOR,,,1785,FEMALE,34,C71.9,Brain,1785
9773acd0-e8bf-4991-8913-53f0d2adfc72,Procarbazine/CCNU/Vincristine,Chemotherapy,,Dead,WITH TUMOR,,,1785,FEMALE,34,C71.9,Brain,1785
e924d7c6-c98f-4469-8089-70e4ac3ca306,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,327,MALE,70,C71.9,Brain,327
b2a01580-d18f-40b5-875b-93e9c000b0e1,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,146,MALE,17,C71.9,Brain,146
b2a01580-d18f-40b5-875b-93e9c000b0e1,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,146,MALE,17,C71.9,Brain,146
51e5a60f-e7b1-4b8b-b0b1-447c28940fe6,IL-13-PE38QQR Cytoxin,Immunotherapy,,Dead,WITH TUMOR,,,635,MALE,61,C71.9,Brain,635
51e5a60f-e7b1-4b8b-b0b1-447c28940fe6,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,635,MALE,61,C71.9,Brain,635
51e5a60f-e7b1-4b8b-b0b1-447c28940fe6,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,,,635,MALE,61,C71.9,Brain,635
51e5a60f-e7b1-4b8b-b0b1-447c28940fe6,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,635,MALE,61,C71.9,Brain,635
51e5a60f-e7b1-4b8b-b0b1-447c28940fe6,LY317615,Targeted Molecular therapy,,Dead,WITH TUMOR,,,635,MALE,61,C71.9,Brain,635
ea8b757b-3d33-47e1-8657-503cf69939bb,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,221,FEMALE,17,C71.9,Brain,221
ea8b757b-3d33-47e1-8657-503cf69939bb,Thalidomide,Targeted Molecular therapy,,Dead,WITH TUMOR,,,221,FEMALE,17,C71.9,Brain,221
ea8b757b-3d33-47e1-8657-503cf69939bb,SCH63666,Targeted Molecular therapy,,Dead,WITH TUMOR,,,221,FEMALE,17,C71.9,Brain,221
ea8b757b-3d33-47e1-8657-503cf69939bb,Gleevec,Targeted Molecular therapy,,Dead,WITH TUMOR,,,221,FEMALE,17,C71.9,Brain,221
ea8b757b-3d33-47e1-8657-503cf69939bb,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,221,FEMALE,17,C71.9,Brain,221
1b042663-dcb1-4fc9-b813-7b90cc2eb392,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,486,MALE,52,C71.9,Brain,486
1b042663-dcb1-4fc9-b813-7b90cc2eb392,OS1-774,Targeted Molecular therapy,,Dead,WITH TUMOR,,,486,MALE,52,C71.9,Brain,486
1b042663-dcb1-4fc9-b813-7b90cc2eb392,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,486,MALE,52,C71.9,Brain,486
aaa7d45b-ce3c-4099-ab4a-377e3aee9f96,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,560,FEMALE,56,C71.9,Brain,560
aaa7d45b-ce3c-4099-ab4a-377e3aee9f96,IL-13 Pseudomonas exotoxin,Immunotherapy,,Dead,WITH TUMOR,,,560,FEMALE,56,C71.9,Brain,560
aaa7d45b-ce3c-4099-ab4a-377e3aee9f96,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,560,FEMALE,56,C71.9,Brain,560
c7b317a4-f5ba-4bd5-bbde-fd09418d3dee,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,230,MALE,64,C71.9,Brain,230
c7b317a4-f5ba-4bd5-bbde-fd09418d3dee,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,230,MALE,64,C71.9,Brain,230
141a1ef1-9be6-46d1-b445-305b222727d2,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,467,FEMALE,78,C71.9,Brain,467
141a1ef1-9be6-46d1-b445-305b222727d2,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,467,FEMALE,78,C71.9,Brain,467
141a1ef1-9be6-46d1-b445-305b222727d2,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,467,FEMALE,78,C71.9,Brain,467
141a1ef1-9be6-46d1-b445-305b222727d2,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,467,FEMALE,78,C71.9,Brain,467
141a1ef1-9be6-46d1-b445-305b222727d2,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,467,FEMALE,78,C71.9,Brain,467
141a1ef1-9be6-46d1-b445-305b222727d2,Gliadel wafers,Chemotherapy,,Dead,WITH TUMOR,,,467,FEMALE,78,C71.9,Brain,467
edcfac32-adb4-4fe7-86a0-309d3c6430e5,Hydroxyurea,Chemotherapy,,Dead,WITH TUMOR,,,448,FEMALE,36,C71.9,Brain,448
edcfac32-adb4-4fe7-86a0-309d3c6430e5,Rad001,Targeted Molecular therapy,,Dead,WITH TUMOR,,,448,FEMALE,36,C71.9,Brain,448
edcfac32-adb4-4fe7-86a0-309d3c6430e5,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,448,FEMALE,36,C71.9,Brain,448
edcfac32-adb4-4fe7-86a0-309d3c6430e5,Gleevac,Targeted Molecular therapy,,Dead,WITH TUMOR,,,448,FEMALE,36,C71.9,Brain,448
edcfac32-adb4-4fe7-86a0-309d3c6430e5,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,448,FEMALE,36,C71.9,Brain,448
edcfac32-adb4-4fe7-86a0-309d3c6430e5,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,448,FEMALE,36,C71.9,Brain,448
edcfac32-adb4-4fe7-86a0-309d3c6430e5,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,448,FEMALE,36,C71.9,Brain,448
edcfac32-adb4-4fe7-86a0-309d3c6430e5,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,448,FEMALE,36,C71.9,Brain,448
f7ba48c8-46cf-40a9-8826-7e1f67d57171,Gliadel wafers,Chemotherapy,,Dead,,,,395,MALE,49,C71.9,Brain,395
f7ba48c8-46cf-40a9-8826-7e1f67d57171,Temodar,Chemotherapy,,Dead,,,,395,MALE,49,C71.9,Brain,395
0389b35b-651b-4776-b12a-d315a100f47c,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
0389b35b-651b-4776-b12a-d315a100f47c,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
0389b35b-651b-4776-b12a-d315a100f47c,Gliadel Wafers,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
0389b35b-651b-4776-b12a-d315a100f47c,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
0389b35b-651b-4776-b12a-d315a100f47c,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
0389b35b-651b-4776-b12a-d315a100f47c,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
0389b35b-651b-4776-b12a-d315a100f47c,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
1dbfbff7-d048-4770-ae02-e6a287256210,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,318,MALE,57,C71.9,Brain,318
1dbfbff7-d048-4770-ae02-e6a287256210,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,318,MALE,57,C71.9,Brain,318
a7b55dae-c9b8-45c6-986f-fb1055f1c67b,Gliadel Wafers,Chemotherapy,,Dead,WITH TUMOR,,,320,MALE,65,C71.9,Brain,320
a7b55dae-c9b8-45c6-986f-fb1055f1c67b,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,320,MALE,65,C71.9,Brain,320
a7b55dae-c9b8-45c6-986f-fb1055f1c67b,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,320,MALE,65,C71.9,Brain,320
a7b55dae-c9b8-45c6-986f-fb1055f1c67b,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,320,MALE,65,C71.9,Brain,320
a7b55dae-c9b8-45c6-986f-fb1055f1c67b,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,320,MALE,65,C71.9,Brain,320
a7b55dae-c9b8-45c6-986f-fb1055f1c67b,O6B6,Targeted Molecular therapy,,Dead,WITH TUMOR,,,320,MALE,65,C71.9,Brain,320
a7b55dae-c9b8-45c6-986f-fb1055f1c67b,O6B6,Targeted Molecular therapy,,Dead,WITH TUMOR,,,320,MALE,65,C71.9,Brain,320
e67edc2e-5de7-4d3c-ba47-e8558a0b9f5a,MAb I-131,Targeted Molecular therapy,,Dead,WITH TUMOR,,,231,FEMALE,48,C71.9,Brain,231
e67edc2e-5de7-4d3c-ba47-e8558a0b9f5a,mu81c6,Targeted Molecular therapy,,Dead,WITH TUMOR,,,231,FEMALE,48,C71.9,Brain,231
c4ff28e5-9de7-43df-89a2-6832b8a0c00b,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,2883,FEMALE,48,C71.9,Brain,2883
c4ff28e5-9de7-43df-89a2-6832b8a0c00b,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,2883,FEMALE,48,C71.9,Brain,2883
c4ff28e5-9de7-43df-89a2-6832b8a0c00b,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,2883,FEMALE,48,C71.9,Brain,2883
c4ff28e5-9de7-43df-89a2-6832b8a0c00b,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,2883,FEMALE,48,C71.9,Brain,2883
c4ff28e5-9de7-43df-89a2-6832b8a0c00b,MAb I-131,Targeted Molecular therapy,,Dead,WITH TUMOR,,,2883,FEMALE,48,C71.9,Brain,2883
c4ff28e5-9de7-43df-89a2-6832b8a0c00b,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,2883,FEMALE,48,C71.9,Brain,2883
c4ff28e5-9de7-43df-89a2-6832b8a0c00b,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,2883,FEMALE,48,C71.9,Brain,2883
c4ff28e5-9de7-43df-89a2-6832b8a0c00b,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,2883,FEMALE,48,C71.9,Brain,2883
c4ff28e5-9de7-43df-89a2-6832b8a0c00b,mu81c6,Targeted Molecular therapy,,Dead,WITH TUMOR,,,2883,FEMALE,48,C71.9,Brain,2883
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,Gliadel Wafers,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,Cytoxan,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,Tamoxifen,Hormone Therapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,Tamoxiten,Hormone Therapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,06GB,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,06GB,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,Celbrex,Immunotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
a3cc2845-8a44-4b50-8a3e-17a3c2c3e077,Thalidomide,Immunotherapy,,Dead,WITH TUMOR,,,1161,MALE,51,C71.9,Brain,1161
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Temozolomide,Chemotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,CPT-11,Chemotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,MAB I131,Targeted Molecular therapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,CPT-11,Chemotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,CCNU,Chemotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,CCNU,Chemotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Temozolomide,Chemotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Celebrex,Immunotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Celebrex,Immunotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Celebrex,Immunotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Tamoxifen,Hormone Therapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Celebrex,Immunotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Tamoxifen,Hormone Therapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Celebrex,Immunotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,ch81c6,Targeted Molecular therapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,CCNU,Chemotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Celebrex,Immunotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Celebrex,Immunotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Temozolomide,Chemotherapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Tamoxifen,Hormone Therapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
f7dd387f-eca9-4028-b296-2ca6d56d3bde,Tamoxifen,Hormone Therapy,,Dead,,,,790,MALE,60,C71.9,Brain,790
65a48904-9532-4dfb-8e84-4deef1881197,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,811,MALE,74,C71.9,Brain,811
65a48904-9532-4dfb-8e84-4deef1881197,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,811,MALE,74,C71.9,Brain,811
65a48904-9532-4dfb-8e84-4deef1881197,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,811,MALE,74,C71.9,Brain,811
65a48904-9532-4dfb-8e84-4deef1881197,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,811,MALE,74,C71.9,Brain,811
65a48904-9532-4dfb-8e84-4deef1881197,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,811,MALE,74,C71.9,Brain,811
65a48904-9532-4dfb-8e84-4deef1881197,Tamoxiten,Hormone Therapy,,Dead,WITH TUMOR,,,811,MALE,74,C71.9,Brain,811
65a48904-9532-4dfb-8e84-4deef1881197,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,811,MALE,74,C71.9,Brain,811
bb0aca6b-55ab-4b24-8e64-29e0c96a9862,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,369,MALE,63,C71.9,Brain,369
bb0aca6b-55ab-4b24-8e64-29e0c96a9862,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,369,MALE,63,C71.9,Brain,369
24164e89-16ae-48c1-a464-9be94141deef,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,111,FEMALE,75,C71.9,Brain,111
0a85c7b4-f07d-4727-b9d2-7b14c52edabb,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,620,MALE,46,C71.9,Brain,620
0a85c7b4-f07d-4727-b9d2-7b14c52edabb,MAb I-131,Targeted Molecular therapy,,Dead,WITH TUMOR,,,620,MALE,46,C71.9,Brain,620
0a85c7b4-f07d-4727-b9d2-7b14c52edabb,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,620,MALE,46,C71.9,Brain,620
0a85c7b4-f07d-4727-b9d2-7b14c52edabb,mu81c6,Targeted Molecular therapy,,Dead,WITH TUMOR,,,620,MALE,46,C71.9,Brain,620
0a85c7b4-f07d-4727-b9d2-7b14c52edabb,Topecan,Chemotherapy,,Dead,WITH TUMOR,,,620,MALE,46,C71.9,Brain,620
29b34909-9cdc-4a52-b0ab-fa99f3ab17bb,cpt-11,Chemotherapy,,Dead,WITH TUMOR,,,458,MALE,52,C71.9,Brain,458
29b34909-9cdc-4a52-b0ab-fa99f3ab17bb,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,458,MALE,52,C71.9,Brain,458
29b34909-9cdc-4a52-b0ab-fa99f3ab17bb,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,458,MALE,52,C71.9,Brain,458
29b34909-9cdc-4a52-b0ab-fa99f3ab17bb,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,458,MALE,52,C71.9,Brain,458
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,ARIAD AP23573,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,Cytoxan,Chemotherapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,Sirolimus,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
3726b315-6cf8-49a3-a581-b7f3f4ca6e16,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1638,MALE,46,C71.9,Brain,1638
df4168bd-9f94-4323-9c33-a446a9fae999,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,Tamoxifen,Hormone Therapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,MAb I-131,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,MU81C6,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
df4168bd-9f94-4323-9c33-a446a9fae999,mu81c6,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1315,MALE,24,C71.9,Brain,1315
7751fc13-ec33-4057-965d-3b2ac6183344,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,232,FEMALE,75,C71.9,Brain,232
7751fc13-ec33-4057-965d-3b2ac6183344,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,232,FEMALE,75,C71.9,Brain,232
c1a00516-091c-480b-991e-7db4e0a30aea,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,296,MALE,52,C71.9,Brain,296
c1a00516-091c-480b-991e-7db4e0a30aea,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,296,MALE,52,C71.9,Brain,296
c1a00516-091c-480b-991e-7db4e0a30aea,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,296,MALE,52,C71.9,Brain,296
c1a00516-091c-480b-991e-7db4e0a30aea,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,296,MALE,52,C71.9,Brain,296
db5ea0e6-4cac-4f18-8643-32afb1e0287d,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,454,MALE,53,C71.9,Brain,454
db5ea0e6-4cac-4f18-8643-32afb1e0287d,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,454,MALE,53,C71.9,Brain,454
db5ea0e6-4cac-4f18-8643-32afb1e0287d,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,454,MALE,53,C71.9,Brain,454
db5ea0e6-4cac-4f18-8643-32afb1e0287d,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,454,MALE,53,C71.9,Brain,454
db5ea0e6-4cac-4f18-8643-32afb1e0287d,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,454,MALE,53,C71.9,Brain,454
db5ea0e6-4cac-4f18-8643-32afb1e0287d,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,454,MALE,53,C71.9,Brain,454
db5ea0e6-4cac-4f18-8643-32afb1e0287d,Rapamcyin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,454,MALE,53,C71.9,Brain,454
db5ea0e6-4cac-4f18-8643-32afb1e0287d,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,454,MALE,53,C71.9,Brain,454
db5ea0e6-4cac-4f18-8643-32afb1e0287d,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,454,MALE,53,C71.9,Brain,454
db5ea0e6-4cac-4f18-8643-32afb1e0287d,Rapamycin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,454,MALE,53,C71.9,Brain,454
120e257d-1cf1-421f-9a6b-6a5681eaea2e,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,452,FEMALE,51,C71.9,Brain,452
120e257d-1cf1-421f-9a6b-6a5681eaea2e,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,452,FEMALE,51,C71.9,Brain,452
120e257d-1cf1-421f-9a6b-6a5681eaea2e,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,452,FEMALE,51,C71.9,Brain,452
120e257d-1cf1-421f-9a6b-6a5681eaea2e,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,452,FEMALE,51,C71.9,Brain,452
120e257d-1cf1-421f-9a6b-6a5681eaea2e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,452,FEMALE,51,C71.9,Brain,452
120e257d-1cf1-421f-9a6b-6a5681eaea2e,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,452,FEMALE,51,C71.9,Brain,452
120e257d-1cf1-421f-9a6b-6a5681eaea2e,Rapamycin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,452,FEMALE,51,C71.9,Brain,452
e57b296a-80e9-4446-a3d1-3dbfeaf04f5e,VP-16,Chemotherapy,,Dead,,,,2791,FEMALE,45,C71.9,Brain,2791
e57b296a-80e9-4446-a3d1-3dbfeaf04f5e,MAB I-131,Targeted Molecular therapy,,Dead,,,,2791,FEMALE,45,C71.9,Brain,2791
e57b296a-80e9-4446-a3d1-3dbfeaf04f5e,CCNU,Chemotherapy,,Dead,,,,2791,FEMALE,45,C71.9,Brain,2791
e57b296a-80e9-4446-a3d1-3dbfeaf04f5e,81c6,Targeted Molecular therapy,,Dead,,,,2791,FEMALE,45,C71.9,Brain,2791
e57b296a-80e9-4446-a3d1-3dbfeaf04f5e,CCNU,Chemotherapy,,Dead,,,,2791,FEMALE,45,C71.9,Brain,2791
e57b296a-80e9-4446-a3d1-3dbfeaf04f5e,VP-16,Chemotherapy,,Dead,,,,2791,FEMALE,45,C71.9,Brain,2791
025a7401-a65d-4ea0-8b4e-0ba775b0322a,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,754,FEMALE,49,C71.9,Brain,754
025a7401-a65d-4ea0-8b4e-0ba775b0322a,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,754,FEMALE,49,C71.9,Brain,754
025a7401-a65d-4ea0-8b4e-0ba775b0322a,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,,,754,FEMALE,49,C71.9,Brain,754
025a7401-a65d-4ea0-8b4e-0ba775b0322a,Topotecan,Chemotherapy,,Dead,WITH TUMOR,,,754,FEMALE,49,C71.9,Brain,754
025a7401-a65d-4ea0-8b4e-0ba775b0322a,mu81c6,Targeted Molecular therapy,,Dead,WITH TUMOR,,,754,FEMALE,49,C71.9,Brain,754
025a7401-a65d-4ea0-8b4e-0ba775b0322a,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,754,FEMALE,49,C71.9,Brain,754
025a7401-a65d-4ea0-8b4e-0ba775b0322a,MAB I 131,Targeted Molecular therapy,,Dead,WITH TUMOR,,,754,FEMALE,49,C71.9,Brain,754
ca261ec9-888b-47c8-8e71-5a22545d7161,06-BG,Targeted Molecular therapy,,Dead,WITH TUMOR,,,562,MALE,40,C71.9,Brain,562
ca261ec9-888b-47c8-8e71-5a22545d7161,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,562,MALE,40,C71.9,Brain,562
ca261ec9-888b-47c8-8e71-5a22545d7161,06-BG,Targeted Molecular therapy,,Dead,WITH TUMOR,,,562,MALE,40,C71.9,Brain,562
ca261ec9-888b-47c8-8e71-5a22545d7161,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,562,MALE,40,C71.9,Brain,562
ca261ec9-888b-47c8-8e71-5a22545d7161,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,562,MALE,40,C71.9,Brain,562
ca261ec9-888b-47c8-8e71-5a22545d7161,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,562,MALE,40,C71.9,Brain,562
ca261ec9-888b-47c8-8e71-5a22545d7161,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,562,MALE,40,C71.9,Brain,562
ca261ec9-888b-47c8-8e71-5a22545d7161,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,562,MALE,40,C71.9,Brain,562
ca261ec9-888b-47c8-8e71-5a22545d7161,Tamoxifen,Hormone Therapy,,Dead,WITH TUMOR,,,562,MALE,40,C71.9,Brain,562
eae44c1c-1628-4b58-8b90-d3372e3577d5,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,323,MALE,62,C71.9,Brain,323
eae44c1c-1628-4b58-8b90-d3372e3577d5,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,323,MALE,62,C71.9,Brain,323
eae44c1c-1628-4b58-8b90-d3372e3577d5,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,323,MALE,62,C71.9,Brain,323
151ca826-a4d7-42eb-8684-f9fe7b93543f,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,715,MALE,46,C71.9,Brain,715
151ca826-a4d7-42eb-8684-f9fe7b93543f,SCH6636,Targeted Molecular therapy,,Dead,WITH TUMOR,,,715,MALE,46,C71.9,Brain,715
151ca826-a4d7-42eb-8684-f9fe7b93543f,SCH66336,Targeted Molecular therapy,,Dead,WITH TUMOR,,,715,MALE,46,C71.9,Brain,715
151ca826-a4d7-42eb-8684-f9fe7b93543f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,715,MALE,46,C71.9,Brain,715
151ca826-a4d7-42eb-8684-f9fe7b93543f,O6BG,Targeted Molecular therapy,,Dead,WITH TUMOR,,,715,MALE,46,C71.9,Brain,715
151ca826-a4d7-42eb-8684-f9fe7b93543f,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,715,MALE,46,C71.9,Brain,715
151ca826-a4d7-42eb-8684-f9fe7b93543f,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,715,MALE,46,C71.9,Brain,715
151ca826-a4d7-42eb-8684-f9fe7b93543f,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,715,MALE,46,C71.9,Brain,715
b75845ed-a19a-4caa-b362-e62b1e538152,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1179,FEMALE,38,C71.9,Brain,1179
b75845ed-a19a-4caa-b362-e62b1e538152,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1179,FEMALE,38,C71.9,Brain,1179
b75845ed-a19a-4caa-b362-e62b1e538152,81C6,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1179,FEMALE,38,C71.9,Brain,1179
b75845ed-a19a-4caa-b362-e62b1e538152,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1179,FEMALE,38,C71.9,Brain,1179
b75845ed-a19a-4caa-b362-e62b1e538152,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,1179,FEMALE,38,C71.9,Brain,1179
b75845ed-a19a-4caa-b362-e62b1e538152,MABI131,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1179,FEMALE,38,C71.9,Brain,1179
b75845ed-a19a-4caa-b362-e62b1e538152,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1179,FEMALE,38,C71.9,Brain,1179
b75845ed-a19a-4caa-b362-e62b1e538152,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1179,FEMALE,38,C71.9,Brain,1179
b75845ed-a19a-4caa-b362-e62b1e538152,Tamoxifen,Hormone Therapy,,Dead,WITH TUMOR,,,1179,FEMALE,38,C71.9,Brain,1179
dae7e5c3-0b17-419c-a5fc-3bb271222bce,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,272,MALE,57,C71.9,Brain,272
97094aed-69f7-4f4e-a87e-533979e11514,Temador,Chemotherapy,,Dead,WITH TUMOR,,,626,MALE,75,C71.9,Brain,626
97094aed-69f7-4f4e-a87e-533979e11514,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,626,MALE,75,C71.9,Brain,626
97094aed-69f7-4f4e-a87e-533979e11514,Temador,Chemotherapy,,Dead,WITH TUMOR,,,626,MALE,75,C71.9,Brain,626
97094aed-69f7-4f4e-a87e-533979e11514,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,626,MALE,75,C71.9,Brain,626
97094aed-69f7-4f4e-a87e-533979e11514,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,626,MALE,75,C71.9,Brain,626
97094aed-69f7-4f4e-a87e-533979e11514,Temador,Chemotherapy,,Dead,WITH TUMOR,,,626,MALE,75,C71.9,Brain,626
97094aed-69f7-4f4e-a87e-533979e11514,ATTAC,Immunotherapy,,Dead,WITH TUMOR,,,626,MALE,75,C71.9,Brain,626
ac72738c-8b33-4f03-917c-86b114a2b9bd,CCNU,Chemotherapy,,Dead,,,,3881,FEMALE,53,C71.9,Brain,3881
ac72738c-8b33-4f03-917c-86b114a2b9bd,CCNU,Chemotherapy,,Dead,,,,3881,FEMALE,53,C71.9,Brain,3881
4f50397e-c4bd-4408-b6e9-776b8a14c8a9,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,177,MALE,64,C71.9,Brain,177
aef8439b-2797-4c3a-b822-fcf640d200f6,Thalidomide,Chemotherapy,,Dead,WITH TUMOR,,,231,MALE,58,C71.9,Brain,231
aef8439b-2797-4c3a-b822-fcf640d200f6,Gliadel Waters,Chemotherapy,,Dead,WITH TUMOR,,,231,MALE,58,C71.9,Brain,231
aef8439b-2797-4c3a-b822-fcf640d200f6,Cyclophosphamide,Chemotherapy,,Dead,WITH TUMOR,,,231,MALE,58,C71.9,Brain,231
f8a5b835-b00b-421e-bdf5-9adb4ee84730,CCNG,Chemotherapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,VP-16,Chemotherapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,Tamoxiten,Hormone Therapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,CCNG,Chemotherapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,Tamoxifen,Hormone Therapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,Tamoxifen,Hormone Therapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
f8a5b835-b00b-421e-bdf5-9adb4ee84730,Tamoxifen,Hormone Therapy,,Dead,WITH TUMOR,,,1010,FEMALE,10,C71.9,Brain,1010
4c070166-025e-49b7-b4d0-fe25c8a355b1,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,661,MALE,58,C71.9,Brain,661
4c070166-025e-49b7-b4d0-fe25c8a355b1,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,661,MALE,58,C71.9,Brain,661
4c070166-025e-49b7-b4d0-fe25c8a355b1,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,661,MALE,58,C71.9,Brain,661
4c070166-025e-49b7-b4d0-fe25c8a355b1,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,661,MALE,58,C71.9,Brain,661
4c070166-025e-49b7-b4d0-fe25c8a355b1,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,661,MALE,58,C71.9,Brain,661
4c070166-025e-49b7-b4d0-fe25c8a355b1,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,661,MALE,58,C71.9,Brain,661
4c070166-025e-49b7-b4d0-fe25c8a355b1,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,661,MALE,58,C71.9,Brain,661
4c070166-025e-49b7-b4d0-fe25c8a355b1,Rapamycin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,661,MALE,58,C71.9,Brain,661
4c070166-025e-49b7-b4d0-fe25c8a355b1,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,661,MALE,58,C71.9,Brain,661
77d4d3ef-3fe0-4f93-a863-b5840926576c,Panzem,Chemotherapy,,Dead,WITH TUMOR,,,486,FEMALE,66,C71.9,Brain,486
77d4d3ef-3fe0-4f93-a863-b5840926576c,ATTAC,Immunotherapy,,Dead,WITH TUMOR,,,486,FEMALE,66,C71.9,Brain,486
77d4d3ef-3fe0-4f93-a863-b5840926576c,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,486,FEMALE,66,C71.9,Brain,486
77d4d3ef-3fe0-4f93-a863-b5840926576c,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,,,486,FEMALE,66,C71.9,Brain,486
77d4d3ef-3fe0-4f93-a863-b5840926576c,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,486,FEMALE,66,C71.9,Brain,486
dca3a016-5e89-4850-80bf-e78dc19a2453,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,372,MALE,56,C71.9,Brain,372
dca3a016-5e89-4850-80bf-e78dc19a2453,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,372,MALE,56,C71.9,Brain,372
dca3a016-5e89-4850-80bf-e78dc19a2453,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,372,MALE,56,C71.9,Brain,372
dca3a016-5e89-4850-80bf-e78dc19a2453,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,372,MALE,56,C71.9,Brain,372
dca3a016-5e89-4850-80bf-e78dc19a2453,CCNG,Chemotherapy,,Dead,WITH TUMOR,,,372,MALE,56,C71.9,Brain,372
dca3a016-5e89-4850-80bf-e78dc19a2453,ACT PEP3 KLH,Immunotherapy,,Dead,WITH TUMOR,,,372,MALE,56,C71.9,Brain,372
82a3f532-ae59-4d06-9bfc-e5e7519c0a33,VP 16,Chemotherapy,,Dead,WITH TUMOR,,,482,FEMALE,65,C71.9,Brain,482
82a3f532-ae59-4d06-9bfc-e5e7519c0a33,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,482,FEMALE,65,C71.9,Brain,482
82a3f532-ae59-4d06-9bfc-e5e7519c0a33,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,482,FEMALE,65,C71.9,Brain,482
82a3f532-ae59-4d06-9bfc-e5e7519c0a33,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,482,FEMALE,65,C71.9,Brain,482
82a3f532-ae59-4d06-9bfc-e5e7519c0a33,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,482,FEMALE,65,C71.9,Brain,482
82a3f532-ae59-4d06-9bfc-e5e7519c0a33,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,482,FEMALE,65,C71.9,Brain,482
b02aa13e-7fd9-40ba-9083-cbf7d4bfc948,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,277,MALE,55,C71.9,Brain,277
b02aa13e-7fd9-40ba-9083-cbf7d4bfc948,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,277,MALE,55,C71.9,Brain,277
b02aa13e-7fd9-40ba-9083-cbf7d4bfc948,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,277,MALE,55,C71.9,Brain,277
b02aa13e-7fd9-40ba-9083-cbf7d4bfc948,CPT-11,Chemotherapy,,Dead,WITH TUMOR,,,277,MALE,55,C71.9,Brain,277
f7106bb6-332a-4542-bc08-59bba48f4b04,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,442,MALE,61,C71.9,Brain,442
f7106bb6-332a-4542-bc08-59bba48f4b04,AMG 102,Targeted Molecular therapy,,Dead,WITH TUMOR,,,442,MALE,61,C71.9,Brain,442
f7106bb6-332a-4542-bc08-59bba48f4b04,VP 16,Chemotherapy,,Dead,WITH TUMOR,,,442,MALE,61,C71.9,Brain,442
f7106bb6-332a-4542-bc08-59bba48f4b04,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,442,MALE,61,C71.9,Brain,442
f7106bb6-332a-4542-bc08-59bba48f4b04,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,442,MALE,61,C71.9,Brain,442
a05c4aca-5b7c-452a-a92c-f252539f9e9a,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,121,FEMALE,75,C71.9,Brain,121
0d04d215-b709-40dd-9d18-d470cfb5bafd,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,126,FEMALE,68,C71.9,Brain,126
0d04d215-b709-40dd-9d18-d470cfb5bafd,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,126,FEMALE,68,C71.9,Brain,126
2b82e941-1b16-444e-af41-24dbc0a7e8b5,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,675,FEMALE,62,C71.9,Brain,675
2b82e941-1b16-444e-af41-24dbc0a7e8b5,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,675,FEMALE,62,C71.9,Brain,675
2b82e941-1b16-444e-af41-24dbc0a7e8b5,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,675,FEMALE,62,C71.9,Brain,675
2b82e941-1b16-444e-af41-24dbc0a7e8b5,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,675,FEMALE,62,C71.9,Brain,675
2b82e941-1b16-444e-af41-24dbc0a7e8b5,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,675,FEMALE,62,C71.9,Brain,675
2b82e941-1b16-444e-af41-24dbc0a7e8b5,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,675,FEMALE,62,C71.9,Brain,675
2b90648c-c99e-4d4d-8d9b-67ff2c4e6115,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,476,FEMALE,75,C71.9,Brain,476
2b90648c-c99e-4d4d-8d9b-67ff2c4e6115,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,476,FEMALE,75,C71.9,Brain,476
165b8f99-f7ba-4553-96ed-235e3f77e19c,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Sirolimus,Targeted Molecular therapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Hydroxyurea,Chemotherapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Hydroxyurea,Chemotherapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Gleevac,Targeted Molecular therapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Cytoxan,Chemotherapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Erlotinib,Targeted Molecular therapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Gleevac,Targeted Molecular therapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
165b8f99-f7ba-4553-96ed-235e3f77e19c,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,781,FEMALE,47,C71.9,Brain,781
12b67dc2-5e4c-48eb-92ba-8d91d2eadfe2,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,448,MALE,86,C71.9,Brain,448
12b67dc2-5e4c-48eb-92ba-8d91d2eadfe2,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,448,MALE,86,C71.9,Brain,448
8ac5b22f-3925-47a9-8d09-d819c2e191e5,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,206,MALE,58,C71.9,Brain,206
8ac5b22f-3925-47a9-8d09-d819c2e191e5,Temodor,Chemotherapy,,Dead,WITH TUMOR,,,206,MALE,58,C71.9,Brain,206
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Accutane,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Hydroxyuerea,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Rapamycin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,06BG,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Acctuane,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Rapamycin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,06BG,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Hydroxyurea,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Rapamycin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
f6c6e2c9-a3d6-4b81-a421-04ffef6b8744,Chloroquine,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1818,FEMALE,47,C71.9,Brain,1818
e8e43a65-4ec8-4e07-a884-a6989eec28cc,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1339,FEMALE,59,C71.9,Brain,1339
e8e43a65-4ec8-4e07-a884-a6989eec28cc,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1339,FEMALE,59,C71.9,Brain,1339
e8e43a65-4ec8-4e07-a884-a6989eec28cc,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1339,FEMALE,59,C71.9,Brain,1339
e8e43a65-4ec8-4e07-a884-a6989eec28cc,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,1339,FEMALE,59,C71.9,Brain,1339
e8e43a65-4ec8-4e07-a884-a6989eec28cc,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1339,FEMALE,59,C71.9,Brain,1339
e8e43a65-4ec8-4e07-a884-a6989eec28cc,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1339,FEMALE,59,C71.9,Brain,1339
e8e43a65-4ec8-4e07-a884-a6989eec28cc,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1339,FEMALE,59,C71.9,Brain,1339
e8e43a65-4ec8-4e07-a884-a6989eec28cc,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1339,FEMALE,59,C71.9,Brain,1339
407849a8-8447-4ede-a9d1-c1dfb535222e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,819,FEMALE,61,C71.9,Brain,819
407849a8-8447-4ede-a9d1-c1dfb535222e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,819,FEMALE,61,C71.9,Brain,819
407849a8-8447-4ede-a9d1-c1dfb535222e,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,819,FEMALE,61,C71.9,Brain,819
407849a8-8447-4ede-a9d1-c1dfb535222e,Vp 16,Chemotherapy,,Dead,WITH TUMOR,,,819,FEMALE,61,C71.9,Brain,819
407849a8-8447-4ede-a9d1-c1dfb535222e,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,819,FEMALE,61,C71.9,Brain,819
407849a8-8447-4ede-a9d1-c1dfb535222e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,819,FEMALE,61,C71.9,Brain,819
407849a8-8447-4ede-a9d1-c1dfb535222e,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,819,FEMALE,61,C71.9,Brain,819
407849a8-8447-4ede-a9d1-c1dfb535222e,PEP3 KLH,Immunotherapy,,Dead,WITH TUMOR,,,819,FEMALE,61,C71.9,Brain,819
93737759-b088-4d64-adfe-c2d5ec715341,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,463,MALE,76,C71.9,Brain,463
93737759-b088-4d64-adfe-c2d5ec715341,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,463,MALE,76,C71.9,Brain,463
93737759-b088-4d64-adfe-c2d5ec715341,ATTAC,Immunotherapy,,Dead,WITH TUMOR,,,463,MALE,76,C71.9,Brain,463
93737759-b088-4d64-adfe-c2d5ec715341,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,463,MALE,76,C71.9,Brain,463
93737759-b088-4d64-adfe-c2d5ec715341,ATTAC,Immunotherapy,,Dead,WITH TUMOR,,,463,MALE,76,C71.9,Brain,463
93737759-b088-4d64-adfe-c2d5ec715341,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,463,MALE,76,C71.9,Brain,463
93737759-b088-4d64-adfe-c2d5ec715341,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,463,MALE,76,C71.9,Brain,463
93737759-b088-4d64-adfe-c2d5ec715341,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,463,MALE,76,C71.9,Brain,463
5ef9486a-aeff-421d-b620-03ef119d85a5,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,Tarceva,Targeted Molecular therapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
5ef9486a-aeff-421d-b620-03ef119d85a5,VP 16,Chemotherapy,,Dead,WITH TUMOR,,,333,MALE,46,C71.9,Brain,333
d540d6d2-266c-48f9-8e73-304389b2060b,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,386,MALE,77,C71.9,Brain,386
d540d6d2-266c-48f9-8e73-304389b2060b,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,386,MALE,77,C71.9,Brain,386
d540d6d2-266c-48f9-8e73-304389b2060b,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,386,MALE,77,C71.9,Brain,386
d540d6d2-266c-48f9-8e73-304389b2060b,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,386,MALE,77,C71.9,Brain,386
d540d6d2-266c-48f9-8e73-304389b2060b,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,386,MALE,77,C71.9,Brain,386
d540d6d2-266c-48f9-8e73-304389b2060b,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,386,MALE,77,C71.9,Brain,386
159e0318-6173-440f-be07-8d956086e99d,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
159e0318-6173-440f-be07-8d956086e99d,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
159e0318-6173-440f-be07-8d956086e99d,VP 16,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
159e0318-6173-440f-be07-8d956086e99d,Hydroxurea,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
159e0318-6173-440f-be07-8d956086e99d,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
159e0318-6173-440f-be07-8d956086e99d,Gleevac,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
159e0318-6173-440f-be07-8d956086e99d,Hydroxurea,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
159e0318-6173-440f-be07-8d956086e99d,VP 16,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
159e0318-6173-440f-be07-8d956086e99d,Gleevac,Targeted Molecular therapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
159e0318-6173-440f-be07-8d956086e99d,CCNU,Chemotherapy,,Dead,WITH TUMOR,,,1062,MALE,60,C71.9,Brain,1062
2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,442,FEMALE,34,C71.9,Brain,442
2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,442,FEMALE,34,C71.9,Brain,442
2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,442,FEMALE,34,C71.9,Brain,442
2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd,Angiocept,Targeted Molecular therapy,,Dead,WITH TUMOR,,,442,FEMALE,34,C71.9,Brain,442
2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd,Daclizumab,Immunotherapy,,Dead,WITH TUMOR,,,442,FEMALE,34,C71.9,Brain,442
2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd,VP 16,Chemotherapy,,Dead,WITH TUMOR,,,442,FEMALE,34,C71.9,Brain,442
c970240f-03e2-4395-85be-5eb81a69b710,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,454,FEMALE,60,C71.9,Brain,454
c970240f-03e2-4395-85be-5eb81a69b710,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,454,FEMALE,60,C71.9,Brain,454
c970240f-03e2-4395-85be-5eb81a69b710,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,454,FEMALE,60,C71.9,Brain,454
c970240f-03e2-4395-85be-5eb81a69b710,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,454,FEMALE,60,C71.9,Brain,454
5327e899-a20d-4571-8236-98454bad574e,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,98,FEMALE,56,C71.9,Brain,98
5327e899-a20d-4571-8236-98454bad574e,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,98,FEMALE,56,C71.9,Brain,98
10efeb3c-ef55-4227-91b9-8c2bb4ff43d5,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,62,MALE,59,C71.9,Brain,62
cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6,Gliadel,Chemotherapy,,Dead,WITH TUMOR,,,460,MALE,49,C71.9,Brain,460
cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,460,MALE,49,C71.9,Brain,460
cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6,Temador,Chemotherapy,,Dead,WITH TUMOR,,,460,MALE,49,C71.9,Brain,460
cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,460,MALE,49,C71.9,Brain,460
70c887ce-43e1-4093-9a2f-a9d3dc62da78,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,364,MALE,70,C71.9,Brain,364
9b9654c9-5a64-4a8e-b1f0-987437e6012e,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,29,MALE,49,C71.9,Brain,29
27c8c458-eb2f-43e4-a06b-6cd61a9a3a28,Carboxy amido triazole,Chemotherapy,,Dead,WITH TUMOR,,,189,FEMALE,36,C71.9,Brain,189
27c8c458-eb2f-43e4-a06b-6cd61a9a3a28,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,189,FEMALE,36,C71.9,Brain,189
12824b2b-9c0a-4dcf-8941-34593a4e93da,CPT 11,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Etoposide,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Streptozocin,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Thalidomide,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Carmustine,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,6-Mercaptopurine,Chemotherapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
12824b2b-9c0a-4dcf-8941-34593a4e93da,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,701,FEMALE,50,C71.9,Brain,701
a2338b30-f511-4163-af3b-1e4a40ff00e1,Dexmethasone,Hormone Therapy,,Dead,,,,68,MALE,69,C71.9,Brain,68
a2338b30-f511-4163-af3b-1e4a40ff00e1,,Targeted Molecular therapy,,Dead,,,,68,MALE,69,C71.9,Brain,68
7cbabf1d-ec38-4048-ae1c-7d0f3001691b,Gliadel Wafer (BCNU),Chemotherapy,,Dead,,,,342,MALE,54,C71.9,Brain,342
7cbabf1d-ec38-4048-ae1c-7d0f3001691b,Temodar,Chemotherapy,,Dead,,,,342,MALE,54,C71.9,Brain,342
7cbabf1d-ec38-4048-ae1c-7d0f3001691b,Dexamethasone,Hormone Therapy,,Dead,,,,342,MALE,54,C71.9,Brain,342
7cbabf1d-ec38-4048-ae1c-7d0f3001691b,Dexamethazone,Hormone Therapy,,Dead,,,,342,MALE,54,C71.9,Brain,342
7fe37feb-e205-4524-8c98-1f9ac5fe0700,Gliadel BCNU,Chemotherapy,,Dead,WITH TUMOR,,,419,FEMALE,64,C71.9,Brain,419
7fe37feb-e205-4524-8c98-1f9ac5fe0700,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,419,FEMALE,64,C71.9,Brain,419
7fe37feb-e205-4524-8c98-1f9ac5fe0700,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,419,FEMALE,64,C71.9,Brain,419
eff7f13b-ed32-4e85-a8d0-831b655d773f,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,99,MALE,65,C71.9,Brain,99
eff7f13b-ed32-4e85-a8d0-831b655d773f,Gliadel Wafers,Chemotherapy,,Dead,WITH TUMOR,,,99,MALE,65,C71.9,Brain,99
cb58b5fe-ee0d-46f1-8502-1c8bcf729f3b,Dexamethasone,Hormone Therapy,,Dead,,,,41,MALE,78,C71.9,Brain,41
5a86d9f1-d38d-4b78-9a23-c7855a20ca2d,Dexamethasone,Hormone Therapy,,Dead,,,,164,FEMALE,69,C71.9,Brain,164
31b21dcf-7e13-4522-8b34-a5eb6c0e5d1d,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,88,MALE,60,C71.9,Brain,88
7d5c3699-ce28-4129-8391-736f670e8beb,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,502,MALE,67,C71.9,Brain,502
7d5c3699-ce28-4129-8391-736f670e8beb,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,502,MALE,67,C71.9,Brain,502
7d5c3699-ce28-4129-8391-736f670e8beb,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,502,MALE,67,C71.9,Brain,502
c3432b21-d2e9-4caf-9c8e-c6a8d92b195d,Dexamethasone,Hormone Therapy,,Dead,,,,801,MALE,55,C71.9,Brain,801
c3432b21-d2e9-4caf-9c8e-c6a8d92b195d,Temodar,Chemotherapy,,Dead,,,,801,MALE,55,C71.9,Brain,801
5c890137-e03c-4897-8af4-02aafa2fdb70,Dexamethasone,Hormone Therapy,,Dead,,,,62,MALE,67,C71.9,Brain,62
72f88d18-03be-4b51-9f4a-1151521b7292,Dexamethasone,Hormone Therapy,,Dead,,,,880,FEMALE,74,C71.9,Brain,880
0078b0c4-68a9-483b-9aab-61156d263213,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,485,FEMALE,60,C71.9,Brain,485
0078b0c4-68a9-483b-9aab-61156d263213,Gliadel,Chemotherapy,,Dead,WITH TUMOR,,,485,FEMALE,60,C71.9,Brain,485
0078b0c4-68a9-483b-9aab-61156d263213,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,485,FEMALE,60,C71.9,Brain,485
6a9d719d-249a-4756-adc8-e92fa60da229,Oxaliplatin,Chemotherapy,,Dead,WITH TUMOR,,,587,FEMALE,66,C71.9,Brain,587
6a9d719d-249a-4756-adc8-e92fa60da229,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,587,FEMALE,66,C71.9,Brain,587
6a9d719d-249a-4756-adc8-e92fa60da229,PS 341,Targeted Molecular therapy,,Dead,WITH TUMOR,,,587,FEMALE,66,C71.9,Brain,587
6a9d719d-249a-4756-adc8-e92fa60da229,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,587,FEMALE,66,C71.9,Brain,587
6a9d719d-249a-4756-adc8-e92fa60da229,Dexamethasome,Hormone Therapy,,Dead,WITH TUMOR,,,587,FEMALE,66,C71.9,Brain,587
a6cda2a0-21d9-4b72-a4c5-de1142d7ddb8,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,24,MALE,61,C71.9,Brain,24
74331114-65b1-4697-abc4-4769ff377528,Oxaliplatin,Chemotherapy,,Dead,WITH TUMOR,,,42,MALE,52,C71.9,Brain,42
74331114-65b1-4697-abc4-4769ff377528,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,42,MALE,52,C71.9,Brain,42
aad2c954-39a4-4ef3-9940-e754619007a4,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,34,FEMALE,78,C71.9,Brain,34
6176621d-8534-4fba-a0e7-74a5a78245a9,Dexamethsone,Hormone Therapy,,Dead,WITH TUMOR,,,114,MALE,54,C71.9,Brain,114
bf339349-062f-4ea9-a0b2-d87d3a21099e,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,975,FEMALE,58,C71.9,Brain,975
bf339349-062f-4ea9-a0b2-d87d3a21099e,Carboplatin,Chemotherapy,,Dead,WITH TUMOR,,,975,FEMALE,58,C71.9,Brain,975
bf339349-062f-4ea9-a0b2-d87d3a21099e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,975,FEMALE,58,C71.9,Brain,975
bf339349-062f-4ea9-a0b2-d87d3a21099e,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,975,FEMALE,58,C71.9,Brain,975
bf339349-062f-4ea9-a0b2-d87d3a21099e,Prednisone,Hormone Therapy,,Dead,WITH TUMOR,,,975,FEMALE,58,C71.9,Brain,975
bf339349-062f-4ea9-a0b2-d87d3a21099e,Sovatenib,Targeted Molecular therapy,,Dead,WITH TUMOR,,,975,FEMALE,58,C71.9,Brain,975
bf339349-062f-4ea9-a0b2-d87d3a21099e,Arsenic Trioxide,Chemotherapy,,Dead,WITH TUMOR,,,975,FEMALE,58,C71.9,Brain,975
bf339349-062f-4ea9-a0b2-d87d3a21099e,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,975,FEMALE,58,C71.9,Brain,975
f2ec3b94-cb92-4335-bdf9-02c046130bab,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,57,C71.9,Brain,
f2ec3b94-cb92-4335-bdf9-02c046130bab,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,57,C71.9,Brain,
f2ec3b94-cb92-4335-bdf9-02c046130bab,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,57,C71.9,Brain,
f2ec3b94-cb92-4335-bdf9-02c046130bab,Dexamethasone,Hormone Therapy,,Alive,WITH TUMOR,,,,FEMALE,57,C71.9,Brain,
f2ec3b94-cb92-4335-bdf9-02c046130bab,Dexamethasone,Hormone Therapy,,Alive,WITH TUMOR,,,,FEMALE,57,C71.9,Brain,
06c427a1-8c2d-4003-b744-139114a04440,Etoposide,Chemotherapy,,Dead,WITH TUMOR,,,703,MALE,39,C71.9,Brain,703
06c427a1-8c2d-4003-b744-139114a04440,Gliadel,Chemotherapy,,Dead,WITH TUMOR,,,703,MALE,39,C71.9,Brain,703
06c427a1-8c2d-4003-b744-139114a04440,Erlotinib,Targeted Molecular therapy,,Dead,WITH TUMOR,,,703,MALE,39,C71.9,Brain,703
06c427a1-8c2d-4003-b744-139114a04440,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,703,MALE,39,C71.9,Brain,703
06c427a1-8c2d-4003-b744-139114a04440,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,703,MALE,39,C71.9,Brain,703
06c427a1-8c2d-4003-b744-139114a04440,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,703,MALE,39,C71.9,Brain,703
06c427a1-8c2d-4003-b744-139114a04440,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,703,MALE,39,C71.9,Brain,703
06c427a1-8c2d-4003-b744-139114a04440,Oxaliplatin,Chemotherapy,,Dead,WITH TUMOR,,,703,MALE,39,C71.9,Brain,703
06c427a1-8c2d-4003-b744-139114a04440,Vincristin,Chemotherapy,,Dead,WITH TUMOR,,,703,MALE,39,C71.9,Brain,703
06c427a1-8c2d-4003-b744-139114a04440,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,703,MALE,39,C71.9,Brain,703
f82bfa67-4e72-4a09-8022-a2fe0050090f,Temador,Chemotherapy,,Dead,WITH TUMOR,,,216,MALE,60,C71.9,Brain,216
f82bfa67-4e72-4a09-8022-a2fe0050090f,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,216,MALE,60,C71.9,Brain,216
f82bfa67-4e72-4a09-8022-a2fe0050090f,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,216,MALE,60,C71.9,Brain,216
f82bfa67-4e72-4a09-8022-a2fe0050090f,Gliadel,Chemotherapy,,Dead,WITH TUMOR,,,216,MALE,60,C71.9,Brain,216
a9597785-a1d3-4788-a431-d25d69025690,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,35,MALE,69,C71.9,Brain,35
c2399f5d-dc29-42e9-81f1-1d164d4cc55d,Gliadel,Chemotherapy,,Dead,WITH TUMOR,,,918,FEMALE,54,C71.9,Brain,918
c2399f5d-dc29-42e9-81f1-1d164d4cc55d,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,918,FEMALE,54,C71.9,Brain,918
c2399f5d-dc29-42e9-81f1-1d164d4cc55d,Hydroxyurea,Chemotherapy,,Dead,WITH TUMOR,,,918,FEMALE,54,C71.9,Brain,918
c2399f5d-dc29-42e9-81f1-1d164d4cc55d,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,918,FEMALE,54,C71.9,Brain,918
c2399f5d-dc29-42e9-81f1-1d164d4cc55d,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,918,FEMALE,54,C71.9,Brain,918
c2399f5d-dc29-42e9-81f1-1d164d4cc55d,Gleevac,Chemotherapy,,Dead,WITH TUMOR,,,918,FEMALE,54,C71.9,Brain,918
04b4ebb4-6780-42d8-a980-711cd10cfe14,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,28,MALE,61,C71.9,Brain,28
04b4ebb4-6780-42d8-a980-711cd10cfe14,Gliadel wafer,Chemotherapy,,Dead,WITH TUMOR,,,28,MALE,61,C71.9,Brain,28
0fe6684a-5ab2-4999-b69d-d99aa5679c97,Dexamthasone,Hormone Therapy,,Alive,WITH TUMOR,,,,MALE,23,C71.9,Brain,
0fe6684a-5ab2-4999-b69d-d99aa5679c97,Tarceva,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,23,C71.9,Brain,
0fe6684a-5ab2-4999-b69d-d99aa5679c97,Arsenic Tnoxide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,23,C71.9,Brain,
0fe6684a-5ab2-4999-b69d-d99aa5679c97,Dexamethasone,Hormone Therapy,,Alive,WITH TUMOR,,,,MALE,23,C71.9,Brain,
0fe6684a-5ab2-4999-b69d-d99aa5679c97,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,23,C71.9,Brain,
0fe6684a-5ab2-4999-b69d-d99aa5679c97,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,23,C71.9,Brain,
5d2487b9-e0cd-40fc-a158-7b1803c8dc88,Temodar,Chemotherapy,,Dead,,,,203,MALE,54,C71.9,Brain,203
5d2487b9-e0cd-40fc-a158-7b1803c8dc88,Dexamethasone,Hormone Therapy,,Dead,,,,203,MALE,54,C71.9,Brain,203
5d2487b9-e0cd-40fc-a158-7b1803c8dc88,Avastin,Targeted Molecular therapy,,Dead,,,,203,MALE,54,C71.9,Brain,203
5d2487b9-e0cd-40fc-a158-7b1803c8dc88,Temodar,Chemotherapy,,Dead,,,,203,MALE,54,C71.9,Brain,203
5d2487b9-e0cd-40fc-a158-7b1803c8dc88,Dexaethasone,Hormone Therapy,,Dead,,,,203,MALE,54,C71.9,Brain,203
0798dbe2-1914-427c-a2fe-2a865d0d6eda,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,378,FEMALE,63,C71.9,Brain,378
0798dbe2-1914-427c-a2fe-2a865d0d6eda,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,378,FEMALE,63,C71.9,Brain,378
0798dbe2-1914-427c-a2fe-2a865d0d6eda,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,378,FEMALE,63,C71.9,Brain,378
eb9c8e66-6710-4141-ae28-1e5c88eaee47,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,30,MALE,59,C71.9,Brain,30
7db115ea-082b-45bb-97d2-4254270b8bb6,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,60,MALE,66,C71.9,Brain,60
7db115ea-082b-45bb-97d2-4254270b8bb6,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,60,MALE,66,C71.9,Brain,60
38dd826d-06dc-4a73-b852-c3d78c9c3ff4,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,541,MALE,31,C71.9,Brain,541
38dd826d-06dc-4a73-b852-c3d78c9c3ff4,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,541,MALE,31,C71.9,Brain,541
38dd826d-06dc-4a73-b852-c3d78c9c3ff4,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,541,MALE,31,C71.9,Brain,541
a515cf2d-e918-4958-9bf6-e611b425a97e,Gliadel Wafers,Chemotherapy,,Dead,WITH TUMOR,,,543,FEMALE,58,C71.9,Brain,543
a515cf2d-e918-4958-9bf6-e611b425a97e,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,543,FEMALE,58,C71.9,Brain,543
a515cf2d-e918-4958-9bf6-e611b425a97e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,543,FEMALE,58,C71.9,Brain,543
a515cf2d-e918-4958-9bf6-e611b425a97e,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,543,FEMALE,58,C71.9,Brain,543
a515cf2d-e918-4958-9bf6-e611b425a97e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,543,FEMALE,58,C71.9,Brain,543
a515cf2d-e918-4958-9bf6-e611b425a97e,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,543,FEMALE,58,C71.9,Brain,543
e0e1b5b3-6e3c-4b79-aa2a-32b320c3e45a,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,232,MALE,70,C71.9,Brain,232
e0e1b5b3-6e3c-4b79-aa2a-32b320c3e45a,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,232,MALE,70,C71.9,Brain,232
61ed8fbd-b753-451e-9683-edd4b266b0f3,Dexamethasone,Hormone Therapy,,Dead,,,,179,MALE,51,C71.9,Brain,179
61ed8fbd-b753-451e-9683-edd4b266b0f3,Cisplatin,Chemotherapy,,Dead,,,,179,MALE,51,C71.9,Brain,179
61ed8fbd-b753-451e-9683-edd4b266b0f3,BCNU,Chemotherapy,,Dead,,,,179,MALE,51,C71.9,Brain,179
47a4161c-9c61-48f5-b9bc-a6d1acad4e5a,Dexamethasone,Hormone Therapy,,Alive,WITH TUMOR,,,,MALE,57,C71.9,Brain,
47a4161c-9c61-48f5-b9bc-a6d1acad4e5a,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,57,C71.9,Brain,
b1c4579c-72fa-4974-830c-b6a81ace45f4,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,532,FEMALE,52,C71.9,Brain,532
5aa15b7f-35c7-4022-b1b2-74a4f6d3ea85,Dexamethasone,Hormone Therapy,,Alive,,,,,FEMALE,44,C71.9,Brain,
5aa15b7f-35c7-4022-b1b2-74a4f6d3ea85,Temodar,Chemotherapy,,Alive,,,,,FEMALE,44,C71.9,Brain,
872511fb-98cd-4fba-82f6-4c3689c75ae2,Dexamethasone,Hormone Therapy,,Dead,,,,12,MALE,74,C71.9,Brain,12
60e47b7d-c664-46c0-ac13-db688d4b8a58,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,38,C71.9,Brain,
60e47b7d-c664-46c0-ac13-db688d4b8a58,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,38,C71.9,Brain,
60e47b7d-c664-46c0-ac13-db688d4b8a58,Dexamethasone,Hormone Therapy,,Alive,WITH TUMOR,,,,FEMALE,38,C71.9,Brain,
38acdfc8-8abc-4d89-a68b-58c493650b48,Dexamethasone,Hormone Therapy,,Alive,,,,,MALE,40,C71.9,Brain,
38acdfc8-8abc-4d89-a68b-58c493650b48,Temodar,Chemotherapy,,Alive,,,,,MALE,40,C71.9,Brain,
38acdfc8-8abc-4d89-a68b-58c493650b48,Temodar,Chemotherapy,,Alive,,,,,MALE,40,C71.9,Brain,
f19850cb-50c4-4f3a-ba80-b1464958ffa8,Temozolomide,Chemotherapy,,Dead,,,,419,MALE,65,C71.9,Brain,419
f19850cb-50c4-4f3a-ba80-b1464958ffa8,SAHA,Targeted Molecular therapy,,Dead,,,,419,MALE,65,C71.9,Brain,419
05d5da50-52fe-4342-9c15-9ee4c1d6662e,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,55,C71.9,Brain,
03e9a354-7c95-4484-9ead-ed04acce7cb6,CPT-11,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,36,C71.9,Brain,
03e9a354-7c95-4484-9ead-ed04acce7cb6,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,36,C71.9,Brain,
03e9a354-7c95-4484-9ead-ed04acce7cb6,BCNU,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,36,C71.9,Brain,
2749c671-dee1-4d91-b3fa-4b50accf7a11,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,404,MALE,65,C71.9,Brain,404
f473a0d0-72b6-465e-93f7-122224960e80,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,71,C71.9,Brain,
a589e2dc-7649-492c-9569-592698acaa6f,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,,,666,FEMALE,48,C71.9,Brain,666
a589e2dc-7649-492c-9569-592698acaa6f,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,666,FEMALE,48,C71.9,Brain,666
a589e2dc-7649-492c-9569-592698acaa6f,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,666,FEMALE,48,C71.9,Brain,666
a589e2dc-7649-492c-9569-592698acaa6f,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,,,666,FEMALE,48,C71.9,Brain,666
a589e2dc-7649-492c-9569-592698acaa6f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,666,FEMALE,48,C71.9,Brain,666
a589e2dc-7649-492c-9569-592698acaa6f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,666,FEMALE,48,C71.9,Brain,666
a589e2dc-7649-492c-9569-592698acaa6f,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,666,FEMALE,48,C71.9,Brain,666
a589e2dc-7649-492c-9569-592698acaa6f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,666,FEMALE,48,C71.9,Brain,666
37a47ea2-1daa-44a4-ade5-84d383c2b13c,Temodar,Chemotherapy,,Alive,,,,,FEMALE,83,C71.9,Brain,
163e93a7-4d8d-4f28-a9f6-4d0ed16630cd,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,434,MALE,61,C71.9,Brain,434
163e93a7-4d8d-4f28-a9f6-4d0ed16630cd,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,434,MALE,61,C71.9,Brain,434
746aa9fb-0af2-4719-9d48-56e9bf21260c,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,70,C71.9,Brain,
a79b97df-d7f7-4df4-861b-936f94a1ab30,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,327,MALE,69,C71.9,Brain,327
a79b97df-d7f7-4df4-861b-936f94a1ab30,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,327,MALE,69,C71.9,Brain,327
fb86044c-161e-41d7-a49e-3d5ec18294ef,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,276,MALE,51,C71.9,Brain,276
fb86044c-161e-41d7-a49e-3d5ec18294ef,Tarceva,Chemotherapy,,Dead,WITH TUMOR,,,276,MALE,51,C71.9,Brain,276
fb86044c-161e-41d7-a49e-3d5ec18294ef,Tarceva,Chemotherapy,,Dead,WITH TUMOR,,,276,MALE,51,C71.9,Brain,276
fb86044c-161e-41d7-a49e-3d5ec18294ef,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,276,MALE,51,C71.9,Brain,276
fb86044c-161e-41d7-a49e-3d5ec18294ef,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,276,MALE,51,C71.9,Brain,276
2f8b698a-cbd0-4cab-a814-dc683e0e9305,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,81,C71.9,Brain,
166e76db-ccd8-4760-a517-d2bc8937ea29,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,394,MALE,58,C71.9,Brain,394
166e76db-ccd8-4760-a517-d2bc8937ea29,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,394,MALE,58,C71.9,Brain,394
166e76db-ccd8-4760-a517-d2bc8937ea29,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,394,MALE,58,C71.9,Brain,394
166e76db-ccd8-4760-a517-d2bc8937ea29,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,394,MALE,58,C71.9,Brain,394
309005a2-93a8-4566-b8d3-6b9310144266,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,141,MALE,51,C71.9,Brain,141
309005a2-93a8-4566-b8d3-6b9310144266,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,141,MALE,51,C71.9,Brain,141
309005a2-93a8-4566-b8d3-6b9310144266,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,141,MALE,51,C71.9,Brain,141
456bcab3-165d-456f-94e3-f34f81a61d2e,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,385,MALE,48,C71.9,Brain,385
456bcab3-165d-456f-94e3-f34f81a61d2e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,385,MALE,48,C71.9,Brain,385
456bcab3-165d-456f-94e3-f34f81a61d2e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,385,MALE,48,C71.9,Brain,385
456bcab3-165d-456f-94e3-f34f81a61d2e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,385,MALE,48,C71.9,Brain,385
9a41f05b-19b1-4269-9997-4b59e378280c,Temozolomide,Chemotherapy,,Dead,,,,112,MALE,39,C71.9,Brain,112
3a56ef5c-9259-4cdc-905e-5fcf21dac09b,Temozolomide,Chemotherapy,,Dead,,,,99,FEMALE,69,C71.9,Brain,99
aeeaf19a-3b0d-4c79-a029-44642581f4d8,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,154,MALE,56,C71.9,Brain,154
f2de4316-026c-4c2d-b091-47bc0ec8612a,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,55,C71.9,Brain,
f2de4316-026c-4c2d-b091-47bc0ec8612a,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,55,C71.9,Brain,
f2de4316-026c-4c2d-b091-47bc0ec8612a,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,55,C71.9,Brain,
352768f9-3ce1-419c-beef-6515c78f5d7a,Temozolomide,Chemotherapy,,Dead,TUMOR FREE,,,148,MALE,70,C71.9,Brain,148
c01ae0ee-fa58-45d2-ac33-d7f64d053bbb,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,65,C71.9,Brain,
c01ae0ee-fa58-45d2-ac33-d7f64d053bbb,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,65,C71.9,Brain,
c01ae0ee-fa58-45d2-ac33-d7f64d053bbb,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,65,C71.9,Brain,
e17a6048-7a72-42c0-ad3f-97cbff02bc9f,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,737,MALE,60,C71.9,Brain,737
e17a6048-7a72-42c0-ad3f-97cbff02bc9f,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,737,MALE,60,C71.9,Brain,737
e17a6048-7a72-42c0-ad3f-97cbff02bc9f,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,737,MALE,60,C71.9,Brain,737
a262928c-e20a-4c02-8114-1227e05c43e1,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,36,C71.9,Brain,
a262928c-e20a-4c02-8114-1227e05c43e1,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,36,C71.9,Brain,
a262928c-e20a-4c02-8114-1227e05c43e1,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,36,C71.9,Brain,
a262928c-e20a-4c02-8114-1227e05c43e1,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,36,C71.9,Brain,
ef646014-78a9-43af-b6fa-85fa288cd51b,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,FEMALE,68,C71.9,Brain,
ef646014-78a9-43af-b6fa-85fa288cd51b,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,FEMALE,68,C71.9,Brain,
ec56b685-022b-44b4-8051-d8bbbcc17ee0,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,52,C71.9,Brain,
ec56b685-022b-44b4-8051-d8bbbcc17ee0,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,523,FEMALE,52,C71.9,Brain,523
ec56b685-022b-44b4-8051-d8bbbcc17ee0,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,52,C71.9,Brain,
ec56b685-022b-44b4-8051-d8bbbcc17ee0,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,523,FEMALE,52,C71.9,Brain,523
ec56b685-022b-44b4-8051-d8bbbcc17ee0,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,52,C71.9,Brain,
ec56b685-022b-44b4-8051-d8bbbcc17ee0,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,523,FEMALE,52,C71.9,Brain,523
ec56b685-022b-44b4-8051-d8bbbcc17ee0,GDC-0449,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,52,C71.9,Brain,
ec56b685-022b-44b4-8051-d8bbbcc17ee0,GDC-0449,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,523,FEMALE,52,C71.9,Brain,523
61e00782-b709-43b1-a164-ee7f89c867e4,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,244,FEMALE,76,C71.9,Brain,244
18e04edc-04a3-4d1c-b536-3797e1924f48,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,72,C71.9,Brain,
18e04edc-04a3-4d1c-b536-3797e1924f48,Temodar,Chemotherapy,,Dead,WITH TUMOR,,Stable Disease,368,FEMALE,72,C71.9,Brain,368
18e04edc-04a3-4d1c-b536-3797e1924f48,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,72,C71.9,Brain,
18e04edc-04a3-4d1c-b536-3797e1924f48,Temodar,Chemotherapy,,Dead,WITH TUMOR,,Stable Disease,368,FEMALE,72,C71.9,Brain,368
7e70a318-3acc-42f3-8287-158a2199f0bc,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
7e70a318-3acc-42f3-8287-158a2199f0bc,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,684,FEMALE,53,C71.9,Brain,684
7e70a318-3acc-42f3-8287-158a2199f0bc,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
7e70a318-3acc-42f3-8287-158a2199f0bc,Avastin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,684,FEMALE,53,C71.9,Brain,684
7e70a318-3acc-42f3-8287-158a2199f0bc,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Brain,
7e70a318-3acc-42f3-8287-158a2199f0bc,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,684,FEMALE,53,C71.9,Brain,684
81622677-9742-40ea-ad60-5f9b2a624ea7,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,56,C71.9,Brain,
81622677-9742-40ea-ad60-5f9b2a624ea7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,428,MALE,56,C71.9,Brain,428
81622677-9742-40ea-ad60-5f9b2a624ea7,Avastin,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,56,C71.9,Brain,
81622677-9742-40ea-ad60-5f9b2a624ea7,Avastin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,428,MALE,56,C71.9,Brain,428
81622677-9742-40ea-ad60-5f9b2a624ea7,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,56,C71.9,Brain,
81622677-9742-40ea-ad60-5f9b2a624ea7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,428,MALE,56,C71.9,Brain,428
42e92d73-29eb-4508-a653-9b77f36021c0,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,77,C71.9,Brain,
42e92d73-29eb-4508-a653-9b77f36021c0,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,511,FEMALE,77,C71.9,Brain,511
42e92d73-29eb-4508-a653-9b77f36021c0,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,77,C71.9,Brain,
42e92d73-29eb-4508-a653-9b77f36021c0,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,511,FEMALE,77,C71.9,Brain,511
42e92d73-29eb-4508-a653-9b77f36021c0,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,77,C71.9,Brain,
42e92d73-29eb-4508-a653-9b77f36021c0,Avastin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,511,FEMALE,77,C71.9,Brain,511
93ed7a2b-b0cb-4a84-871f-5c34a0b6a640,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,56,C71.9,Brain,
93ed7a2b-b0cb-4a84-871f-5c34a0b6a640,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,455,MALE,56,C71.9,Brain,455
93ed7a2b-b0cb-4a84-871f-5c34a0b6a640,Avastin,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,56,C71.9,Brain,
93ed7a2b-b0cb-4a84-871f-5c34a0b6a640,Avastin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,455,MALE,56,C71.9,Brain,455
93ed7a2b-b0cb-4a84-871f-5c34a0b6a640,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,56,C71.9,Brain,
93ed7a2b-b0cb-4a84-871f-5c34a0b6a640,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,455,MALE,56,C71.9,Brain,455
D8628D35-C4C6-443F-9DA2-8517A157F137,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,39,C71.9,Brain,
D8628D35-C4C6-443F-9DA2-8517A157F137,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,39,C71.9,Brain,
7638E294-2DCF-4C03-B238-24E40491C2AD,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,40,C71.9,Brain,
7638E294-2DCF-4C03-B238-24E40491C2AD,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,40,C71.9,Brain,
7638E294-2DCF-4C03-B238-24E40491C2AD,Avastin,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,40,C71.9,Brain,
7638E294-2DCF-4C03-B238-24E40491C2AD,Lomustine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,40,C71.9,Brain,
17dffffc-65d6-4209-9075-18a441001f0f,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,36,C71.9,Brain,
17dffffc-65d6-4209-9075-18a441001f0f,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,36,C71.9,Brain,
17dffffc-65d6-4209-9075-18a441001f0f,Recentin Placebo AXDX2171,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,36,C71.9,Brain,
17dffffc-65d6-4209-9075-18a441001f0f,Lomustine,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,36,C71.9,Brain,
a6312802-12ad-4545-8109-178a7ebd618f,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,422,MALE,63,C71.9,Brain,422
9b775a6a-242a-4bfa-818d-d2d2f5bac5bf,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,48,C71.9,Brain,
9b775a6a-242a-4bfa-818d-d2d2f5bac5bf,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,48,C71.9,Brain,
c29d73c0-c885-4105-bf74-38e9178e71c9,Motexafin Gadolinium,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,43,C71.9,Brain,
c29d73c0-c885-4105-bf74-38e9178e71c9,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,43,C71.9,Brain,
c29d73c0-c885-4105-bf74-38e9178e71c9,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,43,C71.9,Brain,
e4aafd82-fd32-4a52-96fe-21a21297849f,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,60,C71.9,Brain,
e4aafd82-fd32-4a52-96fe-21a21297849f,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,60,C71.9,Brain,
ff61d536-b505-47e7-9d3c-a7252e9037a1,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,285,MALE,68,C71.9,Brain,285
2c5fa2d4-8e35-42e4-8bca-9fb3371a19c8,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,74,C71.9,Brain,
2c5fa2d4-8e35-42e4-8bca-9fb3371a19c8,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,74,C71.9,Brain,
a28b256e-e085-467d-bdba-5c39718012d7,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,59,C71.9,Brain,
a28b256e-e085-467d-bdba-5c39718012d7,Temozolamide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,59,C71.9,Brain,
a28b256e-e085-467d-bdba-5c39718012d7,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,59,C71.9,Brain,
60e69f41-571e-4a1b-ae75-9d49eed620ca,Cilengitide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,57,C71.9,Brain,
60e69f41-571e-4a1b-ae75-9d49eed620ca,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,57,C71.9,Brain,
60e69f41-571e-4a1b-ae75-9d49eed620ca,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,57,C71.9,Brain,
60e69f41-571e-4a1b-ae75-9d49eed620ca,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,57,C71.9,Brain,
4b606edf-07fc-4665-a7cd-a794004e5aca,Temozolomide,Chemotherapy,,Alive,,,,,FEMALE,65,C71.9,Brain,
5F9BAF9B-6D2D-495A-83A1-77F7E4CB9CCD,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,47,C71.9,Brain,
5F9BAF9B-6D2D-495A-83A1-77F7E4CB9CCD,Lomustine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,47,C71.9,Brain,
5F9BAF9B-6D2D-495A-83A1-77F7E4CB9CCD,Avastin,Targeted Molecular therapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,47,C71.9,Brain,
6e72d2e2-96fe-4fbb-9fe6-39ec28753eb6,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,154,MALE,57,C71.9,Brain,154
6e72d2e2-96fe-4fbb-9fe6-39ec28753eb6,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,154,MALE,57,C71.9,Brain,154
6e72d2e2-96fe-4fbb-9fe6-39ec28753eb6,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,154,MALE,57,C71.9,Brain,154
f45f4a30-6b4c-4f15-9140-959d6a25a45f,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,505,MALE,66,C71.9,Brain,505
f45f4a30-6b4c-4f15-9140-959d6a25a45f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,505,MALE,66,C71.9,Brain,505
f45f4a30-6b4c-4f15-9140-959d6a25a45f,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,505,MALE,66,C71.9,Brain,505
f45f4a30-6b4c-4f15-9140-959d6a25a45f,Oxcarbazepine,Hormone Therapy,,Dead,WITH TUMOR,,,505,MALE,66,C71.9,Brain,505
dd76930a-1678-4b70-9864-730534174d41,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,300,FEMALE,59,C71.9,Brain,300
dd76930a-1678-4b70-9864-730534174d41,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,300,FEMALE,59,C71.9,Brain,300
dd76930a-1678-4b70-9864-730534174d41,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,300,FEMALE,59,C71.9,Brain,300
f40e45c8-2042-4844-99b5-b629f20afd58,Fotemustine,Chemotherapy,,Dead,WITH TUMOR,,,737,FEMALE,67,C71.9,Brain,737
f40e45c8-2042-4844-99b5-b629f20afd58,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,737,FEMALE,67,C71.9,Brain,737
f40e45c8-2042-4844-99b5-b629f20afd58,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,737,FEMALE,67,C71.9,Brain,737
f40e45c8-2042-4844-99b5-b629f20afd58,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,737,FEMALE,67,C71.9,Brain,737
f40e45c8-2042-4844-99b5-b629f20afd58,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,737,FEMALE,67,C71.9,Brain,737
7340f325-579f-4b90-96aa-3a7b362129ca,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,1233,MALE,56,C71.9,Brain,1233
7340f325-579f-4b90-96aa-3a7b362129ca,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,,1233,MALE,56,C71.9,Brain,1233
7340f325-579f-4b90-96aa-3a7b362129ca,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,1233,MALE,56,C71.9,Brain,1233
7340f325-579f-4b90-96aa-3a7b362129ca,Fotemustine,Chemotherapy,,Dead,WITH TUMOR,,,1233,MALE,56,C71.9,Brain,1233
7340f325-579f-4b90-96aa-3a7b362129ca,Temozolomoide,Chemotherapy,,Dead,WITH TUMOR,,,1233,MALE,56,C71.9,Brain,1233
7340f325-579f-4b90-96aa-3a7b362129ca,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,1233,MALE,56,C71.9,Brain,1233
987cb702-057b-4198-8ef3-9cf6a9c51989,PC2,Chemotherapy,,Dead,WITH TUMOR,,,648,FEMALE,53,C71.9,Brain,648
987cb702-057b-4198-8ef3-9cf6a9c51989,Levetiracetam,Hormone Therapy,,Dead,WITH TUMOR,,,648,FEMALE,53,C71.9,Brain,648
987cb702-057b-4198-8ef3-9cf6a9c51989,BCNU,Chemotherapy,,Dead,WITH TUMOR,,,648,FEMALE,53,C71.9,Brain,648
987cb702-057b-4198-8ef3-9cf6a9c51989,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,648,FEMALE,53,C71.9,Brain,648
987cb702-057b-4198-8ef3-9cf6a9c51989,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,648,FEMALE,53,C71.9,Brain,648
987cb702-057b-4198-8ef3-9cf6a9c51989,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,648,FEMALE,53,C71.9,Brain,648
987cb702-057b-4198-8ef3-9cf6a9c51989,FT,Chemotherapy,,Dead,WITH TUMOR,,,648,FEMALE,53,C71.9,Brain,648
4d18f820-6396-46ae-b5d6-4ba446279be8,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,914,FEMALE,33,C71.9,Brain,914
4d18f820-6396-46ae-b5d6-4ba446279be8,Fotemustine,Chemotherapy,,Dead,WITH TUMOR,,,914,FEMALE,33,C71.9,Brain,914
4d18f820-6396-46ae-b5d6-4ba446279be8,Bevacizumab,Chemotherapy,,Dead,WITH TUMOR,,,914,FEMALE,33,C71.9,Brain,914
4d18f820-6396-46ae-b5d6-4ba446279be8,Valproic Acid,Hormone Therapy,,Dead,WITH TUMOR,,,914,FEMALE,33,C71.9,Brain,914
4d18f820-6396-46ae-b5d6-4ba446279be8,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,914,FEMALE,33,C71.9,Brain,914
4d18f820-6396-46ae-b5d6-4ba446279be8,PCB,Chemotherapy,,Dead,WITH TUMOR,,,914,FEMALE,33,C71.9,Brain,914
4d18f820-6396-46ae-b5d6-4ba446279be8,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,,,914,FEMALE,33,C71.9,Brain,914
4d18f820-6396-46ae-b5d6-4ba446279be8,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,914,FEMALE,33,C71.9,Brain,914
4d18f820-6396-46ae-b5d6-4ba446279be8,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,914,FEMALE,33,C71.9,Brain,914
bc7a0c8f-c1c1-447c-8019-389e52525081,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,427,MALE,36,C71.9,Brain,427
bc7a0c8f-c1c1-447c-8019-389e52525081,Doxorubicin,Chemotherapy,,Dead,WITH TUMOR,,,427,MALE,36,C71.9,Brain,427
bc7a0c8f-c1c1-447c-8019-389e52525081,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,427,MALE,36,C71.9,Brain,427
bc7a0c8f-c1c1-447c-8019-389e52525081,CDDP,Chemotherapy,,Dead,WITH TUMOR,,,427,MALE,36,C71.9,Brain,427
6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,350,FEMALE,59,C71.9,Brain,350
6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,350,FEMALE,59,C71.9,Brain,350
6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02,Oxcarbazepine,Hormone Therapy,,Dead,WITH TUMOR,,,350,FEMALE,59,C71.9,Brain,350
6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,350,FEMALE,59,C71.9,Brain,350
d3d27286-73e1-4cdd-914a-34c210fd6398,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,753,MALE,52,C71.9,Brain,753
d3d27286-73e1-4cdd-914a-34c210fd6398,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,753,MALE,52,C71.9,Brain,753
d3d27286-73e1-4cdd-914a-34c210fd6398,Fotemustine,Chemotherapy,,Dead,WITH TUMOR,,,753,MALE,52,C71.9,Brain,753
d3d27286-73e1-4cdd-914a-34c210fd6398,PC2,Chemotherapy,,Dead,WITH TUMOR,,,753,MALE,52,C71.9,Brain,753
d3d27286-73e1-4cdd-914a-34c210fd6398,Levenracetam,Hormone Therapy,,Dead,WITH TUMOR,,,753,MALE,52,C71.9,Brain,753
d3d27286-73e1-4cdd-914a-34c210fd6398,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,753,MALE,52,C71.9,Brain,753
6ff96a7e-1b96-4530-b8a8-7f2e9e541955,Fotemustine,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,48,C71.9,Brain,
6ff96a7e-1b96-4530-b8a8-7f2e9e541955,Fotemustine,Chemotherapy,,Dead,,Scheduled Follow-up Submission,,550,MALE,48,C71.9,Brain,550
6ff96a7e-1b96-4530-b8a8-7f2e9e541955,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,48,C71.9,Brain,
6ff96a7e-1b96-4530-b8a8-7f2e9e541955,Temozolomide,Chemotherapy,,Dead,,Scheduled Follow-up Submission,,550,MALE,48,C71.9,Brain,550
6ff96a7e-1b96-4530-b8a8-7f2e9e541955,Levetiracetam,Hormone Therapy,,Alive,WITH TUMOR,,,,MALE,48,C71.9,Brain,
6ff96a7e-1b96-4530-b8a8-7f2e9e541955,Levetiracetam,Hormone Therapy,,Dead,,Scheduled Follow-up Submission,,550,MALE,48,C71.9,Brain,550
6ff96a7e-1b96-4530-b8a8-7f2e9e541955,Dexamethasone,Hormone Therapy,,Alive,WITH TUMOR,,,,MALE,48,C71.9,Brain,
6ff96a7e-1b96-4530-b8a8-7f2e9e541955,Dexamethasone,Hormone Therapy,,Dead,,Scheduled Follow-up Submission,,550,MALE,48,C71.9,Brain,550
6ff96a7e-1b96-4530-b8a8-7f2e9e541955,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,48,C71.9,Brain,
6ff96a7e-1b96-4530-b8a8-7f2e9e541955,Temozolomide,Chemotherapy,,Dead,,Scheduled Follow-up Submission,,550,MALE,48,C71.9,Brain,550
4776b959-d5f5-41ad-ab39-dba6031f6884,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,34,C71.9,Brain,
4776b959-d5f5-41ad-ab39-dba6031f6884,Temozolomide,Chemotherapy,,Dead,,Scheduled Follow-up Submission,,510,MALE,34,C71.9,Brain,510
4776b959-d5f5-41ad-ab39-dba6031f6884,Levetiracetam,Hormone Therapy,,Alive,WITH TUMOR,,,,MALE,34,C71.9,Brain,
4776b959-d5f5-41ad-ab39-dba6031f6884,Levetiracetam,Hormone Therapy,,Dead,,Scheduled Follow-up Submission,,510,MALE,34,C71.9,Brain,510
4776b959-d5f5-41ad-ab39-dba6031f6884,Dexamethasone,Hormone Therapy,,Alive,WITH TUMOR,,,,MALE,34,C71.9,Brain,
4776b959-d5f5-41ad-ab39-dba6031f6884,Dexamethasone,Hormone Therapy,,Dead,,Scheduled Follow-up Submission,,510,MALE,34,C71.9,Brain,510
737b35e1-d668-4fce-9b6e-76946c7952b6,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,489,MALE,63,C71.9,Brain,489
737b35e1-d668-4fce-9b6e-76946c7952b6,Erlotinib,Chemotherapy,,Dead,WITH TUMOR,,,489,MALE,63,C71.9,Brain,489
737b35e1-d668-4fce-9b6e-76946c7952b6,Phenytoin Sodium,Hormone Therapy,,Dead,WITH TUMOR,,,489,MALE,63,C71.9,Brain,489
737b35e1-d668-4fce-9b6e-76946c7952b6,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,489,MALE,63,C71.9,Brain,489
737b35e1-d668-4fce-9b6e-76946c7952b6,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,489,MALE,63,C71.9,Brain,489
737b35e1-d668-4fce-9b6e-76946c7952b6,Lumustine,Chemotherapy,,Dead,WITH TUMOR,,,489,MALE,63,C71.9,Brain,489
a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff,Oxcarbazepine,Hormone Therapy,,Dead,WITH TUMOR,,,231,MALE,56,C71.9,Brain,231
a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,231,MALE,56,C71.9,Brain,231
a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,231,MALE,56,C71.9,Brain,231
a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,231,MALE,56,C71.9,Brain,231
69d0a566-5fbf-45f6-a240-649b06868e27,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,87,FEMALE,79,C71.9,Brain,87
a61e88cd-5121-4e6e-9319-2978071547c3,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,438,MALE,81,C71.9,Brain,438
a61e88cd-5121-4e6e-9319-2978071547c3,Valproic acid,Hormone Therapy,,Dead,WITH TUMOR,,,438,MALE,81,C71.9,Brain,438
be3a7ef3-34ed-40e1-9d9c-187940596b26,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,480,MALE,62,C71.9,Brain,480
be3a7ef3-34ed-40e1-9d9c-187940596b26,Cisplatin,Chemotherapy,,Dead,WITH TUMOR,,,480,MALE,62,C71.9,Brain,480
be3a7ef3-34ed-40e1-9d9c-187940596b26,Dexamethasone,Hormone Therapy,,Dead,WITH TUMOR,,,480,MALE,62,C71.9,Brain,480
be3a7ef3-34ed-40e1-9d9c-187940596b26,Levetiracetam,Hormone Therapy,,Dead,WITH TUMOR,,,480,MALE,62,C71.9,Brain,480
be3a7ef3-34ed-40e1-9d9c-187940596b26,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,480,MALE,62,C71.9,Brain,480
1e2108e8-b620-4865-a8d8-77f9a0fe28a2,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,76,C71.9,Brain,
1e2108e8-b620-4865-a8d8-77f9a0fe28a2,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,76,C71.9,Brain,
1e2108e8-b620-4865-a8d8-77f9a0fe28a2,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,76,C71.9,Brain,
35a7e49e-747b-45ce-9a07-3a5faba0ca94,Temodar,Chemotherapy,,Dead,,,,77,MALE,44,C71.9,Brain,77
b92047e1-8a76-46dd-baa7-6e629cfaebdb,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,73,C71.9,Brain,
b92047e1-8a76-46dd-baa7-6e629cfaebdb,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,73,C71.9,Brain,
b92047e1-8a76-46dd-baa7-6e629cfaebdb,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,73,C71.9,Brain,
f077df02-5056-402f-8522-7198c42bcc98,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,40,C71.9,Brain,
f077df02-5056-402f-8522-7198c42bcc98,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,40,C71.9,Brain,
f077df02-5056-402f-8522-7198c42bcc98,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,40,C71.9,Brain,
28df4629-204f-4352-a19f-303a2e067633,Dendriticcell Vaccine,Immunotherapy,,Alive,WITH TUMOR,,,,FEMALE,61,C71.9,Brain,
28df4629-204f-4352-a19f-303a2e067633,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,61,C71.9,Brain,
28df4629-204f-4352-a19f-303a2e067633,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,61,C71.9,Brain,
28df4629-204f-4352-a19f-303a2e067633,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,61,C71.9,Brain,
68f6976e-d3f2-432d-a121-274e228735b0,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,42,C71.9,Brain,
68f6976e-d3f2-432d-a121-274e228735b0,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,42,C71.9,Brain,
68f6976e-d3f2-432d-a121-274e228735b0,Dendriticcell Vaccine,Immunotherapy,,Alive,WITH TUMOR,,,,FEMALE,42,C71.9,Brain,
68f6976e-d3f2-432d-a121-274e228735b0,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,42,C71.9,Brain,
68f6976e-d3f2-432d-a121-274e228735b0,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,42,C71.9,Brain,
3c5e7a3f-29b3-4af4-9023-dc7b151f0445,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,47,FEMALE,52,C71.9,Brain,47
0c0333c9-60dc-4487-baa2-7ec27acced27,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,78,C71.9,Brain,
b7b86c1f-9688-4129-891c-843e3a37b3e5,Tarceva,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,48,C71.9,Brain,
b7b86c1f-9688-4129-891c-843e3a37b3e5,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,48,C71.9,Brain,
b7b86c1f-9688-4129-891c-843e3a37b3e5,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,48,C71.9,Brain,
ec1791b3-0192-45da-89c1-f942a6736704,Tumor Vaccine,Immunotherapy,,Alive,WITH TUMOR,,,,FEMALE,63,C71.9,Brain,
ec1791b3-0192-45da-89c1-f942a6736704,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,63,C71.9,Brain,
ec1791b3-0192-45da-89c1-f942a6736704,BIBW 2992,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,63,C71.9,Brain,
aa7ad106-eadc-489e-83b2-5698652434ea,Temodar,Chemotherapy,,Alive,,,,,FEMALE,77,C71.9,Brain,
aa7ad106-eadc-489e-83b2-5698652434ea,Cilenaitide,Targeted Molecular therapy,,Alive,,,,,FEMALE,77,C71.9,Brain,
4ca9c0f2-1be9-4376-aa27-d9db948d3f68,Etoposide,Chemotherapy,,Dead,WITH TUMOR,,,343,MALE,37,C71.9,Brain,343
4ca9c0f2-1be9-4376-aa27-d9db948d3f68,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,343,MALE,37,C71.9,Brain,343
30256f61-7be9-4d47-8afd-afafa7a079c0,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,69,C71.9,Brain,
30256f61-7be9-4d47-8afd-afafa7a079c0,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,69,C71.9,Brain,
30256f61-7be9-4d47-8afd-afafa7a079c0,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,69,C71.9,Brain,
350232cb-b9ba-465b-be9a-81afbc6a92e9,Temozolomide,Chemotherapy,,Alive,,,,,MALE,45,C71.9,Brain,
28da11ec-f46a-4abc-b4c8-bbb784419c71,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,454,MALE,72,C71.9,Brain,454
28da11ec-f46a-4abc-b4c8-bbb784419c71,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,454,MALE,72,C71.9,Brain,454
28da11ec-f46a-4abc-b4c8-bbb784419c71,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,454,MALE,72,C71.9,Brain,454
28da11ec-f46a-4abc-b4c8-bbb784419c71,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,454,MALE,72,C71.9,Brain,454
d9fcf27f-48e3-43fd-a8cf-3db246cf4221,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,343,MALE,71,C71.9,Brain,343
d9fcf27f-48e3-43fd-a8cf-3db246cf4221,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,343,MALE,71,C71.9,Brain,343
d9fcf27f-48e3-43fd-a8cf-3db246cf4221,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,343,MALE,71,C71.9,Brain,343
d9fcf27f-48e3-43fd-a8cf-3db246cf4221,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,343,MALE,71,C71.9,Brain,343
d9fcf27f-48e3-43fd-a8cf-3db246cf4221,,Chemotherapy,,Dead,WITH TUMOR,,,343,MALE,71,C71.9,Brain,343
d9fcf27f-48e3-43fd-a8cf-3db246cf4221,,Chemotherapy,,Dead,WITH TUMOR,,,343,MALE,71,C71.9,Brain,343
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,Progressive Disease,Dead,,Scheduled Follow-up Submission,Progressive Disease,544,MALE,52,C71.9,Brain,544
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,Progressive Disease,Dead,,Scheduled Follow-up Submission,Progressive Disease,544,MALE,52,C71.9,Brain,544
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Avastin,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Avastin,Chemotherapy,Progressive Disease,Dead,,Scheduled Follow-up Submission,Progressive Disease,544,MALE,52,C71.9,Brain,544
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Avastin,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Avastin,Chemotherapy,Progressive Disease,Dead,,Scheduled Follow-up Submission,Progressive Disease,544,MALE,52,C71.9,Brain,544
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,Progressive Disease,Dead,,Scheduled Follow-up Submission,Progressive Disease,544,MALE,52,C71.9,Brain,544
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,CPT11,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,CPT11,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,CPT11,Chemotherapy,Progressive Disease,Dead,,Scheduled Follow-up Submission,Progressive Disease,544,MALE,52,C71.9,Brain,544
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,Temodar,Chemotherapy,Progressive Disease,Dead,,Scheduled Follow-up Submission,Progressive Disease,544,MALE,52,C71.9,Brain,544
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,CPT11,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,CPT11,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,52,C71.9,Brain,
46bfebf4-0ef6-4348-81dc-d7d3cb52c08f,CPT11,Chemotherapy,Progressive Disease,Dead,,Scheduled Follow-up Submission,Progressive Disease,544,MALE,52,C71.9,Brain,544
153c2442-ea61-4b5e-8c5c-c71d287c6055,Temodar,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,FEMALE,66,C71.9,Brain,
153c2442-ea61-4b5e-8c5c-c71d287c6055,Temodar,Chemotherapy,,Alive,,,,,FEMALE,66,C71.9,Brain,
153c2442-ea61-4b5e-8c5c-c71d287c6055,Temodar,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,FEMALE,66,C71.9,Brain,
153c2442-ea61-4b5e-8c5c-c71d287c6055,Temodar,Chemotherapy,,Alive,,,,,FEMALE,66,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,Avastin,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,Avastin,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,CPT11,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,CPT11,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,CPT11,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,42,C71.9,Brain,
cf6689b9-d0fa-4461-a6b7-db477629e258,CPT11,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,42,C71.9,Brain,
7338e476-10ff-444a-a16f-429d28355f65,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,72,C71.9,Brain,
7338e476-10ff-444a-a16f-429d28355f65,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,72,C71.9,Brain,
7338e476-10ff-444a-a16f-429d28355f65,Temodar,Chemotherapy,,,WITH TUMOR,,,,MALE,72,C71.9,Brain,
7338e476-10ff-444a-a16f-429d28355f65,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,72,C71.9,Brain,
7338e476-10ff-444a-a16f-429d28355f65,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,72,C71.9,Brain,
7338e476-10ff-444a-a16f-429d28355f65,Temodar,Chemotherapy,,,WITH TUMOR,,,,MALE,72,C71.9,Brain,
7338e476-10ff-444a-a16f-429d28355f65,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,72,C71.9,Brain,
7338e476-10ff-444a-a16f-429d28355f65,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,72,C71.9,Brain,
7338e476-10ff-444a-a16f-429d28355f65,Temodar,Chemotherapy,,,WITH TUMOR,,,,MALE,72,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Temodar,Chemotherapy,,Alive,,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Temodar,Chemotherapy,,Dead,,,,713,MALE,53,C71.9,Brain,713
cb4f4617-8260-475d-a650-2f049474b001,Temodar,Chemotherapy,,Alive,,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Temodar,Chemotherapy,,Dead,,,,713,MALE,53,C71.9,Brain,713
cb4f4617-8260-475d-a650-2f049474b001,CPT 11,Chemotherapy,,Alive,,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,CPT 11,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,CPT 11,Chemotherapy,,Dead,,,,713,MALE,53,C71.9,Brain,713
cb4f4617-8260-475d-a650-2f049474b001,Avastin,Chemotherapy,,Alive,,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Avastin,Chemotherapy,,Dead,,,,713,MALE,53,C71.9,Brain,713
cb4f4617-8260-475d-a650-2f049474b001,Avastin,Chemotherapy,,Alive,,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Avastin,Chemotherapy,,Dead,,,,713,MALE,53,C71.9,Brain,713
cb4f4617-8260-475d-a650-2f049474b001,CPT 11,Chemotherapy,,Alive,,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,CPT 11,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,CPT 11,Chemotherapy,,Dead,,,,713,MALE,53,C71.9,Brain,713
cb4f4617-8260-475d-a650-2f049474b001,Temodar,Chemotherapy,,Alive,,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,53,C71.9,Brain,
cb4f4617-8260-475d-a650-2f049474b001,Temodar,Chemotherapy,,Dead,,,,713,MALE,53,C71.9,Brain,713
c9e4f0bf-48fc-4600-9e03-314bc575273f,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,335,FEMALE,62,C71.9,Brain,335
c9e4f0bf-48fc-4600-9e03-314bc575273f,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,335,FEMALE,62,C71.9,Brain,335
c9e4f0bf-48fc-4600-9e03-314bc575273f,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,335,FEMALE,62,C71.9,Brain,335
c9e4f0bf-48fc-4600-9e03-314bc575273f,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,335,FEMALE,62,C71.9,Brain,335
c9e4f0bf-48fc-4600-9e03-314bc575273f,Avastin,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,335,FEMALE,62,C71.9,Brain,335
c9e4f0bf-48fc-4600-9e03-314bc575273f,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,335,FEMALE,62,C71.9,Brain,335
c9e4f0bf-48fc-4600-9e03-314bc575273f,,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,335,FEMALE,62,C71.9,Brain,335
c9e4f0bf-48fc-4600-9e03-314bc575273f,,Chemotherapy,,Dead,WITH TUMOR,,,335,FEMALE,62,C71.9,Brain,335
c2f7f72f-13ae-4efc-9cda-69ca037b4498,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
c2f7f72f-13ae-4efc-9cda-69ca037b4498,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,52,C71.9,Brain,
c2f7f72f-13ae-4efc-9cda-69ca037b4498,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
c2f7f72f-13ae-4efc-9cda-69ca037b4498,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,52,C71.9,Brain,
c2f7f72f-13ae-4efc-9cda-69ca037b4498,Temodar,,,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,MALE,52,C71.9,Brain,
c2f7f72f-13ae-4efc-9cda-69ca037b4498,Temodar,,,Alive,TUMOR FREE,,,,MALE,52,C71.9,Brain,
d558203d-3f70-42d4-accb-008ace280f48,Temodar,Chemotherapy,,Dead,,Scheduled Follow-up Submission,,157,MALE,63,C71.9,Brain,157
d558203d-3f70-42d4-accb-008ace280f48,Temodar,Chemotherapy,,Dead,,,,157,MALE,63,C71.9,Brain,157
d558203d-3f70-42d4-accb-008ace280f48,Temodar,Chemotherapy,,Dead,,Scheduled Follow-up Submission,,157,MALE,63,C71.9,Brain,157
d558203d-3f70-42d4-accb-008ace280f48,Temodar,Chemotherapy,,Dead,,,,157,MALE,63,C71.9,Brain,157
567a8bf1-3793-46bc-9943-16302df056ce,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,47,C71.9,Brain,
567a8bf1-3793-46bc-9943-16302df056ce,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,47,C71.9,Brain,
567a8bf1-3793-46bc-9943-16302df056ce,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,FEMALE,47,C71.9,Brain,
567a8bf1-3793-46bc-9943-16302df056ce,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,47,C71.9,Brain,
567a8bf1-3793-46bc-9943-16302df056ce,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,47,C71.9,Brain,
567a8bf1-3793-46bc-9943-16302df056ce,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,FEMALE,47,C71.9,Brain,
8e6b9705-e9d2-4fbc-ac03-35c1a5115eef,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,67,C71.9,Brain,
8e6b9705-e9d2-4fbc-ac03-35c1a5115eef,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,67,C71.9,Brain,
8e6b9705-e9d2-4fbc-ac03-35c1a5115eef,Temodar,Chemotherapy,,Dead,,,,388,MALE,67,C71.9,Brain,388
8e6b9705-e9d2-4fbc-ac03-35c1a5115eef,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,67,C71.9,Brain,
8e6b9705-e9d2-4fbc-ac03-35c1a5115eef,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,67,C71.9,Brain,
8e6b9705-e9d2-4fbc-ac03-35c1a5115eef,Temodar,Chemotherapy,,Dead,,,,388,MALE,67,C71.9,Brain,388
8e6b9705-e9d2-4fbc-ac03-35c1a5115eef,Temodar,,,Alive,WITH TUMOR,,,,MALE,67,C71.9,Brain,
8e6b9705-e9d2-4fbc-ac03-35c1a5115eef,Temodar,,,Alive,WITH TUMOR,,,,MALE,67,C71.9,Brain,
8e6b9705-e9d2-4fbc-ac03-35c1a5115eef,Temodar,,,Dead,,,,388,MALE,67,C71.9,Brain,388
82ecf2ce-0782-4238-be0a-668a2b22c57c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,165,MALE,60,C71.9,Brain,165
82ecf2ce-0782-4238-be0a-668a2b22c57c,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,165,MALE,60,C71.9,Brain,165
82ecf2ce-0782-4238-be0a-668a2b22c57c,Temoxolomide,Chemotherapy,,Dead,WITH TUMOR,,,165,MALE,60,C71.9,Brain,165
82ecf2ce-0782-4238-be0a-668a2b22c57c,Temoxolomide,Chemotherapy,,Dead,WITH TUMOR,,,165,MALE,60,C71.9,Brain,165
6c5154d2-af36-492f-b520-d925528824e4,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,468,MALE,59,C71.9,Brain,468
6c5154d2-af36-492f-b520-d925528824e4,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,468,MALE,59,C71.9,Brain,468
f6d64459-e639-4557-bf10-a9148263ee26,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,641,MALE,21,C71.9,Brain,641
f6d64459-e639-4557-bf10-a9148263ee26,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,641,MALE,21,C71.9,Brain,641
f6d64459-e639-4557-bf10-a9148263ee26,Irinotecan,Chemotherapy,,Dead,WITH TUMOR,,,641,MALE,21,C71.9,Brain,641
f6d64459-e639-4557-bf10-a9148263ee26,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,641,MALE,21,C71.9,Brain,641
f6d64459-e639-4557-bf10-a9148263ee26,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,641,MALE,21,C71.9,Brain,641
f6d64459-e639-4557-bf10-a9148263ee26,BIBW2992,Chemotherapy,,Dead,WITH TUMOR,,,641,MALE,21,C71.9,Brain,641
f6d64459-e639-4557-bf10-a9148263ee26,Metexafin Gadolinium,Chemotherapy,,Dead,WITH TUMOR,,,641,MALE,21,C71.9,Brain,641
c34760a2-f70e-48c4-a7c2-eb359f8aeb71,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,142,FEMALE,76,C71.9,Brain,142
7ac80045-7c05-4e8f-8217-a380544a6125,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,386,MALE,68,C71.2,Brain,386
582f0912-20e9-4790-afd9-1e858728223e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,452,FEMALE,49,C71.9,Brain,452
582f0912-20e9-4790-afd9-1e858728223e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,452,FEMALE,49,C71.9,Brain,452
582f0912-20e9-4790-afd9-1e858728223e,Gliadle Wafer,Chemotherapy,,Dead,WITH TUMOR,,,452,FEMALE,49,C71.9,Brain,452
582f0912-20e9-4790-afd9-1e858728223e,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,452,FEMALE,49,C71.9,Brain,452
73655446-bbf3-4cc9-a032-2c95051bc3e7,Gliadel wafer,Chemotherapy,,Dead,WITH TUMOR,,,515,MALE,60,C71.9,Brain,515
73655446-bbf3-4cc9-a032-2c95051bc3e7,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,515,MALE,60,C71.9,Brain,515
73655446-bbf3-4cc9-a032-2c95051bc3e7,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,515,MALE,60,C71.9,Brain,515
73655446-bbf3-4cc9-a032-2c95051bc3e7,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,515,MALE,60,C71.9,Brain,515
73655446-bbf3-4cc9-a032-2c95051bc3e7,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,515,MALE,60,C71.9,Brain,515
73655446-bbf3-4cc9-a032-2c95051bc3e7,Motexafin Gadolinium,Chemotherapy,,Dead,WITH TUMOR,,,515,MALE,60,C71.9,Brain,515
ace727ec-036b-4ddc-9af8-eecf70ec6b46,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,372,MALE,63,C71.9,Brain,372
ace727ec-036b-4ddc-9af8-eecf70ec6b46,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,372,MALE,63,C71.9,Brain,372
c50998f6-369c-48fe-a8e7-a4c5a4cef0e6,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,632,FEMALE,58,C71.9,Brain,632
c50998f6-369c-48fe-a8e7-a4c5a4cef0e6,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,632,FEMALE,58,C71.9,Brain,632
c50998f6-369c-48fe-a8e7-a4c5a4cef0e6,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,632,FEMALE,58,C71.9,Brain,632
c50998f6-369c-48fe-a8e7-a4c5a4cef0e6,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,632,FEMALE,58,C71.9,Brain,632
c50998f6-369c-48fe-a8e7-a4c5a4cef0e6,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,632,FEMALE,58,C71.9,Brain,632
c50998f6-369c-48fe-a8e7-a4c5a4cef0e6,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,632,FEMALE,58,C71.9,Brain,632
c50998f6-369c-48fe-a8e7-a4c5a4cef0e6,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,632,FEMALE,58,C71.9,Brain,632
e7d728e5-1a9f-4f27-9604-272e1235e08a,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,457,FEMALE,59,C71.9,Brain,457
e7d728e5-1a9f-4f27-9604-272e1235e08a,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,457,FEMALE,59,C71.9,Brain,457
e7d728e5-1a9f-4f27-9604-272e1235e08a,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,457,FEMALE,59,C71.9,Brain,457
e7d728e5-1a9f-4f27-9604-272e1235e08a,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,457,FEMALE,59,C71.9,Brain,457
e7d728e5-1a9f-4f27-9604-272e1235e08a,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,457,FEMALE,59,C71.9,Brain,457
30011f30-2926-47f2-a8f3-4f1b58ffa227,Gliadel Wafers,Chemotherapy,,Dead,WITH TUMOR,,,485,MALE,62,C71.9,Brain,485
30011f30-2926-47f2-a8f3-4f1b58ffa227,Bevacizumab Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,485,MALE,62,C71.9,Brain,485
30011f30-2926-47f2-a8f3-4f1b58ffa227,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,485,MALE,62,C71.9,Brain,485
30011f30-2926-47f2-a8f3-4f1b58ffa227,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,485,MALE,62,C71.9,Brain,485
30011f30-2926-47f2-a8f3-4f1b58ffa227,Metronomic Temodar,Chemotherapy,,Dead,WITH TUMOR,,,485,MALE,62,C71.9,Brain,485
30011f30-2926-47f2-a8f3-4f1b58ffa227,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,485,MALE,62,C71.9,Brain,485
30011f30-2926-47f2-a8f3-4f1b58ffa227,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,485,MALE,62,C71.9,Brain,485
30011f30-2926-47f2-a8f3-4f1b58ffa227,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,485,MALE,62,C71.9,Brain,485
52408d9f-2637-4952-9b90-cb607a860f23,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,224,FEMALE,48,C71.9,Brain,224
52408d9f-2637-4952-9b90-cb607a860f23,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,224,FEMALE,48,C71.9,Brain,224
52408d9f-2637-4952-9b90-cb607a860f23,Motexatin Gadoinium,Targeted Molecular therapy,,Dead,WITH TUMOR,,,224,FEMALE,48,C71.9,Brain,224
52408d9f-2637-4952-9b90-cb607a860f23,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,224,FEMALE,48,C71.9,Brain,224
1030a6b9-0df8-4d60-b69f-2a36e630a6ad,Gliadel Wafer,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,82,C71.9,Brain,
1030a6b9-0df8-4d60-b69f-2a36e630a6ad,Gliadel Wafer,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,82,C71.9,Brain,
1030a6b9-0df8-4d60-b69f-2a36e630a6ad,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,82,C71.9,Brain,
1030a6b9-0df8-4d60-b69f-2a36e630a6ad,Temodar,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,82,C71.9,Brain,
1030a6b9-0df8-4d60-b69f-2a36e630a6ad,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,82,C71.9,Brain,
1030a6b9-0df8-4d60-b69f-2a36e630a6ad,Temodar,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,82,C71.9,Brain,
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Bevacizumab or placebo RTOG 0825,Targeted Molecular therapy,,Alive,TUMOR FREE,,,,MALE,67,C71.9,Brain,
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Bevacizumab or placebo RTOG 0825,Targeted Molecular therapy,,Alive,,,,,MALE,67,C71.9,Brain,
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Bevacizumab or placebo RTOG 0825,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,67,C71.9,Brain,
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Bevacizumab or placebo RTOG 0825,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,766,MALE,67,C71.9,Brain,766
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,67,C71.9,Brain,
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Temozolomide,Chemotherapy,,Alive,,,,,MALE,67,C71.9,Brain,
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,67,C71.9,Brain,
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,766,MALE,67,C71.9,Brain,766
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,,,MALE,67,C71.9,Brain,
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Temozolomide,Chemotherapy,,Alive,,,,,MALE,67,C71.9,Brain,
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,67,C71.9,Brain,
1b25795e-69ad-47fd-bb2f-94ff0910fae1,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,766,MALE,67,C71.9,Brain,766
581e04f9-4d0b-4ed2-97f5-2f97ace24928,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,25,C71.9,Brain,
581e04f9-4d0b-4ed2-97f5-2f97ace24928,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,25,C71.9,Brain,
581e04f9-4d0b-4ed2-97f5-2f97ace24928,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,25,C71.9,Brain,
581e04f9-4d0b-4ed2-97f5-2f97ace24928,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,25,C71.9,Brain,
581e04f9-4d0b-4ed2-97f5-2f97ace24928,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,25,C71.9,Brain,
581e04f9-4d0b-4ed2-97f5-2f97ace24928,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,25,C71.9,Brain,
5438322c-9db0-4974-ba01-801020559f97,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,40,C71.9,Brain,
5438322c-9db0-4974-ba01-801020559f97,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,40,C71.9,Brain,
5438322c-9db0-4974-ba01-801020559f97,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,40,C71.9,Brain,
5438322c-9db0-4974-ba01-801020559f97,Temodar,Chemotherapy,,Dead,WITH TUMOR,Additional New Tumor Event,,618,MALE,40,C71.9,Brain,618
5438322c-9db0-4974-ba01-801020559f97,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,40,C71.9,Brain,
5438322c-9db0-4974-ba01-801020559f97,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,40,C71.9,Brain,
5438322c-9db0-4974-ba01-801020559f97,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,40,C71.9,Brain,
5438322c-9db0-4974-ba01-801020559f97,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,Additional New Tumor Event,,618,MALE,40,C71.9,Brain,618
5438322c-9db0-4974-ba01-801020559f97,CCNU,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,40,C71.9,Brain,
5438322c-9db0-4974-ba01-801020559f97,CCNU,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,40,C71.9,Brain,
5438322c-9db0-4974-ba01-801020559f97,CCNU,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,40,C71.9,Brain,
5438322c-9db0-4974-ba01-801020559f97,CCNU,Chemotherapy,,Dead,WITH TUMOR,Additional New Tumor Event,,618,MALE,40,C71.9,Brain,618
516194e7-2143-4049-be54-141f515bcee5,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,383,MALE,56,C71.9,Brain,383
516194e7-2143-4049-be54-141f515bcee5,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,383,MALE,56,C71.9,Brain,383
516194e7-2143-4049-be54-141f515bcee5,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,383,MALE,56,C71.9,Brain,383
22e0c3ea-9f6d-4d73-9282-17ee4553f436,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,47,C71.9,Brain,
22e0c3ea-9f6d-4d73-9282-17ee4553f436,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,47,C71.9,Brain,
22e0c3ea-9f6d-4d73-9282-17ee4553f436,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,47,C71.9,Brain,
22e0c3ea-9f6d-4d73-9282-17ee4553f436,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,47,C71.9,Brain,
22e0c3ea-9f6d-4d73-9282-17ee4553f436,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,47,C71.9,Brain,
22e0c3ea-9f6d-4d73-9282-17ee4553f436,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,47,C71.9,Brain,
22e0c3ea-9f6d-4d73-9282-17ee4553f436,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,47,C71.9,Brain,
22e0c3ea-9f6d-4d73-9282-17ee4553f436,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,47,C71.9,Brain,
71bb1ef7-2bda-4478-b5b8-318f2e1bf5ac,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,330,MALE,73,C71.9,Brain,330
71bb1ef7-2bda-4478-b5b8-318f2e1bf5ac,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,330,MALE,73,C71.9,Brain,330
e876dd29-68b0-4bf1-83d1-488c40068a35,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,66,C71.9,Brain,
e876dd29-68b0-4bf1-83d1-488c40068a35,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,66,C71.9,Brain,
e876dd29-68b0-4bf1-83d1-488c40068a35,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,585,MALE,66,C71.9,Brain,585
722f462d-f939-4bc1-aae4-8f78b1335a87,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,26,MALE,89,C71.9,Brain,26
1e80ccf6-ef81-4662-bf5e-392f092c1e67,Bevacizumab,Chemotherapy,,Dead,WITH TUMOR,,,406,MALE,67,C71.9,Brain,406
1e80ccf6-ef81-4662-bf5e-392f092c1e67,Temodar,Targeted Molecular therapy,,Dead,WITH TUMOR,,,406,MALE,67,C71.9,Brain,406
12084e89-dbc2-43b3-a6d0-0e71e53d0eac,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
12084e89-dbc2-43b3-a6d0-0e71e53d0eac,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
12084e89-dbc2-43b3-a6d0-0e71e53d0eac,BSI-201,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
12084e89-dbc2-43b3-a6d0-0e71e53d0eac,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,59,C71.9,Brain,
2c922593-d94d-4e8f-b68b-b4b8cfcbf3e4,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,290,MALE,75,C71.9,Brain,290
2c922593-d94d-4e8f-b68b-b4b8cfcbf3e4,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,290,MALE,75,C71.9,Brain,290
6fac5bce-2bc0-4234-9e3e-11891c2fe00e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,135,FEMALE,81,C71.9,Brain,135
43d98306-8b1f-4840-a1a0-146ba0c36400,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,360,MALE,48,C71.9,Brain,360
43d98306-8b1f-4840-a1a0-146ba0c36400,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,360,MALE,48,C71.9,Brain,360
43d98306-8b1f-4840-a1a0-146ba0c36400,temodar,Chemotherapy,,Dead,WITH TUMOR,,,360,MALE,48,C71.9,Brain,360
c184c3ca-7ad3-4202-b108-cb9fd5f5d947,Gliadel wafer carmustine,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,59,C71.9,Brain,
c184c3ca-7ad3-4202-b108-cb9fd5f5d947,Gliadel wafer carmustine,Chemotherapy,,Dead,WITH TUMOR,,,460,FEMALE,59,C71.9,Brain,460
c184c3ca-7ad3-4202-b108-cb9fd5f5d947,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,59,C71.9,Brain,
c184c3ca-7ad3-4202-b108-cb9fd5f5d947,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,460,FEMALE,59,C71.9,Brain,460
c184c3ca-7ad3-4202-b108-cb9fd5f5d947,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,59,C71.9,Brain,
c184c3ca-7ad3-4202-b108-cb9fd5f5d947,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,460,FEMALE,59,C71.9,Brain,460
c184c3ca-7ad3-4202-b108-cb9fd5f5d947,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,59,C71.9,Brain,
c184c3ca-7ad3-4202-b108-cb9fd5f5d947,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,460,FEMALE,59,C71.9,Brain,460
c184c3ca-7ad3-4202-b108-cb9fd5f5d947,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,59,C71.9,Brain,
c184c3ca-7ad3-4202-b108-cb9fd5f5d947,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,,,460,FEMALE,59,C71.9,Brain,460
a8d708ab-6388-4d42-bc6e-05a8a718ecff,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,73,C71.9,Brain,
a8d708ab-6388-4d42-bc6e-05a8a718ecff,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,379,FEMALE,73,C71.9,Brain,379
a8d708ab-6388-4d42-bc6e-05a8a718ecff,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,73,C71.9,Brain,
a8d708ab-6388-4d42-bc6e-05a8a718ecff,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,379,FEMALE,73,C71.9,Brain,379
7A8D2E13-315E-4512-85CE-B018D11C3BD3,Temozolomide,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,69,C71.9,Brain,
998C8517-89C1-43B2-84E4-B60905787BF6,Temozolomide,Chemotherapy,Progressive Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,54,C71.9,Brain,
8d0d7a7e-8fae-437d-9b39-f2f17d0f5e4f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,,105,MALE,67,C71.9,Brain,105
8d0d7a7e-8fae-437d-9b39-f2f17d0f5e4f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,,105,MALE,67,C71.9,Brain,105
66a03e91-77c7-4aef-a825-6deef805640c,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,Additional New Tumor Event,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,Additional New Tumor Event,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,73,C71.9,Brain,
66a03e91-77c7-4aef-a825-6deef805640c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,,,FEMALE,73,C71.9,Brain,
9888bf87-d0d1-474b-960d-d76b13352e7c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,51,C71.9,Brain,
9888bf87-d0d1-474b-960d-d76b13352e7c,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,51,C71.9,Brain,
9888bf87-d0d1-474b-960d-d76b13352e7c,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,51,C71.9,Brain,
9888bf87-d0d1-474b-960d-d76b13352e7c,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,51,C71.9,Brain,
4dee170b-175c-4e08-83f4-af1317b07209,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,58,C71.9,Brain,
4dee170b-175c-4e08-83f4-af1317b07209,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,58,C71.9,Brain,
4dee170b-175c-4e08-83f4-af1317b07209,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,58,C71.9,Brain,
4dee170b-175c-4e08-83f4-af1317b07209,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,MALE,58,C71.9,Brain,
4dee170b-175c-4e08-83f4-af1317b07209,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,58,C71.9,Brain,
4dee170b-175c-4e08-83f4-af1317b07209,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,58,C71.9,Brain,
28629bf9-f447-4650-8fc2-53f1e938ab71,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,77,C71.9,Brain,
28629bf9-f447-4650-8fc2-53f1e938ab71,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,77,C71.9,Brain,
28629bf9-f447-4650-8fc2-53f1e938ab71,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,77,C71.9,Brain,
28629bf9-f447-4650-8fc2-53f1e938ab71,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,77,C71.9,Brain,
22b5cbba-cc78-4377-a08c-a9413294c3bf,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,55,C71.9,Brain,
22b5cbba-cc78-4377-a08c-a9413294c3bf,Avastin,Targeted Molecular therapy,,Alive,WITH TUMOR,,,,FEMALE,55,C71.9,Brain,
22b5cbba-cc78-4377-a08c-a9413294c3bf,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,55,C71.9,Brain,
22b5cbba-cc78-4377-a08c-a9413294c3bf,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,55,C71.9,Brain,
22b5cbba-cc78-4377-a08c-a9413294c3bf,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,55,C71.9,Brain,
22b5cbba-cc78-4377-a08c-a9413294c3bf,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,55,C71.9,Brain,
872abc8a-6c1f-4114-b993-7d0327fb38bd,Temodar,Chemotherapy,,Dead,,,,146,MALE,76,C71.9,Brain,146
8df94420-c736-4a36-b001-5dbe3dff17f0,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,138,MALE,68,C71.9,Brain,138
dfa3ef71-7006-4c6d-81c4-e0c0c7b75c26,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,94,FEMALE,85,C71.9,Brain,94
752a6e21-9a91-417f-beba-bfdf331d5cac,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,279,FEMALE,70,C71.9,Brain,279
d6de8d1c-e5ff-45cd-b53e-f943d2578713,Temodar (escalation),Chemotherapy,,Dead,WITH TUMOR,,,1458,FEMALE,50,C71.9,Brain,1458
8820ca5f-4f6b-4389-ba86-9015d0bcec1d,Temodar,Chemotherapy,,Alive,TUMOR FREE,,,,FEMALE,52,C71.9,Brain,
8820ca5f-4f6b-4389-ba86-9015d0bcec1d,Temodar,Chemotherapy,,Dead,,,,1121,FEMALE,52,C71.9,Brain,1121
8820ca5f-4f6b-4389-ba86-9015d0bcec1d,Avastin,Chemotherapy,,Alive,TUMOR FREE,,,,FEMALE,52,C71.9,Brain,
8820ca5f-4f6b-4389-ba86-9015d0bcec1d,Avastin,Chemotherapy,,Dead,,,,1121,FEMALE,52,C71.9,Brain,1121
8c3b2851-fced-473c-9c11-731eb66d8f3e,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,508,MALE,57,C71.9,Brain,508
8c3b2851-fced-473c-9c11-731eb66d8f3e,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,508,MALE,57,C71.9,Brain,508
68749001-c4c2-415d-830c-07e39c3a504a,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,100,MALE,74,C71.9,Brain,100
aa15f655-c1e9-4f4a-acee-2fb76ec82858,Temodar,Chemotherapy,,Dead,,,,82,MALE,78,C71.9,Brain,82
6ccc0eda-96f8-475c-9d8c-016b26fdd81d,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,346,MALE,57,C71.9,Brain,346
c472482e-225d-4ab0-8ba5-b659e7ff3e89,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,519,MALE,63,C71.9,Brain,519
c472482e-225d-4ab0-8ba5-b659e7ff3e89,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,519,MALE,63,C71.9,Brain,519
9e2efb07-826f-4efc-8c69-8625cbc708a6,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,254,FEMALE,64,C71.9,Brain,254
0a211ae1-a48c-4989-9379-04d59500d94d,Avastin,Chemotherapy,,Dead,WITH TUMOR,,,638,MALE,60,C71.9,Brain,638
0a211ae1-a48c-4989-9379-04d59500d94d,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,638,MALE,60,C71.9,Brain,638
770aa1ee-aed9-4219-900e-63523cdf312f,Temodar,Chemotherapy,,Dead,,,,147,MALE,66,C71.9,Brain,147
3763b815-308f-4b64-a3a7-56822079765f,Temodar,Chemotherapy,,Dead,WITH TUMOR,,,153,MALE,74,C71.9,Brain,153
19dd2c8f-05ca-44e8-8c19-bac0327f2ea9,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,54,C71.9,Brain,
19dd2c8f-05ca-44e8-8c19-bac0327f2ea9,Temodar,Chemotherapy,,Dead,,,,727,MALE,54,C71.9,Brain,727
92f323c8-dae4-4fdc-a108-148ddc238d1a,Carmustine,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,58,C71.9,Brain,
92f323c8-dae4-4fdc-a108-148ddc238d1a,Carmustine,Chemotherapy,,Dead,,,,1048,MALE,58,C71.9,Brain,1048
92f323c8-dae4-4fdc-a108-148ddc238d1a,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,58,C71.9,Brain,
92f323c8-dae4-4fdc-a108-148ddc238d1a,Temodar,Chemotherapy,,Dead,,,,1048,MALE,58,C71.9,Brain,1048
933b9daf-a5bf-46cf-92b6-5ddd8279919c,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,44,C71.9,Brain,
933b9daf-a5bf-46cf-92b6-5ddd8279919c,Temodar,Chemotherapy,,Dead,,,,567,FEMALE,44,C71.9,Brain,567
933b9daf-a5bf-46cf-92b6-5ddd8279919c,ICT-107,Immunotherapy,,Alive,WITH TUMOR,,,,FEMALE,44,C71.9,Brain,
933b9daf-a5bf-46cf-92b6-5ddd8279919c,ICT-107,Immunotherapy,,Dead,,,,567,FEMALE,44,C71.9,Brain,567
97b4eeec-7230-446b-b376-6742fae6f6ab,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,49,C71.9,Brain,
97b4eeec-7230-446b-b376-6742fae6f6ab,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,49,C71.9,Brain,
97b4eeec-7230-446b-b376-6742fae6f6ab,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,49,C71.9,Brain,
97b4eeec-7230-446b-b376-6742fae6f6ab,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,FEMALE,49,C71.9,Brain,
05944575-8473-4ed0-9de8-8091018001c2,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,33,C71.9,Brain,
05944575-8473-4ed0-9de8-8091018001c2,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,33,C71.9,Brain,
05944575-8473-4ed0-9de8-8091018001c2,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,33,C71.9,Brain,
ed879063-e603-4151-bf5e-22a4ee210281,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,50,C71.9,Brain,
fc222f23-b3b2-4ac0-bc61-e8e8fa5cc160,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,234,MALE,67,C71.9,Central nervous system,234
230f5fa7-aa36-41ea-b40b-08f520767bd5,Avastin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1335,FEMALE,44,C71.9,Central nervous system,1335
952dfd5d-e65a-4307-b6a9-2ed2b0d2d9ce,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,37,C71.9,Central nervous system,
952dfd5d-e65a-4307-b6a9-2ed2b0d2d9ce,Temodar,Chemotherapy,,Dead,,,,1106,MALE,37,C71.9,Central nervous system,1106
c6cf2b8e-40ed-4c9f-8419-d868bd5afe11,Temodar,Chemotherapy,Complete Remission/Response,Alive,,,Complete Remission/Response,,FEMALE,47,C71.9,Central nervous system,
c6cf2b8e-40ed-4c9f-8419-d868bd5afe11,Temodar,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,,,FEMALE,47,C71.9,Central nervous system,
e8d3d888-e5fc-4469-ad0b-2c1df6e04790,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,,Complete Remission/Response,,MALE,39,C71.9,Central nervous system,
f86fa219-34e9-4812-8edf-2b66d7219779,Bevacizumab,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,639,MALE,43,C71.9,Central nervous system,639
f86fa219-34e9-4812-8edf-2b66d7219779,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,639,MALE,43,C71.9,Central nervous system,639
b6c2c9bd-625b-4a98-830c-49c344f6cb5f,Temodar,Chemotherapy,,Alive,WITH TUMOR,,Partial Remission/Response,,FEMALE,53,C71.9,Central nervous system,
b6c2c9bd-625b-4a98-830c-49c344f6cb5f,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Central nervous system,
bdfade49-9059-4665-beea-c55117ba6564,Temodar,Chemotherapy,,Dead,WITH TUMOR,,Progressive Disease,194,FEMALE,54,C71.9,Central nervous system,194
9ee6e821-3af2-42d7-9d14-f0ca455f338c,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,538,MALE,58,C71.9,Central nervous system,538
9ee6e821-3af2-42d7-9d14-f0ca455f338c,Avastin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,538,MALE,58,C71.9,Central nervous system,538
3f70c3e3-0131-466f-92aa-0a63ab3d4258,Temodar,Chemotherapy,,Alive,WITH TUMOR,,Progressive Disease,,MALE,48,C71.9,Central nervous system,
3f70c3e3-0131-466f-92aa-0a63ab3d4258,Temodar,Chemotherapy,,Dead,,,,814,MALE,48,C71.9,Central nervous system,814
42fe260f-520b-4fac-8c09-d2b31aed59fb,Temodar,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,MALE,31,C71.9,Central nervous system,
42fe260f-520b-4fac-8c09-d2b31aed59fb,Temodar,Chemotherapy,,Dead,,,,1137,MALE,31,C71.9,Central nervous system,1137
c16d9f69-26f9-4ec7-b2d5-ff9f7dacfe0f,Temodar,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,51,C71.9,Central nervous system,
c16d9f69-26f9-4ec7-b2d5-ff9f7dacfe0f,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,,Stable Disease,,FEMALE,51,C71.9,Central nervous system,
8cba230b-46db-4d35-8123-3879eba32402,Temodar,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,MALE,22,C71.9,Central nervous system,
8cba230b-46db-4d35-8123-3879eba32402,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,,Complete Remission/Response,,MALE,22,C71.9,Central nervous system,
a5d3f3fb-6541-419d-b47e-720d438f1bff,Temodar,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,57,C71.9,Central nervous system,
a5d3f3fb-6541-419d-b47e-720d438f1bff,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,,Stable Disease,,FEMALE,57,C71.9,Central nervous system,
dc5bdd21-b23f-400e-bbe2-4c98a517fc9e,Temodar,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,26,C71.9,Central nervous system,
dc5bdd21-b23f-400e-bbe2-4c98a517fc9e,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,,Stable Disease,,FEMALE,26,C71.9,Central nervous system,
60b30a95-3e4c-413a-9de6-16a5bca163c4,Temodar,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,43,C71.9,Central nervous system,
60b30a95-3e4c-413a-9de6-16a5bca163c4,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,,,MALE,43,C71.9,Central nervous system,
60b30a95-3e4c-413a-9de6-16a5bca163c4,Vinblastine,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,43,C71.9,Central nervous system,
60b30a95-3e4c-413a-9de6-16a5bca163c4,Vinblastine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,,,MALE,43,C71.9,Central nervous system,
60b30a95-3e4c-413a-9de6-16a5bca163c4,Avastin,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,43,C71.9,Central nervous system,
60b30a95-3e4c-413a-9de6-16a5bca163c4,Avastin,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,,,MALE,43,C71.9,Central nervous system,
b7cd3b44-ef6a-4207-a44f-14f5b3b56ed4,BCNU,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,38,C71.0,Central nervous system,
ae2db022-eb4f-4b65-89b6-9fd4439ddeef,Temodar,Chemotherapy,Complete Remission/Response,Alive,,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,33,C71.0,Central nervous system,
ae2db022-eb4f-4b65-89b6-9fd4439ddeef,Temodar,Chemotherapy,Complete Remission/Response,Alive,,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,33,C71.0,Central nervous system,
0b54cda4-7568-481e-b0c6-2c5c6de0026c,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,37,C71.0,Central nervous system,
0b54cda4-7568-481e-b0c6-2c5c6de0026c,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,37,C71.0,Central nervous system,
bbfb5399-8d43-4b75-bf90-23ec142697d7,Temodar,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,36,C71.0,Central nervous system,
bbfb5399-8d43-4b75-bf90-23ec142697d7,Temodar,Chemotherapy,,,,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,36,C71.0,Central nervous system,
bbfb5399-8d43-4b75-bf90-23ec142697d7,Temodar,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,36,C71.0,Central nervous system,
bbfb5399-8d43-4b75-bf90-23ec142697d7,Temodar,Chemotherapy,,,,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,36,C71.0,Central nervous system,
9d0c1552-00a7-4f0a-a04a-a82e721ee4e3,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,32,C71.0,Central nervous system,
9d0c1552-00a7-4f0a-a04a-a82e721ee4e3,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,32,C71.0,Central nervous system,
9d0c1552-00a7-4f0a-a04a-a82e721ee4e3,Gleevec,Targeted Molecular therapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,32,C71.0,Central nervous system,
9d0c1552-00a7-4f0a-a04a-a82e721ee4e3,Gleevec,Targeted Molecular therapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,32,C71.0,Central nervous system,
d05079f2-9883-46e6-ad06-9e561f08d819,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,1547,MALE,34,C71.0,Central nervous system,1547
d05079f2-9883-46e6-ad06-9e561f08d819,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,1547,MALE,34,C71.0,Central nervous system,1547
d05079f2-9883-46e6-ad06-9e561f08d819,Temozolamide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,1547,MALE,34,C71.0,Central nervous system,1547
15a6ad18-a81c-4f5b-80ae-ef56ccf722f9,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,61,C71.0,Central nervous system,
15a6ad18-a81c-4f5b-80ae-ef56ccf722f9,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,61,C71.0,Central nervous system,
FB6437F9-ADE8-4C33-A0D0-CEACB2BF784D,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,38,C71.4,Central nervous system,
1BFF1E07-4923-43D5-B2D3-CB46B6568EED,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,32,C71.2,Central nervous system,
40587B69-0F62-4A2A-88CB-1BD711377F19,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,41,C71.1,Central nervous system,
7704E4A8-C7AA-4288-B1ED-68C23ABBE924,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,34,C71.1,Central nervous system,
0536F465-1650-4411-823C-C660BC7F3ADC,Temodar,Chemotherapy,,Dead,,Scheduled Follow-up Submission,Stable Disease,775,MALE,59,C71.0,Central nervous system,775
12F02422-585D-4068-BBDE-BC279C6A89AB,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,40,C71.0,Central nervous system,
887DEF39-E212-490D-8849-2BC932FCEFF0,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,31,C71.0,Central nervous system,
176D89D7-F8F1-4A72-B45A-31CBE1632A30,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,54,C71.0,Central nervous system,
DF22BC30-96E2-42DE-9A39-2954DB49841D,Temodar,Chemotherapy,Stable Disease,Dead,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,438,FEMALE,65,C71.0,Central nervous system,438
9922DE10-9280-44C0-B86F-6D1CA7E55BF2,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,56,C71.0,Central nervous system,
5F853A88-811D-4EB4-914E-D90862C5D2A2,Temozolomide,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,55,C71.0,Central nervous system,
BA62B5EB-E169-4B41-B949-E004D66E98A1,Temozolomide,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,36,C71.0,Central nervous system,
0709DBCC-0828-4066-AA01-96F059E5FA97,CDR0000654697,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,47,C71.0,Central nervous system,
2c03e8b9-8856-43a7-853d-5ec51a6e5330,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,607,FEMALE,38,C71.0,Central nervous system,607
2c03e8b9-8856-43a7-853d-5ec51a6e5330,AT 101,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,607,FEMALE,38,C71.0,Central nervous system,607
2c03e8b9-8856-43a7-853d-5ec51a6e5330,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,607,FEMALE,38,C71.0,Central nervous system,607
2c03e8b9-8856-43a7-853d-5ec51a6e5330,BCNU (carmustine),Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,607,FEMALE,38,C71.0,Central nervous system,607
2cf49bac-dea1-45ff-9e1d-09f5a2ac5215,Temozolomide,Chemotherapy,,Alive,,,Stable Disease,,MALE,32,C71.0,Central nervous system,
2cf49bac-dea1-45ff-9e1d-09f5a2ac5215,Temozolomide,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,32,C71.0,Central nervous system,
2cf49bac-dea1-45ff-9e1d-09f5a2ac5215,Temozolomide,Chemotherapy,,Alive,,,Stable Disease,,MALE,32,C71.0,Central nervous system,
2cf49bac-dea1-45ff-9e1d-09f5a2ac5215,Temozolomide,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,32,C71.0,Central nervous system,
5b744051-7355-4e15-b035-0621e709a5d7,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,,Stable Disease,,MALE,29,C71.0,Central nervous system,
5b744051-7355-4e15-b035-0621e709a5d7,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,29,C71.0,Central nervous system,
5b744051-7355-4e15-b035-0621e709a5d7,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,,Stable Disease,,MALE,29,C71.0,Central nervous system,
5b744051-7355-4e15-b035-0621e709a5d7,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,29,C71.0,Central nervous system,
5b744051-7355-4e15-b035-0621e709a5d7,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,,Stable Disease,,MALE,29,C71.0,Central nervous system,
5b744051-7355-4e15-b035-0621e709a5d7,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,29,C71.0,Central nervous system,
dcd0856d-423a-40d7-8070-4c0988d61416,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,,Stable Disease,,MALE,30,C71.0,Central nervous system,
dcd0856d-423a-40d7-8070-4c0988d61416,Temozolomide,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,30,C71.0,Central nervous system,
dcd0856d-423a-40d7-8070-4c0988d61416,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,,Stable Disease,,MALE,30,C71.0,Central nervous system,
dcd0856d-423a-40d7-8070-4c0988d61416,Temozolomide,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,30,C71.0,Central nervous system,
dcd0856d-423a-40d7-8070-4c0988d61416,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,,Stable Disease,,MALE,30,C71.0,Central nervous system,
dcd0856d-423a-40d7-8070-4c0988d61416,Temozolomide,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,30,C71.0,Central nervous system,
CB1E9916-C03F-405A-A797-15823DF09C8E,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,52,C71.0,Central nervous system,
F005FA99-7E4E-4308-B11C-83B25683B1FD,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,43,C71.0,Central nervous system,
DA40E6D3-A2A9-4517-AAA2-AEF6C3892EBF,Temodar,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,49,C71.0,Central nervous system,
B37ABDC8-B9E3-4F1A-B16D-2E59442DB335,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,59,C71.0,Central nervous system,
B37ABDC8-B9E3-4F1A-B16D-2E59442DB335,Temodar,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,FEMALE,59,C71.0,Central nervous system,
B2B57E93-2722-4546-9A0B-20155B86EDEF,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,30,C71.0,Central nervous system,
B2B57E93-2722-4546-9A0B-20155B86EDEF,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,531,MALE,30,C71.0,Central nervous system,531
977118C8-B446-4696-AA6E-9F1A1055E241,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,43,C71.0,Central nervous system,
977118C8-B446-4696-AA6E-9F1A1055E241,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,43,C71.0,Central nervous system,
3B19B5D1-13AF-4669-A082-1BD546048185,Temodar,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,49,C71.0,Central nervous system,
92a7c445-2217-400a-bdcd-df41502416b6,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,34,C71.9,Central nervous system,
92a7c445-2217-400a-bdcd-df41502416b6,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,34,C71.9,Central nervous system,
92a7c445-2217-400a-bdcd-df41502416b6,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,34,C71.9,Central nervous system,
5af8ada5-86b5-4832-8a8e-e975ecca5515,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,Stable Disease,,MALE,48,C71.9,Central nervous system,
55c78413-d102-4113-930e-6d842862fe75,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,40,C71.9,Central nervous system,
55c78413-d102-4113-930e-6d842862fe75,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,40,C71.9,Central nervous system,
9ed5af0e-c87f-46ff-81e7-9d3041b4034e,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,205,FEMALE,61,C71.9,Central nervous system,205
2d42dd0e-be3a-46ae-a635-c6f9c52f9fa2,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,MALE,29,C71.9,Central nervous system,
b95afb1a-a1df-4d85-ad34-191928e28a77,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,57,C71.9,Central nervous system,
b95afb1a-a1df-4d85-ad34-191928e28a77,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,57,C71.9,Central nervous system,
b95afb1a-a1df-4d85-ad34-191928e28a77,Bevacizumab,Targeted Molecular therapy,,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,57,C71.9,Central nervous system,
e326c1dd-2ef8-431b-a657-440aa3f35ff3,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,49,C71.9,Central nervous system,
e326c1dd-2ef8-431b-a657-440aa3f35ff3,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,49,C71.9,Central nervous system,
eb42625e-fbbb-4bee-bbe9-315b3ca2138a,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,34,C71.9,Central nervous system,
eb42625e-fbbb-4bee-bbe9-315b3ca2138a,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,34,C71.9,Central nervous system,
ddfd76dc-15d6-4efc-85ea-31674161ebf3,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,Stable Disease,,FEMALE,37,C71.9,Central nervous system,
ddfd76dc-15d6-4efc-85ea-31674161ebf3,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,Stable Disease,,FEMALE,37,C71.9,Central nervous system,
48607130-c09a-491d-882f-7d2591d13182,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,43,C71.9,Central nervous system,
48607130-c09a-491d-882f-7d2591d13182,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,43,C71.9,Central nervous system,
48607130-c09a-491d-882f-7d2591d13182,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,43,C71.9,Central nervous system,
48607130-c09a-491d-882f-7d2591d13182,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,43,C71.9,Central nervous system,
1cc53ade-73c0-492b-a7dc-328269fd0e66,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,Stable Disease,,FEMALE,62,C71.9,Central nervous system,
fcd9e1c4-bddb-4856-844c-03df48fba499,Hydroxyurea,Chemotherapy,Stable Disease,Alive,TUMOR FREE,,Progressive Disease,,FEMALE,35,C71.0,Central nervous system,
fcd9e1c4-bddb-4856-844c-03df48fba499,PCV,Chemotherapy,Stable Disease,Alive,TUMOR FREE,,Progressive Disease,,FEMALE,35,C71.0,Central nervous system,
1937318f-a1bb-4f48-b8ec-4aadd406e52a,Carmustine BCNU,Chemotherapy,,Dead,,,,1585,MALE,66,C71.0,Central nervous system,1585
42cc9620-98fb-4164-a3b2-28d084ca5a03,PCV,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,682,MALE,53,C71.0,Central nervous system,682
42cc9620-98fb-4164-a3b2-28d084ca5a03,PCV,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,682,MALE,53,C71.0,Central nervous system,682
42cc9620-98fb-4164-a3b2-28d084ca5a03,Hydroxyurea,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,682,MALE,53,C71.0,Central nervous system,682
6355cade-7b3a-43a8-9f1f-8e7bc45755a8,Tamoxifen,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1491,MALE,31,C71.0,Central nervous system,1491
6355cade-7b3a-43a8-9f1f-8e7bc45755a8,PCV,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1491,MALE,31,C71.0,Central nervous system,1491
6355cade-7b3a-43a8-9f1f-8e7bc45755a8,PCV,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1491,MALE,31,C71.0,Central nervous system,1491
152eaa99-05f5-4d30-bfb1-494a9a900e49,Isotretinoin,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2286,FEMALE,31,C71.0,Central nervous system,2286
152eaa99-05f5-4d30-bfb1-494a9a900e49,Irinotecan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2286,FEMALE,31,C71.0,Central nervous system,2286
152eaa99-05f5-4d30-bfb1-494a9a900e49,9 Aminocamptothecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2286,FEMALE,31,C71.0,Central nervous system,2286
152eaa99-05f5-4d30-bfb1-494a9a900e49,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2286,FEMALE,31,C71.0,Central nervous system,2286
152eaa99-05f5-4d30-bfb1-494a9a900e49,Capecitabine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2286,FEMALE,31,C71.0,Central nervous system,2286
152eaa99-05f5-4d30-bfb1-494a9a900e49,Bromo deoxyuridine,,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2286,FEMALE,31,C71.0,Central nervous system,2286
152eaa99-05f5-4d30-bfb1-494a9a900e49,PCV,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2286,FEMALE,31,C71.0,Central nervous system,2286
152eaa99-05f5-4d30-bfb1-494a9a900e49,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2286,FEMALE,31,C71.0,Central nervous system,2286
e695b780-17f4-4e71-9120-7c6bcafaa3a7,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1401,MALE,45,C71.0,Central nervous system,1401
97cb8701-7d63-4142-b404-006fbb3ecb0b,Sorafenib (Bay 43-9006),Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2660,FEMALE,31,C71.0,Central nervous system,2660
97cb8701-7d63-4142-b404-006fbb3ecb0b,Procarbazine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2660,FEMALE,31,C71.0,Central nervous system,2660
97cb8701-7d63-4142-b404-006fbb3ecb0b,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2660,FEMALE,31,C71.0,Central nervous system,2660
152f028e-ee29-40e0-8e75-5cafffacbd45,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,214,MALE,52,C71.0,Central nervous system,214
8daa29c0-f652-4130-a004-5183bbe30c63,BCNU (Carmustine),Chemotherapy,,Dead,WITH TUMOR,,,354,FEMALE,60,C71.0,Central nervous system,354
8daa29c0-f652-4130-a004-5183bbe30c63,Hydroxyurea,Chemotherapy,,Dead,WITH TUMOR,,,354,FEMALE,60,C71.0,Central nervous system,354
8daa29c0-f652-4130-a004-5183bbe30c63,Gliadel Wafer,Chemotherapy,,Dead,WITH TUMOR,,,354,FEMALE,60,C71.0,Central nervous system,354
c0d47e0f-4918-4e06-9db6-201671b1259c,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
c0d47e0f-4918-4e06-9db6-201671b1259c,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
c0d47e0f-4918-4e06-9db6-201671b1259c,Irinotecan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
c0d47e0f-4918-4e06-9db6-201671b1259c,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
c0d47e0f-4918-4e06-9db6-201671b1259c,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
c0d47e0f-4918-4e06-9db6-201671b1259c,Irinotecan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
c0d47e0f-4918-4e06-9db6-201671b1259c,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
c0d47e0f-4918-4e06-9db6-201671b1259c,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
c0d47e0f-4918-4e06-9db6-201671b1259c,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
c0d47e0f-4918-4e06-9db6-201671b1259c,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
c0d47e0f-4918-4e06-9db6-201671b1259c,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,4068,FEMALE,24,C71.0,Central nervous system,4068
9239a22e-80b1-49a2-b0d5-cbab7e415254,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,605,FEMALE,51,C71.0,Central nervous system,605
9239a22e-80b1-49a2-b0d5-cbab7e415254,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,605,FEMALE,51,C71.0,Central nervous system,605
9239a22e-80b1-49a2-b0d5-cbab7e415254,PS-341 Bortrezomib,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,605,FEMALE,51,C71.0,Central nervous system,605
9239a22e-80b1-49a2-b0d5-cbab7e415254,Cilengitide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,605,FEMALE,51,C71.0,Central nervous system,605
c13a429c-99ea-478c-ae95-fa499b9ea9fa,Temozolomide,Chemotherapy,,Dead,,,,512,FEMALE,59,C71.0,Central nervous system,512
c13a429c-99ea-478c-ae95-fa499b9ea9fa,Temozolomide,Chemotherapy,,Dead,,,,512,FEMALE,59,C71.0,Central nervous system,512
c13a429c-99ea-478c-ae95-fa499b9ea9fa,Isotrectinoin (acccutane),,,Dead,,,,512,FEMALE,59,C71.0,Central nervous system,512
70939245-41e0-4845-a473-5fef719b9828,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2875,FEMALE,35,C71.0,Central nervous system,2875
70939245-41e0-4845-a473-5fef719b9828,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2875,FEMALE,35,C71.0,Central nervous system,2875
70939245-41e0-4845-a473-5fef719b9828,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2875,FEMALE,35,C71.0,Central nervous system,2875
70939245-41e0-4845-a473-5fef719b9828,Afatinib,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2875,FEMALE,35,C71.0,Central nervous system,2875
14375753-a69f-41e0-b910-2bb8e84cc43a,Capecitabine,Chemotherapy,Progressive Disease,Dead,,,Progressive Disease,3470,FEMALE,23,C71.0,Central nervous system,3470
14375753-a69f-41e0-b910-2bb8e84cc43a,Temozolomide,Chemotherapy,Progressive Disease,Dead,,,Progressive Disease,3470,FEMALE,23,C71.0,Central nervous system,3470
14375753-a69f-41e0-b910-2bb8e84cc43a,Celebrex,,Progressive Disease,Dead,,,Progressive Disease,3470,FEMALE,23,C71.0,Central nervous system,3470
14375753-a69f-41e0-b910-2bb8e84cc43a,Temozolomide,Chemotherapy,Progressive Disease,Dead,,,Progressive Disease,3470,FEMALE,23,C71.0,Central nervous system,3470
467a7e6a-8cba-4ef1-8afd-6c8eaccbc3df,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,,,MALE,56,C71.0,Central nervous system,
cd69d509-a652-4257-a8d3-767296bbb4ec,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,MALE,25,C71.0,Central nervous system,
cd69d509-a652-4257-a8d3-767296bbb4ec,Temozolomide,Chemotherapy,,,,Scheduled Follow-up Submission,,,MALE,25,C71.0,Central nervous system,
cd69d509-a652-4257-a8d3-767296bbb4ec,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,MALE,25,C71.0,Central nervous system,
cd69d509-a652-4257-a8d3-767296bbb4ec,Temozolomide,Chemotherapy,,,,Scheduled Follow-up Submission,,,MALE,25,C71.0,Central nervous system,
215e117c-4d76-463c-8f8a-fd6a28d23929,Lomustine,Chemotherapy,,Dead,WITH TUMOR,,Progressive Disease,349,FEMALE,60,C71.0,Central nervous system,349
215e117c-4d76-463c-8f8a-fd6a28d23929,Vincristine,Chemotherapy,,Dead,WITH TUMOR,,Progressive Disease,349,FEMALE,60,C71.0,Central nervous system,349
215e117c-4d76-463c-8f8a-fd6a28d23929,Procarbazine,Chemotherapy,,Dead,WITH TUMOR,,Progressive Disease,349,FEMALE,60,C71.0,Central nervous system,349
427c40f6-d1bd-49f2-b303-a975793b937e,Lomustin,Chemotherapy,Stable Disease,Alive,TUMOR FREE,,Progressive Disease,,FEMALE,41,C71.0,Central nervous system,
427c40f6-d1bd-49f2-b303-a975793b937e,Vincristine,Chemotherapy,Stable Disease,Alive,TUMOR FREE,,Progressive Disease,,FEMALE,41,C71.0,Central nervous system,
427c40f6-d1bd-49f2-b303-a975793b937e,Procarbazine,Chemotherapy,Stable Disease,Alive,TUMOR FREE,,Progressive Disease,,FEMALE,41,C71.0,Central nervous system,
01c4ca12-ac08-41dd-9e4f-bfb0971688a2,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,32,C71.0,Central nervous system,
01c4ca12-ac08-41dd-9e4f-bfb0971688a2,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4695,FEMALE,32,C71.0,Central nervous system,4695
834e560a-a506-456d-baf2-a206ca058153,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,456,FEMALE,58,C71.0,Central nervous system,456
834e560a-a506-456d-baf2-a206ca058153,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,456,FEMALE,58,C71.0,Central nervous system,456
d61b5d20-4d6d-4fdc-afe8-4b100b686eda,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,269,MALE,59,C71.0,Central nervous system,269
ec82a00f-3909-4781-8ae2-e54cbc1ac7ac,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,41,C71.0,Central nervous system,
ec82a00f-3909-4781-8ae2-e54cbc1ac7ac,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,41,C71.0,Central nervous system,
ec82a00f-3909-4781-8ae2-e54cbc1ac7ac,Irinotecan,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,41,C71.0,Central nervous system,
f18dab99-26b0-4727-89a9-7f16bd382356,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,933,FEMALE,57,C71.0,Central nervous system,933
f18dab99-26b0-4727-89a9-7f16bd382356,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,933,FEMALE,57,C71.0,Central nervous system,933
1b43ff0c-cf13-4620-b5c7-7abd9129612f,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,Stable Disease,,MALE,39,C71.0,Central nervous system,
1b43ff0c-cf13-4620-b5c7-7abd9129612f,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,,Stable Disease,,MALE,39,C71.0,Central nervous system,
145f87a3-5e86-4a87-8e49-b166a2271d02,Tomaxifen,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,242,MALE,69,C71.0,Central nervous system,242
145f87a3-5e86-4a87-8e49-b166a2271d02,Procarbazine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,242,MALE,69,C71.0,Central nervous system,242
292cf158-dd47-44a1-912b-73626095a0f7,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,Progressive Disease,576,FEMALE,38,C71.0,Central nervous system,576
292cf158-dd47-44a1-912b-73626095a0f7,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,,Progressive Disease,576,FEMALE,38,C71.0,Central nervous system,576
81622da8-9f36-4ea3-b223-d831d8c10f87,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1339,MALE,33,C71.0,Central nervous system,1339
81622da8-9f36-4ea3-b223-d831d8c10f87,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1339,MALE,33,C71.0,Central nervous system,1339
81622da8-9f36-4ea3-b223-d831d8c10f87,Irinotecan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1339,MALE,33,C71.0,Central nervous system,1339
81622da8-9f36-4ea3-b223-d831d8c10f87,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1339,MALE,33,C71.0,Central nervous system,1339
81622da8-9f36-4ea3-b223-d831d8c10f87,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1339,MALE,33,C71.0,Central nervous system,1339
a144e4e4-2877-4340-a2bf-524adbde8bc8,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1886,FEMALE,53,C71.0,Central nervous system,1886
a144e4e4-2877-4340-a2bf-524adbde8bc8,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1886,FEMALE,53,C71.0,Central nervous system,1886
a144e4e4-2877-4340-a2bf-524adbde8bc8,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1886,FEMALE,53,C71.0,Central nervous system,1886
a144e4e4-2877-4340-a2bf-524adbde8bc8,Irintotecan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1886,FEMALE,53,C71.0,Central nervous system,1886
a144e4e4-2877-4340-a2bf-524adbde8bc8,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,1886,FEMALE,53,C71.0,Central nervous system,1886
84ae73e4-3b39-4444-9bfb-3fc6057eab32,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,788,MALE,53,C71.0,Central nervous system,788
84ae73e4-3b39-4444-9bfb-3fc6057eab32,Temozlomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,788,MALE,53,C71.0,Central nervous system,788
84ae73e4-3b39-4444-9bfb-3fc6057eab32,Irinotecan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,788,MALE,53,C71.0,Central nervous system,788
84ae73e4-3b39-4444-9bfb-3fc6057eab32,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,788,MALE,53,C71.0,Central nervous system,788
84ae73e4-3b39-4444-9bfb-3fc6057eab32,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,788,MALE,53,C71.0,Central nervous system,788
5a769292-c3ce-4e18-b821-2bfe0e24978c,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,48,C71.0,Central nervous system,
5a769292-c3ce-4e18-b821-2bfe0e24978c,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,48,C71.0,Central nervous system,
5a769292-c3ce-4e18-b821-2bfe0e24978c,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,FEMALE,48,C71.0,Central nervous system,
d61710c1-8ac3-44e3-b567-66288a6ab731,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,709,MALE,43,C71.0,Central nervous system,709
d61710c1-8ac3-44e3-b567-66288a6ab731,Irinotecan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,709,MALE,43,C71.0,Central nervous system,709
d61710c1-8ac3-44e3-b567-66288a6ab731,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,709,MALE,43,C71.0,Central nervous system,709
d61710c1-8ac3-44e3-b567-66288a6ab731,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,709,MALE,43,C71.0,Central nervous system,709
c35f36b1-ba3d-4eea-bf5a-c95480202176,temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Progressive Disease,,MALE,67,C71.0,Central nervous system,
c35f36b1-ba3d-4eea-bf5a-c95480202176,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Progressive Disease,,MALE,67,C71.0,Central nervous system,
c35f36b1-ba3d-4eea-bf5a-c95480202176,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Progressive Disease,,MALE,67,C71.0,Central nervous system,
ca427acb-034e-42e2-961a-b9d5dc30b741,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,41,C71.0,Central nervous system,
b9a3b647-61b3-4d98-90ca-e307ab50984a,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,722,FEMALE,63,C71.0,Central nervous system,722
b9a3b647-61b3-4d98-90ca-e307ab50984a,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,722,FEMALE,63,C71.0,Central nervous system,722
b9a3b647-61b3-4d98-90ca-e307ab50984a,Irinotecan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,722,FEMALE,63,C71.0,Central nervous system,722
b9a3b647-61b3-4d98-90ca-e307ab50984a,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,722,FEMALE,63,C71.0,Central nervous system,722
6fab9c30-354b-4f99-9b60-6823c12b9b0a,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,444,FEMALE,61,C71.0,Central nervous system,444
6fab9c30-354b-4f99-9b60-6823c12b9b0a,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,444,FEMALE,61,C71.0,Central nervous system,444
c81d4681-c02f-4b33-abe0-b6ad7d61194d,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,29,C71.0,Central nervous system,
c81d4681-c02f-4b33-abe0-b6ad7d61194d,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,29,C71.0,Central nervous system,
c81d4681-c02f-4b33-abe0-b6ad7d61194d,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,29,C71.0,Central nervous system,
f97a9afe-e54a-4ef0-b458-0c77f938552e,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,51,C71.0,Central nervous system,
11dffe71-b516-41e8-9987-e0ff5d2356d1,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,60,C71.0,Central nervous system,
11dffe71-b516-41e8-9987-e0ff5d2356d1,temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,60,C71.0,Central nervous system,
e488f613-f155-4e11-87d4-8c789ea81691,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,29,C71.0,Central nervous system,
e488f613-f155-4e11-87d4-8c789ea81691,Lomustine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,29,C71.0,Central nervous system,
e488f613-f155-4e11-87d4-8c789ea81691,Procarbazine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,29,C71.0,Central nervous system,
fc8828ae-484d-4fc8-a168-f8bc58ad65b9,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,55,C71.0,Central nervous system,
fc8828ae-484d-4fc8-a168-f8bc58ad65b9,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,55,C71.0,Central nervous system,
669605F6-39A1-4F8C-81DC-39430FF5F892,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,MALE,33,C71.0,Central nervous system,
669605F6-39A1-4F8C-81DC-39430FF5F892,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,MALE,33,C71.0,Central nervous system,
4BD8EBC1-6F6E-44A2-8544-106901A7BAE5,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,MALE,51,C71.0,Central nervous system,
DD163547-43AD-4FE4-873E-83C4C6BE4465,Temodar,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,42,C71.0,Central nervous system,
699D3BA1-94C8-409F-90C3-E7FE2F1CF825,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,70,C71.0,Central nervous system,
1C095C4A-DF97-402E-902C-FC83BCF8EF88,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,62,C71.0,Central nervous system,
0167CF11-74BE-4701-AB9A-4E057D4BB545,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1033,FEMALE,46,C71.0,Central nervous system,1033
0167CF11-74BE-4701-AB9A-4E057D4BB545,Temozolomide,,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1033,FEMALE,46,C71.0,Central nervous system,1033
0167CF11-74BE-4701-AB9A-4E057D4BB545,Mibefradil,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1033,FEMALE,46,C71.0,Central nervous system,1033
0167CF11-74BE-4701-AB9A-4E057D4BB545,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1033,FEMALE,46,C71.0,Central nervous system,1033
0167CF11-74BE-4701-AB9A-4E057D4BB545,Lomustine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1033,FEMALE,46,C71.0,Central nervous system,1033
0167CF11-74BE-4701-AB9A-4E057D4BB545,Procarbazine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1033,FEMALE,46,C71.0,Central nervous system,1033
0167CF11-74BE-4701-AB9A-4E057D4BB545,bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,,1033,FEMALE,46,C71.0,Central nervous system,1033
3BAA0015-885C-487A-9076-236F404FEB3E,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,35,C71.0,Central nervous system,
3BAA0015-885C-487A-9076-236F404FEB3E,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,35,C71.0,Central nervous system,
3BAA0015-885C-487A-9076-236F404FEB3E,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,35,C71.0,Central nervous system,
A56C2083-33D5-4C98-B85F-3B68A3D80ADD,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,27,C71.0,Central nervous system,
A56C2083-33D5-4C98-B85F-3B68A3D80ADD,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,27,C71.0,Central nervous system,
A56C2083-33D5-4C98-B85F-3B68A3D80ADD,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,27,C71.0,Central nervous system,
9CD3B3C6-2268-4E43-964B-B7A4DAF6FC6F,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,74,C71.0,Central nervous system,
C56FA247-AD97-4DCE-A2D3-9BDFC5DC7B1B,Temozolomide,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,30,C71.0,Central nervous system,
C56FA247-AD97-4DCE-A2D3-9BDFC5DC7B1B,Temozolomide,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,30,C71.0,Central nervous system,
04E6E843-7F31-43DA-B111-280CE2BD1949,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,4229,MALE,35,C71.0,Central nervous system,4229
04E6E843-7F31-43DA-B111-280CE2BD1949,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,4229,MALE,35,C71.0,Central nervous system,4229
04E6E843-7F31-43DA-B111-280CE2BD1949,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,4229,MALE,35,C71.0,Central nervous system,4229
04E6E843-7F31-43DA-B111-280CE2BD1949,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,4229,MALE,35,C71.0,Central nervous system,4229
04E6E843-7F31-43DA-B111-280CE2BD1949,Lomustine (CCNU),Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,4229,MALE,35,C71.0,Central nervous system,4229
04E6E843-7F31-43DA-B111-280CE2BD1949,bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,4229,MALE,35,C71.0,Central nervous system,4229
EF12BFB7-4147-407F-84E9-586DBB10D583,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,32,C71.0,Central nervous system,
EF12BFB7-4147-407F-84E9-586DBB10D583,Temozolomide,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,32,C71.0,Central nervous system,
D3D8987D-0A54-45F8-B9C9-17EC89FA864E,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Progressive Disease,,MALE,56,C71.0,Central nervous system,
D3D8987D-0A54-45F8-B9C9-17EC89FA864E,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Progressive Disease,,MALE,56,C71.0,Central nervous system,
D3D8987D-0A54-45F8-B9C9-17EC89FA864E,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Progressive Disease,,MALE,56,C71.0,Central nervous system,
837b51d0-e6b7-431b-a5f3-7615bdf12b67,Procarbazine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,Vincristine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,Procarbazine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,Celebrex,,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
837b51d0-e6b7-431b-a5f3-7615bdf12b67,Vincristine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1525,MALE,41,C71.9,Central nervous system,1525
44a5c3b4-62a7-407b-b492-7069e1a43a26,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2052,MALE,38,C71.9,Central nervous system,2052
44a5c3b4-62a7-407b-b492-7069e1a43a26,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2052,MALE,38,C71.9,Central nervous system,2052
44a5c3b4-62a7-407b-b492-7069e1a43a26,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Progressive Disease,2052,MALE,38,C71.9,Central nervous system,2052
691d5202-90cc-4e08-83a3-0620a89d3a4b,Temozolomide,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,1251,MALE,42,C71.9,Central nervous system,1251
691d5202-90cc-4e08-83a3-0620a89d3a4b,Temozolomide,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,1251,MALE,42,C71.9,Central nervous system,1251
691d5202-90cc-4e08-83a3-0620a89d3a4b,CCNU,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,1251,MALE,42,C71.9,Central nervous system,1251
691d5202-90cc-4e08-83a3-0620a89d3a4b,Temozolomide,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,1251,MALE,42,C71.9,Central nervous system,1251
691d5202-90cc-4e08-83a3-0620a89d3a4b,CPT-11,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,1251,MALE,42,C71.9,Central nervous system,1251
691d5202-90cc-4e08-83a3-0620a89d3a4b,CCNU,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,1251,MALE,42,C71.9,Central nervous system,1251
691d5202-90cc-4e08-83a3-0620a89d3a4b,VP-16,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,1251,MALE,42,C71.9,Central nervous system,1251
691d5202-90cc-4e08-83a3-0620a89d3a4b,Temozolomide,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,1251,MALE,42,C71.9,Central nervous system,1251
a0bc5147-d9b4-41fd-8df3-a241d23722e8,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,2433,MALE,34,C71.9,Central nervous system,2433
a0bc5147-d9b4-41fd-8df3-a241d23722e8,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,2433,MALE,34,C71.9,Central nervous system,2433
a0bc5147-d9b4-41fd-8df3-a241d23722e8,Topotecan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,2433,MALE,34,C71.9,Central nervous system,2433
a0bc5147-d9b4-41fd-8df3-a241d23722e8,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,2433,MALE,34,C71.9,Central nervous system,2433
a0bc5147-d9b4-41fd-8df3-a241d23722e8,Hydroyurea,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,2433,MALE,34,C71.9,Central nervous system,2433
a0bc5147-d9b4-41fd-8df3-a241d23722e8,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,2433,MALE,34,C71.9,Central nervous system,2433
a0bc5147-d9b4-41fd-8df3-a241d23722e8,Gleevec,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,2433,MALE,34,C71.9,Central nervous system,2433
a0bc5147-d9b4-41fd-8df3-a241d23722e8,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,2433,MALE,34,C71.9,Central nervous system,2433
a0bc5147-d9b4-41fd-8df3-a241d23722e8,Cytoxan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,2433,MALE,34,C71.9,Central nervous system,2433
a0bc5147-d9b4-41fd-8df3-a241d23722e8,Avastin,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,2433,MALE,34,C71.9,Central nervous system,2433
a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1762,FEMALE,62,C71.9,Central nervous system,1762
a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1762,FEMALE,62,C71.9,Central nervous system,1762
a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1762,FEMALE,62,C71.9,Central nervous system,1762
a6ee311c-0a7b-4f47-86f1-f2164b128f9c,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1762,FEMALE,62,C71.9,Central nervous system,1762
a6ee311c-0a7b-4f47-86f1-f2164b128f9c,CCNu,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1762,FEMALE,62,C71.9,Central nervous system,1762
a6ee311c-0a7b-4f47-86f1-f2164b128f9c,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1762,FEMALE,62,C71.9,Central nervous system,1762
a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1762,FEMALE,62,C71.9,Central nervous system,1762
a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1762,FEMALE,62,C71.9,Central nervous system,1762
a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Celebrex,,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,1762,FEMALE,62,C71.9,Central nervous system,1762
0061e9ef-df6a-414e-af64-c88f8192e2d3,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,4084,MALE,31,C71.9,Central nervous system,4084
0061e9ef-df6a-414e-af64-c88f8192e2d3,Celebrex,,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,4084,MALE,31,C71.9,Central nervous system,4084
0061e9ef-df6a-414e-af64-c88f8192e2d3,MAGI131-81c6,,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,4084,MALE,31,C71.9,Central nervous system,4084
0061e9ef-df6a-414e-af64-c88f8192e2d3,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,4084,MALE,31,C71.9,Central nervous system,4084
0061e9ef-df6a-414e-af64-c88f8192e2d3,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,4084,MALE,31,C71.9,Central nervous system,4084
0061e9ef-df6a-414e-af64-c88f8192e2d3,Karerltecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,4084,MALE,31,C71.9,Central nervous system,4084
0061e9ef-df6a-414e-af64-c88f8192e2d3,Cloretazine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,4084,MALE,31,C71.9,Central nervous system,4084
0061e9ef-df6a-414e-af64-c88f8192e2d3,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,,Stable Disease,4084,MALE,31,C71.9,Central nervous system,4084
400b2fa3-baf7-4baa-99b4-88b9f25b5049,CCNU,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,Gliadel Wafers,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,CPT-11,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,CPT-11,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,CCNU,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,Procarbazine,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,CCNU,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,Temazolomide,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,Cytoxan,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,Temozolomide,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,Carboplatin,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,Celebrex,,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,VP-16,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
400b2fa3-baf7-4baa-99b4-88b9f25b5049,Tamoxiten,Hormone Therapy,Stable Disease,Dead,WITH TUMOR,,Progressive Disease,2379,FEMALE,42,C71.9,Central nervous system,2379
84569c1a-6baa-4380-ae3c-707df1be4618,Temodar,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,2907,FEMALE,48,C71.9,Central nervous system,2907
84569c1a-6baa-4380-ae3c-707df1be4618,Celebrex,,Stable Disease,Dead,WITH TUMOR,,Stable Disease,2907,FEMALE,48,C71.9,Central nervous system,2907
84569c1a-6baa-4380-ae3c-707df1be4618,Carboplatin,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,2907,FEMALE,48,C71.9,Central nervous system,2907
84569c1a-6baa-4380-ae3c-707df1be4618,Carboplatin,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,2907,FEMALE,48,C71.9,Central nervous system,2907
84569c1a-6baa-4380-ae3c-707df1be4618,CCNU,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,2907,FEMALE,48,C71.9,Central nervous system,2907
84569c1a-6baa-4380-ae3c-707df1be4618,Temodar,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,2907,FEMALE,48,C71.9,Central nervous system,2907
84569c1a-6baa-4380-ae3c-707df1be4618,CCNU,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,2907,FEMALE,48,C71.9,Central nervous system,2907
84569c1a-6baa-4380-ae3c-707df1be4618,VP-16,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,2907,FEMALE,48,C71.9,Central nervous system,2907
84569c1a-6baa-4380-ae3c-707df1be4618,VP-16,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,2907,FEMALE,48,C71.9,Central nervous system,2907
5ea230a6-77aa-4aa5-867c-09651d481d8b,Gliadel Wafer,Chemotherapy,Stable Disease,Dead,,,Stable Disease,3978,FEMALE,38,C71.9,Central nervous system,3978
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Gliadel wafers,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Gliadel wafers,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Gliadel wafers,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Gliadel wafers,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Gliadel wafers,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Celebrex,Ancillary,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Celebrex,Ancillary,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Celebrex,Ancillary,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Celebrex,Ancillary,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Celebrex,Ancillary,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Benzylguanine,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Benzylguanine,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Benzylguanine,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Benzylguanine,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Benzylguanine,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,886
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Erlotinib,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Erlotinib,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Erlotinib,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Erlotinib,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Avastin,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Avastin,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Avastin,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Avastin,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Avastin,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Avastin,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Avastin,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Avastin,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,2835
BC6FBB3C-870D-40B5-983B-7C88705E020D,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,592,MALE,55,C71.0,Central nervous system,592
BC6FBB3C-870D-40B5-983B-7C88705E020D,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,592,MALE,55,C71.0,Central nervous system,592
BC6FBB3C-870D-40B5-983B-7C88705E020D,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,592,MALE,55,C71.0,Central nervous system,592
BC6FBB3C-870D-40B5-983B-7C88705E020D,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,592,MALE,55,C71.0,Central nervous system,592
BC6FBB3C-870D-40B5-983B-7C88705E020D,MR1-1,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,592,MALE,55,C71.0,Central nervous system,592
BB4A30D5-4EBA-45DB-B05A-BD843044D508,Temodar,Chemotherapy,,Dead,,,Stable Disease,378,MALE,52,C71.0,Central nervous system,378
BB4A30D5-4EBA-45DB-B05A-BD843044D508,Temodar,Chemotherapy,,Dead,,,Stable Disease,378,MALE,52,C71.0,Central nervous system,378
96D9249E-501C-49E0-9559-01DA978A9CA6,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
96D9249E-501C-49E0-9559-01DA978A9CA6,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,492,MALE,46,C71.0,Central nervous system,492
4250AC3C-C8B0-46CE-B9C8-7963BC386041,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,648,MALE,63,C71.0,Central nervous system,648
4250AC3C-C8B0-46CE-B9C8-7963BC386041,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,648,MALE,63,C71.0,Central nervous system,648
4250AC3C-C8B0-46CE-B9C8-7963BC386041,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,648,MALE,63,C71.0,Central nervous system,648
4250AC3C-C8B0-46CE-B9C8-7963BC386041,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,648,MALE,63,C71.0,Central nervous system,648
4250AC3C-C8B0-46CE-B9C8-7963BC386041,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,648,MALE,63,C71.0,Central nervous system,648
4250AC3C-C8B0-46CE-B9C8-7963BC386041,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,648,MALE,63,C71.0,Central nervous system,648
4250AC3C-C8B0-46CE-B9C8-7963BC386041,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,648,MALE,63,C71.0,Central nervous system,648
4250AC3C-C8B0-46CE-B9C8-7963BC386041,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,648,MALE,63,C71.0,Central nervous system,648
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
BCC17E9A-6FE3-44FF-963C-D2D850A431F1,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,727
992452EE-8D9F-406B-9708-7BCB60062743,I131-81C6,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,2282,MALE,45,C71.0,Central nervous system,2282
75DBC8FB-4DB8-4764-824C-ECCF3A223884,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,1578,FEMALE,58,C71.0,Central nervous system,1578
75DBC8FB-4DB8-4764-824C-ECCF3A223884,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,1578,FEMALE,58,C71.0,Central nervous system,1578
75DBC8FB-4DB8-4764-824C-ECCF3A223884,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,1578,FEMALE,58,C71.0,Central nervous system,1578
5E2539E0-2088-43DF-AD2A-F854D8BB6D30,Temodar,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,466,MALE,71,C71.0,Central nervous system,466
5E2539E0-2088-43DF-AD2A-F854D8BB6D30,Temodar,Chemotherapy,Stable Disease,Dead,WITH TUMOR,,Stable Disease,466,MALE,71,C71.0,Central nervous system,466
23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
23C335F6-5749-4443-8AE8-61CCCBB137CB,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,987
5EEF573E-6A44-4DC7-8AA7-B136863CE910,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
5EEF573E-6A44-4DC7-8AA7-B136863CE910,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,MALE,28,C71.0,Central nervous system,1120
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,VP-16,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
722C172F-46E6-47A1-82E5-3207278DF89B,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,4445
97FFBE14-9070-4A5A-8760-225A88834B40,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,398,FEMALE,58,C71.0,Central nervous system,398
97FFBE14-9070-4A5A-8760-225A88834B40,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,398,FEMALE,58,C71.0,Central nervous system,398
97FFBE14-9070-4A5A-8760-225A88834B40,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,398,FEMALE,58,C71.0,Central nervous system,398
97FFBE14-9070-4A5A-8760-225A88834B40,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,398,FEMALE,58,C71.0,Central nervous system,398
97FFBE14-9070-4A5A-8760-225A88834B40,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,398,FEMALE,58,C71.0,Central nervous system,398
97FFBE14-9070-4A5A-8760-225A88834B40,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,398,FEMALE,58,C71.0,Central nervous system,398
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,I131-81C6,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,I131-81C6,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,I131-81C6,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,Procarbazine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,Procarbazine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,Procarbazine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,Vincristine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,Vincristine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,Vincristine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,CPT-11,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,2235
975E17C2-B93C-4D45-8A85-786F365E4A93,Gliadel,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Gliadel,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Gliadel,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Gliadel,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Gliadel,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Gliadel,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Gliadel,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Gliadel,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Thalidomide,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Thalidomide,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Thalidomide,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Thalidomide,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Thalidomide,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Thalidomide,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Thalidomide,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Thalidomide,,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Cyclophosphamide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Cyclophosphamide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Cyclophosphamide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Cyclophosphamide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Cyclophosphamide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Cyclophosphamide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Cyclophosphamide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Cyclophosphamide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Karenitecin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Tamoxifen,Hormone Therapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
975E17C2-B93C-4D45-8A85-786F365E4A93,Carboplatin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,4412,MALE,35,C71.0,Central nervous system,4412
8B10F00F-FDE6-423D-BC36-027931359A5A,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,984,FEMALE,41,C71.0,Central nervous system,984
8B10F00F-FDE6-423D-BC36-027931359A5A,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,984,FEMALE,41,C71.0,Central nervous system,984
8B10F00F-FDE6-423D-BC36-027931359A5A,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,984,FEMALE,41,C71.0,Central nervous system,984
8B10F00F-FDE6-423D-BC36-027931359A5A,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,984,FEMALE,41,C71.0,Central nervous system,984
8B10F00F-FDE6-423D-BC36-027931359A5A,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,984,FEMALE,41,C71.0,Central nervous system,984
8B10F00F-FDE6-423D-BC36-027931359A5A,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,984,FEMALE,41,C71.0,Central nervous system,984
e09f93e1-1649-48fa-9e2e-d13ac6d50b97,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,54,C71.0,Central nervous system,
e09f93e1-1649-48fa-9e2e-d13ac6d50b97,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,54,C71.0,Central nervous system,
e09f93e1-1649-48fa-9e2e-d13ac6d50b97,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,54,C71.0,Central nervous system,
e09f93e1-1649-48fa-9e2e-d13ac6d50b97,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,54,C71.0,Central nervous system,
e09f93e1-1649-48fa-9e2e-d13ac6d50b97,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,54,C71.0,Central nervous system,
e09f93e1-1649-48fa-9e2e-d13ac6d50b97,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,54,C71.0,Central nervous system,
68f550ca-3a33-45e4-b1c9-14f99e543263,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,MALE,23,C71.0,Central nervous system,
68f550ca-3a33-45e4-b1c9-14f99e543263,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,775,MALE,23,C71.0,Central nervous system,775
68f550ca-3a33-45e4-b1c9-14f99e543263,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,MALE,23,C71.0,Central nervous system,
68f550ca-3a33-45e4-b1c9-14f99e543263,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,775,MALE,23,C71.0,Central nervous system,775
68f550ca-3a33-45e4-b1c9-14f99e543263,Avastin,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,MALE,23,C71.0,Central nervous system,
68f550ca-3a33-45e4-b1c9-14f99e543263,Avastin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,775,MALE,23,C71.0,Central nervous system,775
68f550ca-3a33-45e4-b1c9-14f99e543263,BCNU,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,,Progressive Disease,,MALE,23,C71.0,Central nervous system,
68f550ca-3a33-45e4-b1c9-14f99e543263,BCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,775,MALE,23,C71.0,Central nervous system,775
2cfc07f3-a31c-41a2-a9e3-b708d2421a78,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,39,C71.0,Central nervous system,
2cfc07f3-a31c-41a2-a9e3-b708d2421a78,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,1120,FEMALE,39,C71.0,Central nervous system,1120
dadd7428-9e4d-4652-9469-ab521b88d529,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,59,C71.0,Central nervous system,
dadd7428-9e4d-4652-9469-ab521b88d529,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,59,C71.0,Central nervous system,
dadd7428-9e4d-4652-9469-ab521b88d529,Avastin,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,59,C71.0,Central nervous system,
dadd7428-9e4d-4652-9469-ab521b88d529,Avastin,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,59,C71.0,Central nervous system,
8d07b1e8-5d1d-4a43-b616-d29dd58ce5fe,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,30,C71.0,Central nervous system,
8d07b1e8-5d1d-4a43-b616-d29dd58ce5fe,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,30,C71.0,Central nervous system,
8d07b1e8-5d1d-4a43-b616-d29dd58ce5fe,Temodar,Chemotherapy,,,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,30,C71.0,Central nervous system,
e4d9b696-3311-44e7-9191-fde56c080a00,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,23,C71.0,Central nervous system,
e4d9b696-3311-44e7-9191-fde56c080a00,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,23,C71.0,Central nervous system,
e4d9b696-3311-44e7-9191-fde56c080a00,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,23,C71.0,Central nervous system,
e4d9b696-3311-44e7-9191-fde56c080a00,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,23,C71.0,Central nervous system,
5f10cd91-1e03-4016-b35a-8629a1a8fcc9,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,63,C71.0,Central nervous system,
5f10cd91-1e03-4016-b35a-8629a1a8fcc9,Temodar,Chemotherapy,,Dead,,Scheduled Follow-up Submission,Stable Disease,561,MALE,63,C71.0,Central nervous system,561
b342e980-8383-4f1b-bf57-4098c37a536c,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,48,C71.0,Central nervous system,
1f54d21e-752f-496d-8453-4b9b8738cbce,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,31,C71.0,Central nervous system,
1f54d21e-752f-496d-8453-4b9b8738cbce,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,31,C71.0,Central nervous system,
1f54d21e-752f-496d-8453-4b9b8738cbce,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,31,C71.0,Central nervous system,
1159c88c-39d0-4c03-9c66-36af5340a67a,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,23,C71.0,Central nervous system,
1159c88c-39d0-4c03-9c66-36af5340a67a,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,23,C71.0,Central nervous system,
fb3884df-3680-4c5b-8092-981007aeba03,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,37,C71.0,Central nervous system,
fb3884df-3680-4c5b-8092-981007aeba03,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,37,C71.0,Central nervous system,
5469c0e8-0c58-4870-b897-8fa0704599a7,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,33,C71.0,Central nervous system,
5469c0e8-0c58-4870-b897-8fa0704599a7,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,33,C71.0,Central nervous system,
029b33b1-7ea9-4b77-a615-7eb0e3ebd5e7,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,30,C71.0,Central nervous system,
029b33b1-7ea9-4b77-a615-7eb0e3ebd5e7,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,30,C71.0,Central nervous system,
029b33b1-7ea9-4b77-a615-7eb0e3ebd5e7,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,30,C71.0,Central nervous system,
029b33b1-7ea9-4b77-a615-7eb0e3ebd5e7,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,30,C71.0,Central nervous system,
DCE168B1-D2A9-4409-8437-AB382F6D7D31,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,559,MALE,63,C71.1,Central nervous system,559
DCE168B1-D2A9-4409-8437-AB382F6D7D31,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,559,MALE,63,C71.1,Central nervous system,559
DCE168B1-D2A9-4409-8437-AB382F6D7D31,Avastin,,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,559,MALE,63,C71.1,Central nervous system,559
AE4F0714-3B74-46C0-9C1B-F028C7CF2E62,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,52,C71.0,Central nervous system,
AE4F0714-3B74-46C0-9C1B-F028C7CF2E62,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,52,C71.0,Central nervous system,
C6CEB220-282E-4EEF-8D36-4CE0A625CF7E,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Complete Remission/Response,,FEMALE,20,C71.0,Central nervous system,
C6CEB220-282E-4EEF-8D36-4CE0A625CF7E,Temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,20,C71.0,Central nervous system,
98E82E98-341A-4BCA-92C0-23C65C1BF94F,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,53,C71.0,Central nervous system,
5B199E7E-CC23-4065-88AD-FDFE3D0683D6,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,50,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1481,FEMALE,33,C71.0,Central nervous system,1481
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1481,FEMALE,33,C71.0,Central nervous system,1481
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Avastin,Immunotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Avastin,Immunotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Avastin,Immunotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Avastin,Immunotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Avastin,Immunotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Avastin,Immunotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1481,FEMALE,33,C71.0,Central nervous system,1481
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,CCNU,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,CCNU,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,CCNU,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,CCNU,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,CCNU,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,CCNU,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1481,FEMALE,33,C71.0,Central nervous system,1481
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Hydroxyurea,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Hydroxyurea,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Hydroxyurea,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Hydroxyurea,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Hydroxyurea,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Hydroxyurea,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1481,FEMALE,33,C71.0,Central nervous system,1481
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Imatinib,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Imatinib,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Imatinib,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Imatinib,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Imatinib,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Imatinib,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1481,FEMALE,33,C71.0,Central nervous system,1481
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Carboplatin 5 AUC,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Carboplatin 5 AUC,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Carboplatin 5 AUC,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Carboplatin 5 AUC,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Carboplatin 5 AUC,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Carboplatin 5 AUC,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1481,FEMALE,33,C71.0,Central nervous system,1481
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Etoposide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Etoposide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Etoposide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Etoposide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Etoposide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,33,C71.0,Central nervous system,
1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Etoposide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1481,FEMALE,33,C71.0,Central nervous system,1481
872A12B4-8CBD-49D2-AC98-D846587F5794,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,37,C71.0,Central nervous system,
872A12B4-8CBD-49D2-AC98-D846587F5794,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,37,C71.0,Central nervous system,
7E17E6FD-ED83-471F-91E3-5934885C8E87,Temodar,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,61,C71.0,Central nervous system,
5b9d7565-a933-449d-8ffa-ec5f82db2e77,Temozolomide,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,25,C71.0,Central nervous system,
e6c55ba6-4c8a-4ea4-8dde-74d01915db02,temodar,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,30,C71.0,Central nervous system,
b9e2f4d1-866c-4c62-a9c8-8de7eb364a6e,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,351,MALE,30,C71.0,Central nervous system,351
b9e2f4d1-866c-4c62-a9c8-8de7eb364a6e,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Additional New Tumor Event,Progressive Disease,351,MALE,30,C71.0,Central nervous system,351
fee2114e-f723-4374-91f8-f1dcc6b3eaee,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,37,C71.9,Central nervous system,
fee2114e-f723-4374-91f8-f1dcc6b3eaee,Temodar,Chemotherapy,Progressive Disease,Dead,,Scheduled Follow-up Submission,Progressive Disease,1220,MALE,37,C71.9,Central nervous system,1220
41456932-436e-4cdb-bfe8-97d089656786,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,67,C71.9,Central nervous system,
41456932-436e-4cdb-bfe8-97d089656786,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,67,C71.9,Central nervous system,
41456932-436e-4cdb-bfe8-97d089656786,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,67,C71.9,Central nervous system,
27d0d3cb-16c0-4ba8-9662-95917f665004,temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,26,C71.0,Central nervous system,
27d0d3cb-16c0-4ba8-9662-95917f665004,temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,26,C71.0,Central nervous system,
38f4b9f3-6709-40ff-9a81-5fa2111b1ce6,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,62,C71.0,Central nervous system,
a96fabfa-e830-476a-b2a1-899689570bd9,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,44,C71.9,Central nervous system,
a96fabfa-e830-476a-b2a1-899689570bd9,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,44,C71.9,Central nervous system,
a96fabfa-e830-476a-b2a1-899689570bd9,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,44,C71.9,Central nervous system,
a96fabfa-e830-476a-b2a1-899689570bd9,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,44,C71.9,Central nervous system,
325138ab-2947-4131-b40e-971f024723cc,Avastin,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,33,C71.9,Central nervous system,
325138ab-2947-4131-b40e-971f024723cc,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,33,C71.9,Central nervous system,
325138ab-2947-4131-b40e-971f024723cc,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,33,C71.9,Central nervous system,
448d3e3b-622c-4e79-bb1d-b5f2e92970e8,Temodar,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,18,C71.9,Central nervous system,
448d3e3b-622c-4e79-bb1d-b5f2e92970e8,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,18,C71.9,Central nervous system,
183dd089-e932-4be2-b252-0e8572e7da4e,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,14,C71.0,Central nervous system,
e7fdf164-a85d-4ff5-9676-d2215ca35403,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,30,C71.9,Central nervous system,
e7fdf164-a85d-4ff5-9676-d2215ca35403,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,30,C71.9,Central nervous system,
e7fdf164-a85d-4ff5-9676-d2215ca35403,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,30,C71.9,Central nervous system,
019c5de9-74fd-48b7-95a3-227532e16c5a,Temodar,Chemotherapy,Partial Remission/Response,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,50,C71.0,Central nervous system,
ffcec8e5-9fd3-4b42-a7cb-74761f713cf4,temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,30,C71.9,Central nervous system,
ffcec8e5-9fd3-4b42-a7cb-74761f713cf4,temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,30,C71.9,Central nervous system,
ffcec8e5-9fd3-4b42-a7cb-74761f713cf4,temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,30,C71.9,Central nervous system,
bfbc0d1e-2a0b-4c60-8a37-91e3ce4b79ee,temodar,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,34,C71.0,Central nervous system,
bfbc0d1e-2a0b-4c60-8a37-91e3ce4b79ee,Temodar,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,34,C71.0,Central nervous system,
0d61bdbd-24b1-4885-a099-9e42ca7eedcd,Temodar,Chemotherapy,Progressive Disease,Alive,,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,40,C71.9,Central nervous system,
0d61bdbd-24b1-4885-a099-9e42ca7eedcd,Irinotecan,Chemotherapy,Progressive Disease,Alive,,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,40,C71.9,Central nervous system,
0d61bdbd-24b1-4885-a099-9e42ca7eedcd,Temodar,Chemotherapy,Progressive Disease,Alive,,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,40,C71.9,Central nervous system,
0d61bdbd-24b1-4885-a099-9e42ca7eedcd,Avastin,Chemotherapy,Progressive Disease,Alive,,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,40,C71.9,Central nervous system,
00b18ad6-ff70-41fe-8f4d-0763ac8f28b9,temodar,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,53,C71.0,Central nervous system,
00b18ad6-ff70-41fe-8f4d-0763ac8f28b9,temodar,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,53,C71.0,Central nervous system,
3d58ded1-b7cf-420c-ba59-5b424683f0df,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,29,C71.0,Central nervous system,
3d58ded1-b7cf-420c-ba59-5b424683f0df,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,29,C71.0,Central nervous system,
7740824e-905f-47a0-b235-54561ef58ba3,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,59,C71.0,Central nervous system,
7740824e-905f-47a0-b235-54561ef58ba3,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,59,C71.0,Central nervous system,
7740824e-905f-47a0-b235-54561ef58ba3,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,59,C71.0,Central nervous system,
d58b535a-6c95-43bb-ad88-0600e6447537,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,58,C71.0,Central nervous system,
d58b535a-6c95-43bb-ad88-0600e6447537,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,58,C71.0,Central nervous system,
491ea65b-86c8-4686-99cf-f09505e20183,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,51,C71.0,Central nervous system,
491ea65b-86c8-4686-99cf-f09505e20183,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,51,C71.0,Central nervous system,
5017c115-39b8-4c5c-8be6-2cb298d7c641,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,29,C71.0,Central nervous system,
40343ebd-0d62-401e-83a4-6cdb57662ec0,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,39,C71.0,Central nervous system,
40343ebd-0d62-401e-83a4-6cdb57662ec0,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,39,C71.0,Central nervous system,
c2c16878-b615-496c-8fcb-d49c97e15551,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,35,C71.0,Central nervous system,
775c04e6-a02d-44a4-86f7-496056edd249,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,41,C71.0,Central nervous system,
775c04e6-a02d-44a4-86f7-496056edd249,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,41,C71.0,Central nervous system,
775c04e6-a02d-44a4-86f7-496056edd249,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,41,C71.0,Central nervous system,
c916b9a4-008e-4d79-a50c-f15c3549fcf6,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,31,C71.0,Central nervous system,
c916b9a4-008e-4d79-a50c-f15c3549fcf6,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,31,C71.0,Central nervous system,
86aa5790-9afd-4653-926a-625516df1f56,Temodar,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,FEMALE,44,C71.0,Central nervous system,
86aa5790-9afd-4653-926a-625516df1f56,Temodar,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,FEMALE,44,C71.0,Central nervous system,
58de25d5-8a32-4412-866b-acac2e321bfa,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,55,C71.0,Central nervous system,
58de25d5-8a32-4412-866b-acac2e321bfa,temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,55,C71.0,Central nervous system,
e669a4b7-a494-490a-b78c-e664c59d0697,Temodar,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,1933,FEMALE,37,C71.0,Central nervous system,1933
e669a4b7-a494-490a-b78c-e664c59d0697,Avastin,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,1933,FEMALE,37,C71.0,Central nervous system,1933
9e621541-d603-4d2d-b86e-2834d3b9f9a5,temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,49,C71.0,Central nervous system,
9e621541-d603-4d2d-b86e-2834d3b9f9a5,temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,49,C71.0,Central nervous system,
0906ddde-02fa-417d-927b-1c400b189cac,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,36,C71.0,Central nervous system,
0906ddde-02fa-417d-927b-1c400b189cac,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,36,C71.0,Central nervous system,
f625e522-226b-450f-af94-dd2f5adb605e,Temodar,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,47,C71.0,Central nervous system,
f625e522-226b-450f-af94-dd2f5adb605e,Avastin,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,47,C71.0,Central nervous system,
f625e522-226b-450f-af94-dd2f5adb605e,CeeNU,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,47,C71.0,Central nervous system,
274496D6-0A9B-45CA-876F-B91F7277963C,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,51,C71.0,Central nervous system,
274496D6-0A9B-45CA-876F-B91F7277963C,Temodar,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,51,C71.0,Central nervous system,
7E41BABA-7EF6-4030-B595-D95CD96336B5,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,33,C71.0,Central nervous system,
5A2D3BFA-4BDD-417D-9796-E3699760114C,Temodar,Chemotherapy,Partial Remission/Response,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,65,C71.0,Central nervous system,
A4E2E507-7DDF-43DF-B959-FE451971AF1E,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,37,C71.0,Central nervous system,
C13BAC88-C85B-4EE3-A51C-FD503CD7E726,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,51,C71.0,Central nervous system,
C13BAC88-C85B-4EE3-A51C-FD503CD7E726,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,51,C71.0,Central nervous system,
CF2A1B98-5693-4C04-9167-F85E69A88A4A,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,22,C71.0,Central nervous system,
77396AE6-3838-47BF-AAAE-F9A0F401EC7F,Temodar,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,537,MALE,66,C71.0,Central nervous system,537
FDFF46A7-F92A-45CF-8756-6C73A406C923,Temodar,Chemotherapy,,,,Scheduled Follow-up Submission,,,MALE,62,C71.0,Central nervous system,
55a67639-ed05-4143-af96-a377bc5489ee,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,37,C71.0,Central nervous system,
55a67639-ed05-4143-af96-a377bc5489ee,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,37,C71.0,Central nervous system,
55a67639-ed05-4143-af96-a377bc5489ee,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,37,C71.0,Central nervous system,
55a67639-ed05-4143-af96-a377bc5489ee,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,37,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Lomustine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Lomustine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Lomustine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Lomustine,Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Vincristine (sulfate),Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Vincristine (sulfate),Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Vincristine (sulfate),Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Vincristine (sulfate),Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Procarbazine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Procarbazine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Procarbazine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Procarbazine,Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Carboplatin,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Carboplatin,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Carboplatin,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Carboplatin,Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Bevacizumab,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Bevacizumab,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Bevacizumab,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,39,C71.0,Central nervous system,
42251e02-b687-4bf1-a1b6-e3dd978542e4,Bevacizumab,Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,39,C71.0,Central nervous system,
a85fdb41-24c1-420d-8905-ec297f018bd9,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,35,C71.0,Central nervous system,
a85fdb41-24c1-420d-8905-ec297f018bd9,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,35,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,34,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,34,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1209,FEMALE,34,C71.0,Central nervous system,1209
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,34,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,34,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1209,FEMALE,34,C71.0,Central nervous system,1209
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,34,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,34,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1209,FEMALE,34,C71.0,Central nervous system,1209
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Bevacizumab,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,34,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Bevacizumab,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,34,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Bevacizumab,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1209,FEMALE,34,C71.0,Central nervous system,1209
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Lomustine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,34,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Lomustine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,34,C71.0,Central nervous system,
bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Lomustine,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1209,FEMALE,34,C71.0,Central nervous system,1209
e3ed0c19-6acc-4be1-aae2-73fe73cc9f24,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,36,C71.0,Central nervous system,
e3ed0c19-6acc-4be1-aae2-73fe73cc9f24,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,36,C71.0,Central nervous system,
e3ed0c19-6acc-4be1-aae2-73fe73cc9f24,Temozolomide,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,36,C71.0,Central nervous system,
e3ed0c19-6acc-4be1-aae2-73fe73cc9f24,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,36,C71.0,Central nervous system,
e3ed0c19-6acc-4be1-aae2-73fe73cc9f24,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,36,C71.0,Central nervous system,
e3ed0c19-6acc-4be1-aae2-73fe73cc9f24,Temozolomide,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,36,C71.0,Central nervous system,
36cf458b-3c8e-48e7-92ab-aea1c698e417,Temozolomide,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,31,C71.0,Central nervous system,
36cf458b-3c8e-48e7-92ab-aea1c698e417,Temozolomide,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,31,C71.0,Central nervous system,
6105c037-90f1-42d9-ac38-6e2252999a64,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,39,C71.0,Central nervous system,
6105c037-90f1-42d9-ac38-6e2252999a64,Temozolomide,Chemotherapy,Progressive Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,MALE,39,C71.0,Central nervous system,
8996DC64-8C5E-4E07-8ED8-2EB11C03626B,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,68,C71.0,Central nervous system,
8996DC64-8C5E-4E07-8ED8-2EB11C03626B,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,68,C71.0,Central nervous system,
8996DC64-8C5E-4E07-8ED8-2EB11C03626B,Temozolomide,Chemotherapy,Stable Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,962,MALE,68,C71.0,Central nervous system,962
8996DC64-8C5E-4E07-8ED8-2EB11C03626B,Temozolomide,,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,68,C71.0,Central nervous system,
8996DC64-8C5E-4E07-8ED8-2EB11C03626B,Temozolomide,,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,68,C71.0,Central nervous system,
8996DC64-8C5E-4E07-8ED8-2EB11C03626B,Temozolomide,,Stable Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,962,MALE,68,C71.0,Central nervous system,962
8A94FF28-A74D-4FE2-B9C0-06C01F0A3FB6,Temozolomide,Chemotherapy,,Dead,,Scheduled Follow-up Submission,Progressive Disease,388,MALE,64,C71.0,Central nervous system,388
8A94FF28-A74D-4FE2-B9C0-06C01F0A3FB6,Bevacizumab,Chemotherapy,,Dead,,Scheduled Follow-up Submission,Progressive Disease,388,MALE,64,C71.0,Central nervous system,388
0639B753-4099-4CA4-ADB9-763069A614EF,Temozolomide,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Stable Disease,,FEMALE,42,C71.0,Central nervous system,
0639B753-4099-4CA4-ADB9-763069A614EF,Temozolomide,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,FEMALE,42,C71.0,Central nervous system,
0639B753-4099-4CA4-ADB9-763069A614EF,Temozolomide,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Stable Disease,,FEMALE,42,C71.0,Central nervous system,
0639B753-4099-4CA4-ADB9-763069A614EF,Temozolomide,Chemotherapy,Stable Disease,Alive,,Scheduled Follow-up Submission,Stable Disease,,FEMALE,42,C71.0,Central nervous system,
a5f851c5-6130-4ea1-9f86-be59331a92f7,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,578,MALE,43,C71.0,Central nervous system,578
a5f851c5-6130-4ea1-9f86-be59331a92f7,Irinotecan,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,578,MALE,43,C71.0,Central nervous system,578
a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,62,C71.0,Central nervous system,
a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,62,C71.0,Central nervous system,
a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,62,C71.0,Central nervous system,
a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,62,C71.0,Central nervous system,
442DF188-B678-45BB-BD9D-7071ED8AAA5A,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,26,C71.0,Central nervous system,
77472095-030D-4679-921D-8E8E217956C5,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Progressive Disease,,FEMALE,45,C71.0,Central nervous system,
1F13065A-40F7-455D-B8EB-F9A128722EAC,Temozolomide,,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,41,C71.0,Central nervous system,
7EB5D055-E1C8-4B93-9205-A49A6E79DFD4,Lomustine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,33,C71.9,Central nervous system,
7EB5D055-E1C8-4B93-9205-A49A6E79DFD4,Vincristine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,33,C71.9,Central nervous system,
7EB5D055-E1C8-4B93-9205-A49A6E79DFD4,Procarbazine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,33,C71.9,Central nervous system,
C85FA637-941A-4A9A-8029-F5B44F3DA430,Mustophoran,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,36,C71.0,Central nervous system,
C85FA637-941A-4A9A-8029-F5B44F3DA430,Avastin,,,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,36,C71.0,Central nervous system,
C85FA637-941A-4A9A-8029-F5B44F3DA430,Themozolomide,,,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,36,C71.0,Central nervous system,
0557B788-5AED-4919-85EB-A503AD893D75,Lomustine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,35,C71.0,Central nervous system,
0557B788-5AED-4919-85EB-A503AD893D75,Vincristine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,35,C71.0,Central nervous system,
0557B788-5AED-4919-85EB-A503AD893D75,Procarbazine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,35,C71.0,Central nervous system,
141F0546-F6F2-408F-AC86-07CA4AADF3D0,Temozolomide,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,FEMALE,64,C71.0,Central nervous system,
D81B9957-8C82-4006-B111-449FA9FB95ED,Temozolomide,,,Alive,,Scheduled Follow-up Submission,,,FEMALE,52,C71.0,Central nervous system,
505E9812-D13E-42D3-AEE2-55A85D6F4551,TEMOZOLOMIDE,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,38,C71.9,Central nervous system,
AD72E61E-51E3-4992-AC77-65E895935736,PROCARBAZINE,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,43,C71.0,Central nervous system,
AD72E61E-51E3-4992-AC77-65E895935736,LOMUSTINE,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,43,C71.0,Central nervous system,
AD72E61E-51E3-4992-AC77-65E895935736,VINCRISTINE,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,43,C71.0,Central nervous system,
451BAD4F-6D72-4526-9978-38E090FC479F,temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,28,C71.0,Central nervous system,
451BAD4F-6D72-4526-9978-38E090FC479F,lomustine,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,28,C71.0,Central nervous system,
451BAD4F-6D72-4526-9978-38E090FC479F,vincristine,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,28,C71.0,Central nervous system,
451BAD4F-6D72-4526-9978-38E090FC479F,Procarbazine,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,28,C71.0,Central nervous system,
C2F9DFF7-751B-4704-8E6E-F4F800297030,VINCRISTINE,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,54,C71.0,Central nervous system,
C2F9DFF7-751B-4704-8E6E-F4F800297030,LOMUSTINE,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,54,C71.0,Central nervous system,
C2F9DFF7-751B-4704-8E6E-F4F800297030,procarbazine,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,54,C71.0,Central nervous system,
6D17C327-435A-4CBA-9626-3B5B7B7375BB,TEMOZOLOMIDE,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,41,C71.0,Central nervous system,
6D17C327-435A-4CBA-9626-3B5B7B7375BB,fotemustine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,41,C71.0,Central nervous system,
76CB16F9-37BE-450E-B60A-5F0D0F1EC2BC,Temozolomide,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,FEMALE,52,C71.0,Central nervous system,
E1758D75-B2A0-4386-BD72-6B2421D4DA6B,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,38,C71.0,Central nervous system,
976D067B-9D7F-4920-A04D-E831EDC6C2C2,temozolomide,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,47,C71.0,Central nervous system,
D209CFFC-FE21-4AE7-B610-E5668EA84A3B,temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,FEMALE,56,C71.0,Central nervous system,
62088274-A45B-4616-B086-B0DDD64895F0,temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,48,C71.0,Central nervous system,
62088274-A45B-4616-B086-B0DDD64895F0,lomustine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,48,C71.0,Central nervous system,
62088274-A45B-4616-B086-B0DDD64895F0,Procarbazine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,48,C71.0,Central nervous system,
62088274-A45B-4616-B086-B0DDD64895F0,Vincristine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,48,C71.0,Central nervous system,
345D975C-E666-4614-81EB-5CCBB5BD2CF7,temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,38,C71.0,Central nervous system,
41E4DC71-7767-44C2-9D38-110DCD37B451,Carmustine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1891,FEMALE,48,C71.0,Central nervous system,1891
41E4DC71-7767-44C2-9D38-110DCD37B451,Temozolamide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1891,FEMALE,48,C71.0,Central nervous system,1891
41E4DC71-7767-44C2-9D38-110DCD37B451,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,1891,FEMALE,48,C71.0,Central nervous system,1891
048056CD-39DD-4134-A58B-70BEBB3DD2FF,Temozolamide,Chemotherapy,,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,50,C71.0,Central nervous system,
C45E02E5-7E3C-4F36-8B8D-F54617E8A436,Temozolomide,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Additional New Tumor Event,Partial Remission/Response,,MALE,40,C71.0,Central nervous system,
C45E02E5-7E3C-4F36-8B8D-F54617E8A436,Temozolomide,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,40,C71.0,Central nervous system,
432FE4A9-2CDC-4323-AFF0-59E2FDEDA194,Temozolomide,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,46,C71.0,Central nervous system,
432FE4A9-2CDC-4323-AFF0-59E2FDEDA194,Temozolomide,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,46,C71.0,Central nervous system,
DCBBACA6-A24B-4BED-95DE-314CFF71E436,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,50,C71.0,Central nervous system,
DCBBACA6-A24B-4BED-95DE-314CFF71E436,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,50,C71.0,Central nervous system,
A343FBE3-147A-4656-9E90-5408298CA12C,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,MALE,46,C71.0,Central nervous system,
A343FBE3-147A-4656-9E90-5408298CA12C,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,742,MALE,46,C71.0,Central nervous system,742
A343FBE3-147A-4656-9E90-5408298CA12C,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,MALE,46,C71.0,Central nervous system,
A343FBE3-147A-4656-9E90-5408298CA12C,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,742,MALE,46,C71.0,Central nervous system,742
A343FBE3-147A-4656-9E90-5408298CA12C,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,MALE,46,C71.0,Central nervous system,
A343FBE3-147A-4656-9E90-5408298CA12C,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,742,MALE,46,C71.0,Central nervous system,742
A343FBE3-147A-4656-9E90-5408298CA12C,Carmustine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,MALE,46,C71.0,Central nervous system,
A343FBE3-147A-4656-9E90-5408298CA12C,Carmustine,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,742,MALE,46,C71.0,Central nervous system,742
A343FBE3-147A-4656-9E90-5408298CA12C,Teniposide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,MALE,46,C71.0,Central nervous system,
A343FBE3-147A-4656-9E90-5408298CA12C,Teniposide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,742,MALE,46,C71.0,Central nervous system,742
A5E10E2E-5157-487B-88DC-6C70AD5E244A,Temozolomide,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,22,C71.0,Central nervous system,
A5E10E2E-5157-487B-88DC-6C70AD5E244A,Temozolomide,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,FEMALE,22,C71.0,Central nervous system,
B10A9314-FD40-459E-97EA-AFFC636DCEEA,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,2988,MALE,24,C71.0,Central nervous system,2988
B10A9314-FD40-459E-97EA-AFFC636DCEEA,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,2988,MALE,24,C71.0,Central nervous system,2988
B10A9314-FD40-459E-97EA-AFFC636DCEEA,Carmustin,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,2988,MALE,24,C71.0,Central nervous system,2988
B10A9314-FD40-459E-97EA-AFFC636DCEEA,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,2988,MALE,24,C71.0,Central nervous system,2988
3E4851CA-4D69-4035-A2DD-8ED6E70F1FFB,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,58,C71.0,Central nervous system,
3E4851CA-4D69-4035-A2DD-8ED6E70F1FFB,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,58,C71.0,Central nervous system,
6D2C49C3-0721-4BD2-B39F-7872F2DE996D,Temozolamide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,34,C71.0,Central nervous system,
6D2C49C3-0721-4BD2-B39F-7872F2DE996D,Temozolamide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,34,C71.0,Central nervous system,
6D2C49C3-0721-4BD2-B39F-7872F2DE996D,Temozolamide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,34,C71.0,Central nervous system,
6D2C49C3-0721-4BD2-B39F-7872F2DE996D,Temozolamide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,34,C71.0,Central nervous system,
A1192DF3-7667-4D1E-A1A0-79F6CC827DCF,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,31,C71.0,Central nervous system,
A1192DF3-7667-4D1E-A1A0-79F6CC827DCF,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,31,C71.0,Central nervous system,
F79420CA-B0AE-417C-95F7-D28C35760202,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,FEMALE,59,C71.0,Central nervous system,
F79420CA-B0AE-417C-95F7-D28C35760202,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,FEMALE,59,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Bevacizumab,Targeted Molecular therapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Lomustin,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Lomustin,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Lomustin,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Pembrolizumab,Targeted Molecular therapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Pembrolizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
A418FE65-DFDD-4C84-B27C-B4567B50F457,Pembrolizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,FEMALE,38,C71.0,Central nervous system,
081B6532-0ED4-445A-BECB-CB2290F4854D,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,42,C71.0,Central nervous system,
081B6532-0ED4-445A-BECB-CB2290F4854D,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,42,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,819,MALE,57,C71.0,Central nervous system,819
A80B0FAB-6189-497F-997F-77234B69179C,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Temozolomide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,819,MALE,57,C71.0,Central nervous system,819
A80B0FAB-6189-497F-997F-77234B69179C,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Bevacizumab,Targeted Molecular therapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,819,MALE,57,C71.0,Central nervous system,819
A80B0FAB-6189-497F-997F-77234B69179C,Lomustine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Lomustine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Lomustine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,57,C71.0,Central nervous system,
A80B0FAB-6189-497F-997F-77234B69179C,Lomustine,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,819,MALE,57,C71.0,Central nervous system,819
94B95C07-5F70-4A1B-B40F-DC13F6A160D5,Lomustine,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,39,C71.0,Central nervous system,
94B95C07-5F70-4A1B-B40F-DC13F6A160D5,Procarbazine,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,39,C71.0,Central nervous system,
94B95C07-5F70-4A1B-B40F-DC13F6A160D5,Vincristine,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,39,C71.0,Central nervous system,
01A13ABA-74A4-4895-A5AD-E5119925C202,Carmustine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,48,C71.0,Central nervous system,
01A13ABA-74A4-4895-A5AD-E5119925C202,Carmustine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,FEMALE,48,C71.0,Central nervous system,
01A13ABA-74A4-4895-A5AD-E5119925C202,Teniposide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,48,C71.0,Central nervous system,
01A13ABA-74A4-4895-A5AD-E5119925C202,Teniposide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,FEMALE,48,C71.0,Central nervous system,
6A8241A8-D9EE-414B-89FD-4C3B9F181CC7,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,FEMALE,30,C71.0,Central nervous system,
6A8241A8-D9EE-414B-89FD-4C3B9F181CC7,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,FEMALE,30,C71.0,Central nervous system,
6A8241A8-D9EE-414B-89FD-4C3B9F181CC7,Carmustine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,FEMALE,30,C71.0,Central nervous system,
6A8241A8-D9EE-414B-89FD-4C3B9F181CC7,Bevacizumab,Targeted Molecular therapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,FEMALE,30,C71.0,Central nervous system,
6A8241A8-D9EE-414B-89FD-4C3B9F181CC7,Irinotecan,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Partial Remission/Response,,FEMALE,30,C71.0,Central nervous system,
194E8231-E8D4-477F-8C62-E11F2484ECCE,Lomustine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,25,C71.0,Central nervous system,
194E8231-E8D4-477F-8C62-E11F2484ECCE,Lomustine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,25,C71.0,Central nervous system,
194E8231-E8D4-477F-8C62-E11F2484ECCE,Lomustine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,25,C71.0,Central nervous system,
194E8231-E8D4-477F-8C62-E11F2484ECCE,Procarbazine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,25,C71.0,Central nervous system,
194E8231-E8D4-477F-8C62-E11F2484ECCE,Procarbazine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,25,C71.0,Central nervous system,
194E8231-E8D4-477F-8C62-E11F2484ECCE,Procarbazine,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,25,C71.0,Central nervous system,
194E8231-E8D4-477F-8C62-E11F2484ECCE,VINCRISTINE,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,25,C71.0,Central nervous system,
194E8231-E8D4-477F-8C62-E11F2484ECCE,VINCRISTINE,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,25,C71.0,Central nervous system,
194E8231-E8D4-477F-8C62-E11F2484ECCE,VINCRISTINE,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,25,C71.0,Central nervous system,
032096A6-1923-44B9-A1CB-181BED041C8E,Lomustine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,52,C71.0,Central nervous system,
032096A6-1923-44B9-A1CB-181BED041C8E,Lomustine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,52,C71.0,Central nervous system,
032096A6-1923-44B9-A1CB-181BED041C8E,Procarbazine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,52,C71.0,Central nervous system,
032096A6-1923-44B9-A1CB-181BED041C8E,Procarbazine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,52,C71.0,Central nervous system,
032096A6-1923-44B9-A1CB-181BED041C8E,Vincristine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,52,C71.0,Central nervous system,
032096A6-1923-44B9-A1CB-181BED041C8E,Vincristine,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,52,C71.0,Central nervous system,
765588AA-075F-477F-9C18-099D018D3A1B,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Additional New Tumor Event,Complete Remission/Response,,FEMALE,54,C71.0,Central nervous system,
427F4D23-2B76-4A2A-A498-0C3473F57169,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,36,C71.0,Central nervous system,
427F4D23-2B76-4A2A-A498-0C3473F57169,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,36,C71.0,Central nervous system,
94A2FF09-F7AC-4AEA-A2B2-0DC1B82AE635,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,FEMALE,35,C71.0,Central nervous system,
78A212BC-A740-46BF-A10D-0B9809A5BB3F,Temozolamide,Chemotherapy,,Dead,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,5166,MALE,35,C71.0,Central nervous system,5166
58650D08-7685-41DE-9AE0-21665F8F449F,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,46,C71.0,Central nervous system,
A6975EB0-CFA6-4B7A-BBE4-72BBDD3D3B6F,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,27,C71.0,Central nervous system,
A6975EB0-CFA6-4B7A-BBE4-72BBDD3D3B6F,Temozolamide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,27,C71.0,Central nervous system,
A6975EB0-CFA6-4B7A-BBE4-72BBDD3D3B6F,Carmustine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,27,C71.0,Central nervous system,
C4F522C9-BFF5-4899-8D27-C105DAB795A9,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,70,C71.0,Central nervous system,
C4F522C9-BFF5-4899-8D27-C105DAB795A9,Temozolomide,Chemotherapy,,Alive,WITH TUMOR,Additional New Tumor Event,Progressive Disease,,MALE,70,C71.0,Central nervous system,
CC8614C4-D535-4AD9-82F0-F4DC7AD11D0F,Temozolomide,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,40,C71.0,Central nervous system,
CC8614C4-D535-4AD9-82F0-F4DC7AD11D0F,Temozolomide,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,40,C71.0,Central nervous system,
CC8614C4-D535-4AD9-82F0-F4DC7AD11D0F,Temozolomide,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,40,C71.0,Central nervous system,
CC8614C4-D535-4AD9-82F0-F4DC7AD11D0F,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Partial Remission/Response,,MALE,40,C71.0,Central nervous system,
D13AC936-87A9-4164-BDAB-02CCF3908CFE,Temozolomide,Chemotherapy,Partial Remission/Response,Alive,WITH TUMOR,Additional New Tumor Event,Complete Remission/Response,,FEMALE,43,C71.0,Central nervous system,
D13AC936-87A9-4164-BDAB-02CCF3908CFE,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,1666,FEMALE,43,C71.0,Central nervous system,1666
EE6BF12F-8A73-49E2-B566-368B2B42165B,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,758,MALE,40,C71.0,Central nervous system,758
8643437F-CD1B-47C8-86BD-87B6C2F80747,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,492,MALE,32,C71.0,Central nervous system,492
B3720405-CE3F-49C7-A5D9-BBFFD06F6AEF,Temozolomide,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,63,C71.0,Central nervous system,
B3720405-CE3F-49C7-A5D9-BBFFD06F6AEF,Procarbazine,Chemotherapy,Progressive Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Progressive Disease,,MALE,63,C71.0,Central nervous system,
9B161C41-4F76-4ED1-B60F-2B093BC70EDB,Temozolomide,Chemotherapy,Progressive Disease,Dead,WITH TUMOR,Scheduled Follow-up Submission,Complete Remission/Response,1242,MALE,31,C71.0,Central nervous system,1242
61FF31A4-4FDC-476C-B456-2A2FED4BAE6B,Procarbazine,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,40,C71.0,Central nervous system,
61FF31A4-4FDC-476C-B456-2A2FED4BAE6B,LOMUSTINE (CCNU),Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,40,C71.0,Central nervous system,
61FF31A4-4FDC-476C-B456-2A2FED4BAE6B,VINCRISTINE,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Complete Remission/Response,,MALE,40,C71.0,Central nervous system,
A66A3847-7570-4486-8845-86B6125104A2,Temozolomide,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,FEMALE,50,C71.0,Central nervous system,
A66A3847-7570-4486-8845-86B6125104A2,Temozolomide,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,FEMALE,50,C71.0,Central nervous system,
CDD1FD4C-3427-496C-8391-4AEB6730D3CC,temodar,Chemotherapy,,Alive,WITH TUMOR,Scheduled Follow-up Submission,,,MALE,54,C71.0,Central nervous system,
66C52A31-6503-40B5-A55E-FA476EAF0567,temodar,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,25,C71.0,Central nervous system,
66C52A31-6503-40B5-A55E-FA476EAF0567,temodar,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,25,C71.0,Central nervous system,
66C52A31-6503-40B5-A55E-FA476EAF0567,Vincristine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,25,C71.0,Central nervous system,
66C52A31-6503-40B5-A55E-FA476EAF0567,Vincristine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,25,C71.0,Central nervous system,
66C52A31-6503-40B5-A55E-FA476EAF0567,Procarbazine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,25,C71.0,Central nervous system,
66C52A31-6503-40B5-A55E-FA476EAF0567,Procarbazine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,25,C71.0,Central nervous system,
66C52A31-6503-40B5-A55E-FA476EAF0567,Lomustine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,25,C71.0,Central nervous system,
66C52A31-6503-40B5-A55E-FA476EAF0567,Lomustine,Chemotherapy,,Alive,,Scheduled Follow-up Submission,,,MALE,25,C71.0,Central nervous system,
0073A136-D5F4-4FD6-88F9-711768F2ABC6,Temodar,Chemotherapy,Stable Disease,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,44,C71.0,Central nervous system,
10887E42-444D-49FC-AEE5-DD0E9FC4EA54,Temodar,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,Stable Disease,,MALE,44,C71.0,Central nervous system,
284680B2-F961-402D-8740-E5F9E4FB4A98,Temozolomide,Chemotherapy,Complete Remission/Response,Alive,TUMOR FREE,Scheduled Follow-up Submission,,,FEMALE,36,C71.0,Central nervous system,
42156C6A-416E-4832-9C95-CEE6084B0910,Temodar,Chemotherapy,Stable Disease,Alive,WITH TUMOR,Scheduled Follow-up Submission,Stable Disease,,MALE,65,C71.0,Central nervous system,
